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ABSTRACT
The e ffe c t o f varying the concentration of wheat bran in the d iet on the 
plasma and live r lip id  levels, and bile acid metabolism of the ra t was studied. 
Groups o f male and female rats were maintained on a starch contro l, high bran, 
low bran, high fa t and stock d ie t fo r periods o f up to seventy-two weeks. The 
results o f th is study indicate tha t wheat bran supplementation had no overall 
e ffe c t on lip id  or bile acid metabolism in these animals.
Feeding a chem ically standardised coarse wheat bran a t a dose o f 0.3 g/kg 
body weight per day over a period o f six weeks to young healthy volunteers did 
not s ign ifican tly  a lte r plasma cholesterol and trig lyce ride  concentrations in 
these subjects. However, plasma high-density lipoprote in  cholesterol 
concentrations were s ign ifican tly  increased, while low-density lipopro te in  
cholesterol levels decreased during the six weeks o f bran consumption. Plasma 
glucose concentrations were unaffected by the wheat bran supplementation, 
however, the concentration o f glycosylated haemoglobin decreased in a ll subjects 
throughout the study; indicating tha t wheat bran m ight be e ffe c tiv e  in a lte ring  
the ra te  o f glucose absorption.
Under in v itro  conditions, wheat bran bound the carcinogens safro le and 
benzo(a)pyrene at the pH of the colon; indicating tha t bran may decrease the 
ava ila b ility  o f these carcinogens fo r contact w ith  the colon mucosa, and thus 
absorption at colonic pH. Binding occurred at acid ic, neutra l and basic pH 
values, although the percentage o f carcinogen bound decreased as the pH became 
more basic. However, the in vivo studies are equivocal, and do not fu lly  support 
the in v itro  observations, and may be due to the m etabolic a lte ra tio n  o f the 
wheat bran by the in testina l m icro flo ra .
Wheat bran supplementation had no e ffe c t on the plasma m ineral 
concentration in the ra t, although a complete m ineral balance study was not
-  i i  -
perform ed. Both dephytinised and whole wheat bran bound inorganic iron in 
v it ro , the amount bound depended on pH, the quantity o f fib re , and the presence 
or absence of inh ib itors o f binding. Binding was m inimal below pH 2 but rose 
rapid ly above pH 3, to a maximum near pH 7.
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CHAPTER 1
INTRODUCTION
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1.1 H is to rica l Review
That fru its  and vegetables help bowel a c tiv ity  has long been accepted, but 
the contribu tion o f cereal fib re  in the form  of wholemeal bread has had a 
chequered history (McCance and Widdowson, 1956). Hippocrates in the f i f th  
century B.C. was w e ll aware tha t wholemeal bread a ffected  bowel a c t iv ity  and 
wrote, "Wholemeal bread cleans out the gut and passes through as excrem ent. 
White bread is more nu tritious as i t  makes less faeces". There were at least four 
grades o f flou r in Greek and Roman days, but white bread, w ith  its  higher cost 
and greater aesthetic appeal, had social esteem, which i t  continued to have u n til 
the nineteenth century. This and the easier baking qualities o f white  flou r 
together w ith  the competing claim s fo r bran fo r animal feeding, have a ll been 
p rac tica l reasons which have tended to make white bread the popular choice w ith  
both baker and public. Nevertheless, there has always been a m ino rity  feeling 
tha t wholesomeness needs whole foods, and tha t food must be consumed in as 
near possible to its  natural state.
Early in this century a tten tion  began to centre on bran. In the United 
States, Kellogg (1923) lectured and w rote  on the contribu tion to health o f whole 
cereal foods and advocated the use o f bran. While in England, Hurst (1909) 
emphasised the value o f wholemeal bread in trea ting  constipation and noted the 
high cellulose content o f bran. Stim ulated by Kellogg's early work, several 
American workers made studies on cooked bran in the early 1930's. C ow gill and 
Anderson (1932) observed in subjects on bran the stools doubled in weight, and 
defecation was easier w ith  a more complete sense o f evacuation. Hoppert and 
C lark (1945) carried out a pre lim inary study to compare the laxa tive  e ffe c ts  o f 
bran and certa in  fru its  and vegetables. Bran and cabbage had the most 
consistent and favourable e ffects .
-  3 -
Cleave (1956) published a paper which greatly widened the scope o f the 
debate, pu tting  the blame fo r many o f the diseases o f c iv ilisa tion  on the 
consumption o f refined or fibre-depleted carbohydrate foods, sugar as well as 
wh ite  flou r. The hypothesis was taken up by a number o f workers (Cleave, 1974; 
B u rk itt and Trowell, 1975a). They postulated tha t the low prevalence in 
developing countries o f diabetes, gall stones, large bowel cancer, appendicitis, 
h ia ta l hernia, varicose veins and haemorrhoids, a ll commonly seen in Western 
countries, may be due to differences, pa rticu la rly  to the greater amount o f fib re  
consumed in energy foods in developing countries. Painter et al. (1972) showed 
tha t increased d ie tary fib re  intake, pa rticu la rly  as bran, greatly helped patients 
w ith  d iverticu losis, a condition which had fo r long been treated w ith  low-residue 
diets.
1.2 D e fin ition  of D ie tary Fibre
D ietary fib re  has been defined as tha t part o f plant m ate ria l taken in our 
d ie t which is resistent to digestion by the secretions o f the human 
gastro in testina l tra c t (Trowell, 1972). It comprises a heterogeneous group o f 
carbohydrate compounds including cellulose and the hemicelluloses and a non- 
carbohydrate substance lignin. These substances form  the s tructu re  o f plants, 
being present in the ce ll walls o f a ll parts including the leaf, stem, roo t and seed.
The term  'd ie tary fib re ' is not synonymous w ith  'crude fib re ', which is an 
in te rna tiona lly  accepted te rm  used to define the fib re  content o f foodstu ffs  
(MAFF 1960). Crude fib re , as defined by the Association o f O ff ic ia l A n a ly tica l 
Chemists is the residue o f a feeding m ateria l a fte r trea tm ent w ith  boiling 
sulphuric acid, sodium hydroxide, water, alcohol and ether. However, this 
procedure results in the loss o f pectins, gums and mucilages and only represents 
a frac tion  o f the cellulose, hem icellulose and lignin o f plant m ate ria l.
Trowell's de fin ition  o f d ie ta ry fib re  is a physiological one based upon the 
metabolism of d ietary components in the gastro in testinal tra c t. Cummings
(1981) has c ritic ised  this de fin ition  on the grounds tha t no other d ie ta ry 
component is defined in term s o f its  possible physiological a ffe c ts  in man. 
Cummings (1981) states an a lte rna tive  de fin ition  fo r d ietary fib re  as being a non- 
starch polysaccharide which can be subdivided into cellulose and non-cellulose 
polysaccharide, which include hemicellulose, pectin, storage polysaccharides 
(e.g. gums, inulin) and mucilages. Although such a lterna tive  defin itions need to 
be recognised, the de fin ition  by Trowell (1972) is s t il l tha t most w idely used and 
accepted today.
1.3 Chemistry o f D ie tary Fibre
D ie tary  fib re  is a m ixture  o f high molecular weight polymers, 
polysaccharides and lignins being the two major classes (Figure 1:1).
1.3.1 Polysaccharides
This group may be fu rthe r divided in to cellulose, and the noncellulose 
polysaccharides. The la tte r  are a large and diffuse group o f substances including 
hemicelluloses, the pectic  substances and several somewhat less w e ll defined 
subgroups such as gums, mucilages and algal polysaccharides (Southgate 1976).
Cellulose: This compound is a linear unsubstituted polymer o f 1-4 $-linked 
glucose residues w ith  a c rys ta lline  structure  and is insoluble in strong a lka li. The 
beta configuration provides resistance to the action o f pancreatic amylase, but 
th is linkage is susceptible to cellulases produced by colon bacteria  (Yost, 1972).
Noncellulose polysaccharides: In contrast to cellulose, th is group consists 
o f a large number o f d iffe re n t polymers, frequently branched and containing a 
m ixture  o f pentose and hexose sugars and uronic acids.
(i) Hem icellu lose: This is a ce ll w a ll polysaccharide insoluble in cold d ilu te  
a lka li. Hemicellulose molecules are sm aller in size (usually 150-200 sugar 
residues) than cellulose (often 3000 or more residues) and consist o f a main chain
Fibre P rinc ipa l S tructu ra l Types Main S tructura l Variation
Polysaccharides
Cellulose
Hemicellulose
Pectin
Gums
Mucilages
Algal
polysaccharides
Lignin
1-43-D-G lycan
Heteroglycan containing xylose, 
mannose, galactose and 
glucose
Polymer o f 1-4 3-D  galacturonic 
acid
Variety o f uronic acid polymers 
including 3-glucans, arabino- 
xylans and gluco- and 
galactomannans
Neutra l polysaccharides 
e.g. galactose - mannose, 
glucose - mannose, 
arabinose - xylose, 
galacturonic acid - rhamnose
Sulphated galactans, 
guluronic - mannuronic acid 
polymers
A rom atic  phenylpropane 
polymer (non-polysaccharide)
Degree o f polym erisation
Branching and side chains 
containing arabinose, 
galactose and glucuronic 
acid
Degree o f m ethylation, side 
chains containing rhamnose, 
arabinose, xylose and 
fructose
Side chains containing 
xylose, fructose, galactose. 
Degree o f branching and 
polym erisation.
Side chain-galactose
Degree o f sulphation, 
d is tribu tion  o f uronic 
acids, side chains - 
galactose
Type o f polymer, and 
functiona l groups
Figure 1:1 S tructure and chem ical c lassifica tion  o f d ie try  fib re
(M odified from  Southgate, 1978a; Kay and Strasberg, 1978)
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o f xylose or other sugars w ith  various substitutions and degrees o f branching. 
Between two and four types o f sugars are usually present in each va rie ty  (Siegal, 
1968) (Figure 1:1). The hemicelluloses can be fu rthe r classified in to acid ic or 
neutra l forms based on the content o f uronic acids (glucuronic and galacturonic 
acid) (Aspinall, 1970). As a result o f uronic acid form ation (oxidation o f the 
term ina l -C h^O H  to -COOH) the sugar residues are available fo r m ethylation, 
am idation and the form ation o f m etal complexes. (Kertesz, 1963). 
Hemicellulose especially the hexose and uronic acid fractions o f the molecule, 
are apparently more com plete ly digested in the colon than is cellulose 
(Southgate, 1976).
( ii)  Pectins: Pectic  substances are common to a ll plant ce ll walls, and act as 
in te rce llu la r cementing m ateria ls. This group includes the water-insoluble 
parent compound protopectin , as w ell as pectin ic  acids, pectic acids and pectin . 
The la tte r  is a water-soluble polymer o f p a rtia lly  m ethoxylated 1-43D 
galacturonic acid, and contains 10-25% neutra l sugar residues such as rhamnose 
or arabinose present as single units or polym eric side chains. Pectin is almost 
com plete ly digested in the colon w ith  only 5% o f ingested pectin being recovered 
from  stools (Anderson and Chen, 1979).
( iii)  Mucilages: Although s truc tu ra lly  s im ila r to hemicelluloses, mucilages are
classed separately since they do not occur in the ce ll wall, but are found in the 
endosperm o f seeds where they act to re ta in  water and prevent excess 
dehydration. Most contain a m ixture  o f neutra l sugars and are usually branched. 
Guar is a mucilage w idely used in the food industry.
(iv) Gums: Gums are a chem ically complex group o f highly branched polymers o f 
glucuronic and galacturonic acids w ith  neutra l sugars such as arabinose, xylose 
and mannose. Gums are produced by specialised secretory cells and released to  
form  p ro tec tive  capsules at the site o f in jury to plants. These m ateria ls, such as 
gum arabic and gum tragacanth are used as em ulsifiers or thickeners in foods.
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(v) A lgal polysaccharides: These include a range o f m ateria ls usually derived 
from  the ce ll walls o f marine algae, and are d is tinctive  in tha t cellulose is o ften 
replaced by xylans and mannans. A lgal polysaccharides occur in the d ie t m ainly 
in the form  o f food additives such as alginates, agar and carrageenan. 
Chem ically, they consist o f linear or branched molecules containing mannose, 
xylose, guluronic acid, glucose and galactose.
1.3.2 Lignin
This is not a carbohydrate but a complex cross-linked polymer based on 
oxygenated phenylpropane units. Three broad classes may be distinguished based 
upon the predominance o f sinapyl, con ife ry l and coumaryl alcohols. These are 
generally derived from  softwood, hardwood and grass respective ly. L ignin is a 
highly branched random polymer containing approxim ately 40 phenylpropane 
units combined in a varie ty  o f linkages including carbon to carbon bonds. 
Chemically i t  is very ine rt and demonstrates greater resistance to enzym ic 
digestion than any other na tura lly  occurring polymer.
1.3.3 Other ce ll wa ll m ateria ls
The cell wall also contains a number o f plant derived m ateria ls th a t are 
s im ilar to fib re  in tha t they resist digestion in the upper in testine. Included in 
this category are cu tin  and suberin, polym eric esters o f fa tty  acids, the fo rm er is 
a water-im perm eable substance secreted onto the plant surface, whereas suberin 
is deposited in the la te r stages o f ce ll wall development. These are enzyme and 
acid resistant m ateria ls recoverable in the lign in frac tio n  (Southgate, 1976).
Certa in  fib re -rich  foodstuffs contain s ign ifican t amounts o f p lant sterols. 
Also in close physical and chem ical association w ith  fib re  in the ce ll w a ll are 
proteins, inositol hexaphosphate, silica , the glycoside saponin and 
polyhydroxyphenolic m ateria ls such as tannins.
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1.4 Actions and Fate o f F ibre in the G astro intestinal Tract
The physiological consequences o f fib re  ingestion are in part predictable on 
the basis o f certa in  physicochemical properties (Eastwood and Kay 1979). O f 
pa rticu la r in terest is its  suscep tib ility  to ferm entation by colon bacte ria l 
enzymes, the a b ility  to re ta in  water, adsorptive and ion exchange capacities and 
its  antioxidant role.
1.4.1 Susceptib ility to bacteria l enzyme degradation
Although resistant to the action o f human alim entary tra c t enzymes, fib re  
is susceptible to digestion by bacte ria l enzymes. Digestion occurs almost 
exclusively in the colon, 29-82% of ingested cellulose, 56-87% o f hem icellulose 
and 90% o f pectin  are lost during passage through the gut. Lignin however, is 
v ir tu a lly  com plete ly recovered in the stool.
The nature o f the colon bacteria l flo ra , the tran s it tim e through the colon 
and the physical and chem ical composition o f the fib re  determines the exten t o f 
fib re  breakdown. (Kay and Strasberg, 1978). O f the 400 species o f colon 
bacteria tha t have been id en tified  most are saccharo lytic. Cellulose, 
hemicellulose and pectin  appear to be ferm ented by d iffe re n t bacte ria l species 
and bacteria l flo ra  seem to vary in d iffe re n t cultures on d iffe re n t diets (Bryant 
1974, Finegold e t al., 1974). The la tte r  observation indicates tha t the in tes tina l 
m icrobia l flo ra  m ight be dependent on the fib re  composition o f the d ie t, although 
no conclusive evidence has been presented (McLean-Baird e t al., 1977; Goldberg 
e t al., 1977). F ibre may not only a lte r the character o f the flo ra , but by 
changing the pH and redox conditions o f the colon, lead to a lte ra tions in 
bacteria l metabolism. However, there are two major problems in studies 
a ttem pting to determ ine the relationship between fib re  and bacte ria l f lo ra  in 
vivo namely, i t  is d if f ic u lt  to manipulate fib re  intakes w ithou t a lte ring  o ther
dietary components, and there are methodological problems in accurate ly 
quantify ing colon bacteria  (McLean-Baird e t al., 1977). The e ffe c t o f fib re  on 
colon trans it tim e w ill also influence the extent to which i t  is digested, by 
determ ining the duration o f contact w ith  m icrobia l enzymes (Mertens, 1977; van 
Soest and Robertson, 1976).
As noted above, fe rm enta tion  varies w ith  the chemical and physical form  
o f the fib re . Lignin, by v irtue  o f its  polym eric cross-linked structure  is resistant 
to bacteria l digestion, whereas the other chem ical types of fib re  are much more 
susceptible. Degradation results in the production of several compounds, these 
include methane, carbon dioxide, hydrogen, water and short-chain fa tty  acids 
such as acetic, propionic and bu tyric  acids. A t the colonic pH the la tte r  are 
almost com plete ly ionised, (Wrong et al., 1965) and m ight exert an osm otic 
e ffe c t, increase colon w ater and induce laxation (Cummings, 1973). On the other 
hand, studies in animals have demonstrated a t least pa rtia l absorption o f short- 
chain fa tty  acids (Bauchop and M artucci, 1968). I t  is possible there fo re , tha t 
ferm entation o f d ie tary fib re  in the colon may make a m inor contribu tion  to the 
energy value o f the d iet.
1.4.2 W ater-holding capacity o f d ie ta ry  fib re
The w ater-hold ing capacity o f d ie ta ry fib re  has im portan t physiological 
e ffects  in both the upper and lower in testine. Hydration o f fib re  occurs by 
adsorption to the surface o f the macromolecules, and by entrapm ent w ith in  the 
in terstices o f the fibrous or gel m atrix . Several factors influence the w a te r- 
holding capacity, including the chem ical and physical composition o f fib re , and 
conditions in the surrounding medium (Eastwood and M itche ll, 1976a).
The presence o f sugar residues w ith  free polar groups (e.g. polysaccharides) 
increases the capacity o f hydration, whereas in term olecular bonding such as the 
ether cross-linkage between chains o f cellulose molecules has the opposite e ffe c t 
(Yost, 1972). In general hemicelluloses have a greater water-hold ing capacity 
than cellulose w ith  lign in being much less hygroscopic.
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The influence o f the physical state o f fib re  on its a b ility  to hydrate was 
shown by K irw an e t al. (1974), they demonstrated that fine ly  ground bran (as 
found in com m ercial bran cereals) has a lower in v itro  water-holding capacity 
and less a b ility  to increase stool bulk than the coarse varie ty . This they found 
was due to the volume o f in te rs tit ia l space available fo r hold ing-water being a 
function o f pa rtic le  size.
The in v itro  water-hold ing capacity o f most fibres is l i t t le  a ffec ted  by the 
chem ical environment o f the surrounding medium (McConnell e t al., 1974), the 
gel form ing a b ility  o f pectin is however very susceptible to changes in pH, sugar 
and cation concentrations (P iln ik and Voragen, 1973). The stool bulking capacity 
o f various types o f fib re  is a property which can only be confirm ed by in vivo 
studies since, as noted previously, the d iges tib ility  o f fib re  may influence its  
gastro in testinal e ffects . Pectin, which is largely degraded in the colon, form s 
gels w ith  a very high w ater content in v it ro . Addition o f pectin  to a 
m etabo lica lly-contro lled  d ie t actua lly  decreased the percentage w ater content 
o f faeces and did not a lte r the trans it tim e (Kay and Truswell, 1977a). The 
water-hold ing capacity o f fib re  has also been found to have im portan t 
physiological e ffec ts  on both the upper and lower in testine. Gel form ing 
polysaccharides, such as guar gum and pectin , decreased the ra te  o f glucose 
absorption in the small in testine (Jenkins e t al., 1977a). This e ffe c t is due to the 
pa rtition ing  o f nutrients into the gel structure , thus decreasing the ra te  o f 
d iffusion towards the absorptive mucosal surface. In the colon, the presence o f 
hydratable fib re  increases stool bulk, decreases in tra lum ina l pressure and 
promotes laxation. Kay and Truswell (1977b) reported tha t the addition o f wheat 
bran to a contro lled d ie t caused stool weights to increase s ig n ifica n tly ; in the 
same experiment individual stool w ater contents and tran s it tim es were 
negatively corre lated.
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1.4.3 Adsorption o f organic m ateria ls
A number o f organic m ateria ls such as bile acids and bacteria  may be 
reversib ly bound to fib re  as i t  passes along the gastro in testina l tra c t.
Bile acid adsorption has been the most extensively studied, and is 
dependent on the composition o f the fib re , the chem istry o f the stero l, and the 
pH and osm olarity o f the surrounding medium (Story and Kritchevsky, 1976a; 
Eastwood and Mowbray, 1976b). Lignin has been found to be the most potent b ile 
acid adsorbent, the binding influenced by molecular weight, pH and the presence 
o f m ethoxyl and 3-carbonyl groups in the lign in molecule (Kay e t al., 1979). Kay 
e t al. (1979) reported tha t autohydrolysed lignin bound bile acids ha lf as 
e ffe c tive ly  as DEAE sephadex. Adsorption was maximum for the less polar 
unconjugated dihydroxy bile acids, while a decrease o f environm ental pH 
enhanced binding especially o f trihydroxy bile acids. Eastwood and Ham ilton 
(1968) demonstrated tha t m ethylation o f lignin increased b ile acid adsorption. 
These authors also reported tha t adsorption was greatest a t low pH. Both 
conditions would block or suppress ionisation o f carboxyl and hydroxyl groups on 
lign in phenylpropane units indicating a hydrophobic binding mechanism. Saponins 
also bind bile acids in v itro  (Oakenfell and Fenwick, 1978) and in vivo, (Malinow 
e t a l., 1981) and i t  has been suggested tha t they may be responsible fo r s te ro l 
adsorption associated w ith  fib re . However, bran and a lfa lfa  show no d im inution 
o f adsorptive capacity fo llow ing the removal o f associated saponins (Story 1980).
1.4.4 Cation exchange properties
Fibre may function as a weak cation exchange resin, th is action is re la ted  
to the number o f free carboxyl groups on the sugar residue (McConnell e t al., 
1974). Most p lant fibres appear to act as weak m onofunctional ion-exchange 
resins, although cereals (maize, oatmeal and bran) and tubers (e.g. potato) may 
behave as po lyfunctiona l exchange resins.
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1.4.5 An tiox idant role o f fib re
Lignin, a universal component o f p lant ce ll walls is believed to be active  as 
a free-rad ica l scavenger by v irtue  o f its  reducing phenolic groups (Kay and 
Strasberg, 1978). This is im portant since free radicals, or other oxidative 
processes involving the production o f lip id  peroxides may be im portan t in 
carcinogenesis.
1.5 Intakes o f D ie tary  Fibre
Intakes o f d ie ta ry fib re  vary throughout the world. A random sample o f 
the population in Cambridgeshire, England was shown to have a to ta l d ie ta ry 
fib re  intake o f 19.9 + 5.3g per day (Bingham et al., 1979). Intakes in other 
Western countries are o f the same order although they vary between countries, 
fo r example, the Netherlands has an average intake o f 24.0 + 6.9g per day, 
whereas Denmark has an average intake o f 17.2 + 5.1g per day (Stasse-Wolthius, 
1981). In contrast vegetarians, and the populations o f the less developed 
countries o f the world have a much higher intake. A group o f vegetarians were 
found to consume 42.8 + 12.3g fib re  per day (Stasse-Wolthius, 1981). In the th ird  
world fib re  intake is put a t 40-60g per day, and i t  has been found tha t a typ ica l 
Ugandan d iet m ight contain 100-170g o f d ie ta ry fib re  per day (Bingham et al., 
1979).
The d ietary fib re  content o f the B ritish  d iet has changed considerably since 
1880. (Southgate e t al., 1978b). There has been a slow progressive decline in 
d ie ta ry fib re  intake except during the war when intake almost doubled. Most o f 
the decline in intake is a ttribu ted  to a decline in cereal consumption and to  
increased refinem ent in food products (Raymond et al., 1977).
1.6 Sources o f D ie tary Fibre
A ll plant foods, apart from  refined sucrose and vegetable o il contains some 
d ie tary fib re , the im portan t sources being cereals, f ru it  and vegetables. In 
recent years, wheat bran has been increasingly used in the d ie t as a source o f
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d ietary fib re  (A rvan itakis et al., 1977). Bran, the fib re  rich frac tio n  o f wheat 
discarded during the m illing  o f white  flou r is the richest source o f fib re , 
containing 40-50% die tary fib re  depending upon the m illing  technique and 
method o f analysis. I t  comprises a ll the outer layers o f the wheat grain down to 
and including the aleurone layer (Kent-Jones and Amos, 1967; MacMasters e t al., 
1971). These layers include the pericarp, which incorporates the epidermis, 
cu tic le , cross-cell and tube ce ll layers, the seed coat, which incorporates the 
testa, tegumen, and pigment cells; the hyaline layer and the aleurone layer. 
Together these outer layers form  between 11% and 16% o f whole wheat; in 
practice  however, bran usually contains more than these layers. The aleurone 
layer is very th in  lying close to the endosperm of the grain, therefore  separation 
o f this from  the endosperm during m illing  is not easy, and variable amounts o f 
endosperm are nearly always present in com m ercially available bran. Its 
presence may be one o f the facto rs a ltering the physical properties o f bran 
preparations (K irwan et al., 1974). The inclusion o f some endosperm in the bran 
is also im portan t in another context. Most of the proteins tha t make up gluten 
are contained in the endosperm and thus make bran unsuitable fo r patients w ith  
coeliac disease. Wheat germ may also be present or added to bran preparations. 
Wheat germ is about 2% o f the whole wheat and comprises the embryo and 
scutellum , and is separated from  bran and endosperm during the m illing  process. 
Some wheat germ may remain attached to the bran, the amount depending to 
some extent on the moisture content o f the wheat and the method o f m illin g  
(Z iegler and Greer, 1971).
Bran is therefore not a substance w ith  uniform  composition, nor is i t  
en tire ly  composed of fib re . I t  also contains starch, sugars, proteins, fa t  ash and 
water. The fa tty  acids o f bran are 84% unsaturated (mostly lino le ic  and o le ic  
acid) and 16% saturated. The ch ie f m inerals present are potassium, phosphorus 
and magnesium. Bran also contains a varie ty  o f other substances including
vitam ins, (pyridoxine and fo lic  acid being the major ones) and perhaps more 
im portan t phytic  acid. The inclusion o f the aleurone layer in bran is o f some 
im portance in nu trition , as this layer o f the wheat grain contains about 61% o f 
the to ta l wheat grain m inerals, 83% o f the niacin, 61% of the pyridoxin and most 
o f the phytate and fo lic  acid (MacMasters et al., 1971).
Fresh f ru it  and vegetables, because o f the ir high w ater content are only 
d ilu te  sources o f fib re , whereas legumes, nuts and dried fru it  have a higher fib re  
content. However, because o f the amount consumed, fresh f ru it  and vegetables 
represent an im portant source o f d ie ta ry fib re . The National Food Survey 
showed tha t in 1974 f ru it  and vegetables contributed 58% o f d ie ta ry fib re  intake, 
whereas cereals contributed 30%, the remaining 12% being from  nuts and foods 
containing m ixtures o f ingredients (Southgate, 1978a).
The varia tion  in the composition o f d ie ta ry fib re  in d iffe re n t foods may be 
im portan t in determ ining the physiological role o f d ietary fib re  (Southgate, 
1978a). Bran is composed o f approxim ately 17% cellulose, 71% non-cellulose 
polysaccharides and 12% lign in. F ru it and vegetables in general contain more 
cellulose and lignin, but less non-cellulose polysaccharides than bran and other 
cereals (Southgate, 1978a). The composition o f the non-cellulose polysaccharide 
fractions also varies. The non-cellulose polysaccharides o f bran consist o f 19% 
hexoses, 69% pentoses and 12% uronic acids, in contrast to approxim ate ly 20%, 
34% and 46% respective ly in f ru it  and vegetables. Thus bran is much riche r in 
pentoses, whereas f ru it  and vegetables are much richer in uronic acids 
(Southgate, 1978a).
1.7 Epidem iological Data Linking D ie tary Fibre and Disease
D ietary fib re  has been linked to the incidence o f several diseases. 
Numerous disorders are said to result from  the lack o f fib re  in the d ie t including 
constipation, ischaemic heart disease, polyps, cancer o f the colon, d iv e rtic u la r 
disease, diabetes, appendicitis, ir r ita b le  bowel syndrome, hiatus hernia, varicose
veins, haemorrhoids and gallstones. The basis fo r an association between fib re  
and these diseases is epidem iological in that these disorders are rare in the 
developing countries of A fr ica , South and Centra l America and the Far East, 
where d ie tary fib re  intakes are said to be high; whereas they are common in the 
industrialised countries o f the Western world where fib re  intakes are low 
(B u rk itt, 1971). For some o f the above disorders however, the proposed 
association has never been studied in greater deta il, and fo r others, the results o f 
fu rthe r epidem iological investigations are con flic ting . However, in recent years 
some progress has been made in confirm ing some of these claims, while fo r 
others, doubt s t i l l  remains. The e ffec ts  o f fib re  on faecal bulk, colon cancer, 
m ineral metabolism and atherosclerosis have been the most w idely studied, and 
these are now considered.
1.7.1 E ffe c t o f fib re  on faecal bulk
Many studies have investigated the actions o f d ietary fib re  in animals and 
man. To date, the most c learly  defined action o f d ietary fib re  is its  e ffe c t on 
faecal bulk. Average stool weights in Western countries are in the order o f 
lOOg/day, in comparison to  over 300g/day in populations ingesting high 
carbohydrate high fib re  diets (R end tro ff and Kashgarian, 1967). The 
epidem iological findings o f decreased trans it tim e and increased faecal bulk on 
high fib re  diets have been confirm ed by numerous experiments in which 
volunteers have been given fib re  supplemented diets under m etabo lica lly  
contro lled conditions. The e ffe c t o f fib re  on stool bulk is like ly  to be re la ted  not 
only to the hydration capacity o f the surviving residue and production o f 
osm otica lly active metabolites, but also to induction o f bacteria l grow th, since 
bacteria l cells are norm ally 80% w ater and represent an im portan t fra c tio n  o f 
to ta l stool volume (Stephen and Cummings, 1980). Thus the mechanism by 
which stool bulk and laxation is promoted w ill vary fo r d iffe re n t fibres. Stephen
and Cummings (1980) demonstrated tha t 48% o f the increase in stool bulk and 
water content in subjects fed wheat fib re  could be accounted fo r by the w a te r- 
holding capacity o f the hydrated fib re , while only 36% of the wheat fib re  was 
bacte ria lly  digestible. In contrast, when an almost com plete ly digestible (92%) 
fib re  was fed, stool bulk and w ater content was increased, but much o f this 
increase (33%) was due to enhanced bacteria l output.
Although large amounts o f ferm entable fibres such as pectin and cellulose 
enhance faecal bulk and water content, they are somewhat less e ffe c tive  than 
less ferm entable types. Stasse-Wolthius e t al. (1980) demonstrated tha t the 
mean increase in stool weight was 4.1g/g o f added fib re  from  coarse wheat bran, 
compared to 1.9 g/g o f added fib re  when fru it  and vegetables were used as a 
fib re  source. The influence o f various unprocessed wheat brans on faecal weight 
being p a rtia lly  dependent on pa rtic le  size, (H eller e t al., 1980) which a ffe c ts  the 
water holding capacity o f the fib re  m atrix .
1.7.2 D ie tary fib re  and colon carcinogenesis
One o f the princ ipa l hypothesis on the etio logy o f colon cancer is based on 
d ietary fib re  defic iency. Epidem iological evidence such as tha t o f B u rk itt  e t al.
(1974) forms the main basis fo r the concept tha t fib re -d e fic ie n t diets are 
associated w ith  excessive prevalence o f large bowel cancer. However, fib re  
consumption is only one o f several d ie tary variables ten ta tive ly  im p lica ted  in the 
etio logy o f large bowel cancer (Arm strong and Doll, 1975). Other nutrien ts 
which are thought to be im portan t are fa t, animal prote in and cholesterol. H ill
(1975) suggested tha t high dietary fa t  may fa c ilita te  growth o f in tes tina l 
bacteria capable o f converting dihydroxy bile acids to carcinogenic polynuclear 
hydrocarbons. Although there is no experim ental evidence to ind icate tha t 
dihydroxy bile acids undergo bacteria l m etabolic conversion to carcinogenic 
polynuclear hydrocarbons. Reddy et al. (1975) suggested tha t high fa t  diets 
enhance the production o f bile acids, some of which have been shown to act as 
colon tumour promoters.
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It  is like ly  tha t cancer in the large bowel arises by two re lated processes, 
f irs t, the induction o f malignant po ten tia l in mucosal cells by carcinogenic 
substances, and secondly, the prom otion o f tumour growth by other factors. A t 
the present tim e no substance has been identified  which is d e fin ite ly  
carcinogenic fo r the human colon, and most experimental work has concentrated 
on the mechanisms of tumour prom otion. As a result, d ietary fa t and pro te in  are 
thought to be prom oting agents in the gut. Fibre is seen as being p ro tec tive  
against bowel cancer by neutralising any prom otional e ffe c t o f fa t and proteins 
(B u rk itt, 1971). A d irec t e ffe c t on the in itia tin g  carcinogen (or carcinogens) is 
also possible.
Using animal model systems, several studies have reported tha t fib re - 
containing diets decrease in testina l neoplasia. The principal source o f fib re  
examined in these experiments has been wheat bran. Wilson e t al. (1977) found 
tha t when rats were trea ted w ith  1,2-dim ethylhydrazine (DMH), the ingestion o f 
bran decreased the incidence o f colon tumours. A p ro tective  role fo r wheat bran 
was also claim ed by Chen e t al. (1978) in mice. F le izer e t al. (1978) found a 
s ign ifican t decrease in colon cancer in rats fed bran compared to rats fed other 
fib re-conta in ing diets. Ward e t al. (1973) examined a single source o f fib re , 
cellulose, added at 20% and 40% to a sem i-synthetic d ie t and adm inistered to 
rats dosed w ith  azoxymethane. In this study, the number o f small bowel tumours 
were decreased, but no e ffe c t on colon tumours was seen. Freeman et al. (1978) 
in a double blind study showed tha t the incidence o f colon tumours in rats 
trea ted w ith  DMH was decreased by the ingestion o f cellulose. Tumour 
incidences a t o ther sites, pa rticu la rly  the small bowel were unaffected. In th is 
study, cellulose was provided a t a level o f 4.5% in an energy equivalent d ie t, 
closely approxim ating the cellulose content o f human foods w ith  a high fib re  
content such as the bran cereals. More recently, Bauer et al. (1979) reported 
tha t animals fed a d ie t containing 6.5% c itrus  pectin during carcinogen 
adm in istra tion had an increase in the number o f colon tumours.
Human studies on the role o f d ie tary fib re  in colon cancer is also
inconclusive. Some appear to support the fib re  hypothesis, while others re fu te
its importance, or indicate tha t other d ie ta ry components are more re levant. In 
a case contro l study from  Israel, Modan et al. (1975) described a s ign ifican t 
inverse corre la tion between colon cancer and the ingestion o f certa in  f ib re - 
containing foods. S im ilar observations were reported by Dales e t al. (1979) and
Graham and M e ttlin  (1979). Others however have not found a s ign ifican t
relationship between colon cancer and fibre-conta in ing foodstuffs. Moreover, 
Haenszel e t al. (1973) found a s ign ifican t corre la tion between colon cancer and 
the frequency o f ingestion o f fib re-conta in ing legumes in the Hawaiian Japanese 
population.
The discrepancy in the above results m ight be in part due to the nature o f 
the carcinogen used, to d ifferences in the susceptib ility  o f ra t s tra in  to 
carcinogen trea tm ent, to varia tion in the composition o f diets, to qua lita tive  and 
quan tita tive  differences in administered fibres and the ir components, to re la tive  
d ifferences in the food intake by the animals and/or to d ifferences in 
experim ental design and duration o f the experiment.
Many mechanisms have been suggested fo r the pro tective  role o f fib re  
against colon cancer, i t  is these tha t are now considered. I t  has been postulated 
tha t fib re  may act as a p ro tective  fa c to r in cancer o f the large bowel by 
shortening trans it tim e, thus decreasing the tim e fo r form ation and action o f 
proxim ate carcinogens. In addition, through its  stool bu lk ing -e ffec t fib re  may 
lower the concentration o f faecal carcinogens, thereby decreasing the amount o f 
carcinogen tha t comes in to contact w ith  the gut wall. (H ill, 1974; B u rk itt, 
1975b). Other changes may occur in the physical and chem ical environm ent o f 
the colon, the bacteria l flo ra  or in the in te raction  between bacteria  and 
potentia l carcinogens. As most types o f fib re  increase stool bulk and d ilu te  the 
concentration o f specific substances in the colon, the concentration o f
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bacte ria lly -m od ified  bile acids in the colon has been im plicated in tumour 
form ation (Kay, 1982). B ile acids have been found to a c t as promoters o f colon 
cancer in mutagenesis assay systems (Silverman and Andrews, 1977), as w e ll as in 
conventional and germ -free rats (Narisawa et al., 1974; Reddy e t al., 1976a). 
The extent to which a specific  fib re  decreases faecal bile acid concentration w ill 
also be m odified by its  concom itant e ffe c t on to ta l stero l excretion. Moreover, 
wheat bran decreased the concentration o f bile acids in the stool (Kretsch e t al., 
1979) pectin did not (Kay and Truswell, 1977a). Therefore, i t  is conceivable tha t 
ferm entable fib re  may a lte r the production o f secondary sterols through its  
e ffe c t on colon pH, since most bacteria l enzymes acting on acid ic and neutra l 
steroids have pH optim a of 6.5 or greater (MacDonald et al., 1978). B ac te ria l- 
m odified faecal steroids are found to be decreased in individuals consuming high 
fib re  diets (Avgerinos et al., 1977; H ill, 1971).
Ammonia has also been linked to colon tumour form ation (Topping and 
Visek, 1976). Cummings e t al. (1978) reported a decrease in faecal dialysate 
ammonia in association w ith  a decrease in trans it tim e in subjects given fib re  
supplements.
1.7.3 D ie tary fib re  and m ineral metabolism
Certa in types o f d ie ta ry fib re  a ffe c t faecal cation excretion , many 
endogenous divalent cations and anions secreted in to the gut from  the plasma 
become bound to fib re  and are then e lim inated unabsorbed. A lte rn a tive ly , 
cations or anions may be so t ig h tly  bound to the plant ce ll w all o f food products 
tha t they are excreted unabsorbed.
Fibre being a highly in te racting  agent, should be expected to a ffe c t faecal 
b ivalent m etal excretion d iffe re n tly , depending on the other components o f the 
d ie t and the nu trition a l status o f the individual. There is also a great deal o f 
disagreement on the e ffe c t o f the phytates present in wheat bran v.s. the e ffe c t
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o f fib re  per se (Spiller and Shipley, 1977). C ontrad ictory results are found in two 
studies tha t have a ttem pted to c la r ify  i f  i t  is the enzyme-undigestible polym eric 
portion o f fib re , or the phytate tha t is responsible fo r binding certa in  b ivalent 
metals. Davies e t al. (1977) a ttr ib u te  the binding to phytates, while Ism ail-Beig i 
e t al. (1977) suggests tha t cellulose per se a ffects  the metabolism o f these 
m inerals. In a study on ra ts Davies et a l. (1977) used a rep le tion technique to 
study the ava ilab ility  o f zinc from  diets supplemented w ith  bran, bran fib re  (bran 
w ith  the phytates extracted), phytate and pectin . The rats consuming the bran 
fib re  had growth rates s im ila r to the controls fed adequate zinc (18.5mg Zn/kg). 
The rats consuming bran or phytates (purified sodium phytate) exhibited 
decreased growth and decreased food intake even i f  fed adequate zinc; both 
phenomena were reversed when additional zinc was supplied in th e ir drinking 
water (25]ig/m l). In a separate experiment where a d iet m arginal in zinc (12 
mg/kg) was fed w ith  pectin , there was no difference between the contro ls and 
the rats supplemented w ith  pectin . These authors concluded tha t "Phytate 
ra ther than fib re  is the m ajor determ inant o f Zn ava ilab ility ".
However, in a study w ith  three human subjects and adding cellulose 
(Whatman No. 3 f i l te r  paper homogenised in a kitchen blender) to diets low in 
fib re , Ism ail-Beigi et a l. (1977) showed a s ign ifican t increase in the faecal 
excretion o f calcium  and zinc fo r a ll three subjects w ith  a decrease in the 
plasma levels o f these cations. Negative magnesium balance occurred in two 
subjects and phosphorus balance became negative in one subject. S im ila r results 
were obtained fo r the cations in another experiment they conducted, where the 
cellulose was added to a d ie t already high in fib re . In th is study previously 
negative balances became more negative. They concluded, "We believe th a t the 
impaired absorption o f d ivalent metals in the presence o f fib re  results from  the 
a b ility  o f fib re  to bind these metals f irm ly  under conditions existing in the small 
in testine". Eastwood and M itche ll (1976c) studied the e ffec ts  o f 16g/day o f an
unrefined wheat bran on the faecal excretion o f sodium, potassium, calcium  and 
magnesium. Their results showed an increase in the excretion o f a ll the cations 
studied except calcium , the authors suggested tha t this was due to cereal fib re  
acting as a po lyfunctiona l cation-exchanger.
There is however, much controversy regarding the e ffec ts  o f phytate on 
iron absorption in animals and humans. Some investigators have reported tha t 
phytate inh ib its iron absorption, (McCance et al., 1943; Moore e t al., 1943; 
Sharpe e t al., 1950; Hussain and Patwardhan, 1959; Turnbull e t al., 1962; Davies 
and N ightingale, 1975) while others have found no inh ib ito ry  e ffec ts  (Cowen et 
al., 1966; Ranhorta e t al., 1974) or variable e ffec ts  (Foy et a l., 1959) o f added 
dietary phytate.
Elemental iron absorption entails a complex in te raction  between d ie ta ry 
inorganic iron (derived from  various food sources) and several components in the 
d ie t which a ffe c t the so lub ility  and chemical form  of iron in the in tes tina l 
lumen. Organic iron absorption as haem (the major form  o f iron in meat) is not 
a ffected  by other d ie tary factors and is fa r more readily absorbed than inorganic 
iron as i t  has a separate mucosal uptake system (Hallberg and Solvell, 1967). 
D ie tary  iron can therefore be considered as a two pool system, (Hallberg and 
Bjorn-Rasmussen, 1972) a ll the d ie ta ry forms o f inorganic iron behaving as a 
single pool whose absorption can be promoted by the concom itant ingestion o f 
amino acids and v itam in  C, or inhib ited by phytate. Thus the e ffe c t o f 
increasing fib re  intake on iron absorption is therefore like ly  only to a ffe c t the 
ava ilab ility  o f d ie ta ry inorganic iron.
Iron absorption responds to changes in iron status, and de fin ite  increases in 
the uptake o f iron by the small in testine can be shown in subjects who are iron 
de fic ien t. Nevertheless, an appreciable number o f adults in the United Kingdom 
are iron de fic ien t, pa rticu la rly  menstruating women and the e lderly . Thus 
increasing the fib re  intake o f these groups is like ly  to increase th e ir
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vu lnerab ility . However, the absorption o f inorganic iron to d ie ta ry fib re  may 
also have a benefic ia l e ffe c t. I t  is known tha t in the presence o f water, iron w ill 
generate hydroxyl radicals which are powerfu l cy to tox ic  agents. The presence o f 
these free radicals in tissue could lead to tissue degradation, lip id  peroxidation, 
and possible development o f re la ted diseases i.e. cancer, cardiovascular disease 
and a rth ritis  (a rth r it is  is characterised by anaemia yet high blood levels o f non- 
haem iron). Thus d ie ta ry fib re  may am eliorate these diseases by binding 
inorganic iron.
The a lte ra tion  of m ineral absorption by d ietary fib re  is also suggested to 
have an ind irec t a ffe c t on lip id  metabolism (Klevay, 1974). Decreased 
ava ila b ility  o f zinc as a result o f high intake o f d ietary fib re  (Reinhold e t al., 
1976) could result in a negative balance which could a lte r cholesterol metabolism 
(Klevay, 1973). Other m inerals namely magnesium, and calcium  have been 
suggested to be im portan t in this respect. However, Guthrie and Robinson (1978) 
demonstrated tha t 14g/day o f wheat bran did not a lte r the zinc balance in young 
women. These balance studies were performed a fte r 28 days o f bran 
consumption, in contrast to those carried out im m ediate ly a fte r in it ia tio n  o f a 
high fib re  regimen, and may indicate adaptive changes to lower concentrations 
of m icro-nutrients. Sandstead et al. (1979) demonstrated tha t adu lt males 
ingesting a normal Western d ie t could sustain zinc, copper and iron balance when 
26g o f wheat bran or other fib re  was added to th e ir d ie t, but the requirem ent fo r 
calcium  was increased s ligh tly .
1.7.4 D ietary fib re  and lip id  metabolism - its  relationship to atherosclerosis
The strik ing  increase in death ra te  from  heart disease in Western countries 
which seems to have began in the 1920's has led to an intensive search fo r
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factors in the environment, and in the host tha t are associated w ith  ischaemic 
heart disease (IHD) in individuals or populations. Although i t  has been w e ll 
established tha t an elevated serum cholesterol level is one o f the princ ipa l 
factors (risk factors) ind icating a susceptib ility  to IHD (Truswell, 1978), the 
Framingham study (Kagan et al., 1962) also found elevated systo lic blood 
pressure, excessive c igare tte  smoking and d ie t im portant in th is respect. 
Carlson and B o ttige r (1972) suggested tha t serum trig lycerides should also be 
considered a risk fac to r. This hypothesis is supported by a recent study where 
IHD death rates in 40-year-old Scottish and Swedish men were compared, i t  was 
shown tha t the cholesterol levels o f the two groups were s im ila r, but the Scots, 
who had considerably higher coronary m o rta lity , also had s ig n ifica n tly  higher 
serum trig lyce ride  levels (O liver e t al., 1975).
Recently, several investigations (Trowell, 1975; Klevay, 1974; Cleave, 
1974; Trowell, 1976) have suggested tha t a lack o f fib re  in the d ie t may be just 
as im portant as other d ie ta ry factors (e.g. fa t) in the devlopment o f heart 
disease. Their hypothesis is based on epidem iological evidence ind ica ting tha t 
populations which consume a d ie t containing large amounts o f fib re  are free  o f 
many o f the diseases prevalent in the Western world, including ischaemic heart 
disease. The Departm ent o f Health and Social Security states "populations who 
eat a d ie t rich  in fib re  (pa rticu la rly  from  cereals and legumes) usually have a 
lower serum cholesterol concentration and a lower m o rta lity  from  IHD, than 
those who eat a Western type diet re la tive ly  low in this kind o f f ib re "  (DHSS, 
1974).
The hypothesis tha t a d iet rich  in fib re  may help in the prevention o f 
coronary heart disease has stim ulated a great deal o f in terest in the re la tionsh ip  
between fib re  and lip id  metabolism. Numerous investigations have been 
conducted in order to study the e ffec ts  o f fib re  on serum lip id  levels in humans 
as well as animals. However as several investigators have shown, fib re  is a
complex group o f substances, varying in physical and chemical characteris tics, 
therefore the e ffec ts  o f one type of fib re  may d iffe r  considerably from  those o f 
another. This point was c learly  demonstrated by the early work o f Keys e t al. 
(1961), who found tha t pectin e ffe c tive ly  lowered serum cholesterol 
concentrations, while cellulose fa iled to show any s ign ificant e ffe c t. Most 
investigators are now reporting results s im ila r to these early findings o f Keys 
(M iettinen and Tarpila, 1977; Kay and Truswell, 1977a; Stanley e t al., 1973; 
Eastwood et a l. 1973). A s ign ifican t decrease in serum cholesterol was also 
demonstrated by Durrington et al. (1976) in a study in which 12 healthy 
volunteers consumed 12g/day o f pectin fo r 3 weeks. In agreement w ith  other 
investigators, they found tha t serum trig lyce ride  did not change s ign ifican tly .
Kay and Truswell (1977b) found tha t the addition of wheat bran (23 to 
35g/day) to the d ie t had no e ffe c t on plasma lipids, although i t  did e ffe c tiv e ly  
increase stool bulk and in testina l m o tility ; while in a la te r experim ent, they 
were able to decrease plasma cholesterol concentration in nine subjects by a 
mean of 13% through the addition o f c itrus pectin  (15g/day) to the d ie t (Kay and 
Truswell, 1977a). Jenkins e t al. (1975a) compared the e ffec ts  o f pectin , 
(36g/day) guar gum (36g/day) and wheat bran (36g/day) fed to  12 healthy 
volunteers on a normal d ie t. They found tha t while the volunteers were taking 
guar and pectin , the ir serum cholesterol values fe ll by 36.3 mg/lOOml and 
29.2mg/100 m l respectively, while on wheat bran i t  rose by 6.7 mg/100 m l. 
In form ation o f the e ffe c t o f wheat bran on high-density lipoprote in  cholestero l 
(HDL-C) is also lim ite d  and variable (Dixon, 1978; McDougall e t al., 1978).
Heaton and Pomare (1974) reported tha t the addition o f wheat bran 
(38g/day) to the d ie t fo r 6 weeks caused a decrease in plasma trig lyce rides. In 
another experiment they conducted, they found tha t the add ition o f bran 
(39g/day in the form  o f whole wheat bread) to the d iet fo r 19 weeks fa iled  to 
lower plasma lip ids (Heaton e t al., 1976). The fa c t tha t some o f the subjects had
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fa ir ly  high trig lyce ride  levels in it ia lly , as w ell as possible disturbances in b ile 
acid metabolism may account fo r these earlie r contrad ictory results. Recently 
however, van Berge-Henegouwen et al. (1979) reported that wheat bran fed to 7 
healthy male volunteers a t 0.5g/kg body w t/day fo r 4 weeks, produced s ign ifican t 
decreases in to ta l serum cholesterol as w e ll as in to ta l serum trig lyce ride  levels, 
thus supporting Heaton and Pomare's ea rlie r work. In cholesterol-fed animals, 
studies have been reported where wheat bran supplements fa iled  to lower plasma 
lip id  levels. However, the studies o f Owen et al. (1975) reported tha t the 
addition o f wheat bran to cholesterol containing diets lowered both plasma and 
live r cholesterol levels in rats.
Before disucssing the possible mechanisms by which d ie tary fib re  could 
exert an e ffe c t on plasma and tissue lip id  metabolism, i t  is appropriate a t th is 
stage to describe the nature o f cholesterol and its  metabolism.
1.8 Cholesterol Metabolism and Contro l
Cholesterol is an im portant s truc tu ra l component o f a ll ce llu la r and 
in trace llu la r membranes, as w e ll as plasma lipoproteins. The cholesterol present 
in plasma being only a small frac tion  o f the to ta l present in the body. The 
pathways o f cholesterol metabolism which influences tissue and plasma 
cholesterol levels are summarised in Figure 1:2. Methods used to investigate 
these pathways have been measurement o f whole body stero l balance, and the 
incorporation o f specific iso top ica lly-labe lled precursors. Data derived from  
these studies have fa c ilita te d  the understanding o f three m ajor aspects o f 
cholesterol metabolism i.e. synthesis, absorption and catabolism.
1.8.1 Cholesterol synthesis
Cholesterol is a monohydric stero l found in every ce ll in the body. I t  is 
present in large amounts in nervous tissue and brain, i t  is also present in fa ir
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quantity in skin, adrenals and live r. Most tissues are capable o f 
cholesterogenesis, although the live r and intestine predominate, (D ietschy and 
Wilson, 1970a) and together w ith  skin contribu te in excess o f 90% o f endogenous 
cholesterol (Lewis 1976). A ll 27 carbon atoms of cholesterol arise from  the two 
carbons o f acetate (15 from  the m ethyl group and 12 from  the carboxyl group) 
via a series o f steps o f which the form ation o f mevalonate from  3 -hydroxyl 3 - 
m ethy ig lu ta ry l -CoA (HMG CoA), catalysed by the microsomal enzyme HMG 
CoA reductase is ra te -lim itin g  (Siperstein and Fagan, 1966). This enzyme is 
subject to negative feedback contro l, thus hepatic synthesis is inh ib ited by 
cholesterol its e lf  (Figure 1:2). In ra t live r, exogenous cholesterol (derived from  
chylomicrons) is more e ffe c tive  than endogenous cholesterol in this respect (Weis 
and Dietschy, 1969). In testina l cholesterogenesis is largely regulated by bile 
acids (D ietschy, 1968), although M cIntyre and Isselbacher (1973) have shown tha t 
in testina l cholesterol may also play some part. In some tissue, cholesterol 
synthesis may be depressed due to feedback inh ib ition by low-density 
lipoproteins, mediated by receptors on the ce ll surface (Balasubramaniam e t al.,
1976). I t  has been proposed tha t a major function o f these receptors is to  pe rm it 
the transport o f low-density lipoproteins in to the ce ll, where they suppress the 
a c tiv ity  o f HMG CoA reductase and thereby inh ib it cholesterol synthesis (Brown 
e t al., 1975).
1.8.2 Cholesterol absorption
Cholesterol available fo r absorption from  the intestine is derived from  
three sources: the food, the bile, and to a sm all extent, the w a ll o f the in testine  
itse lf. Cholesterol discharged d ire c tly  from  the in testina l w a ll in to the lumen 
arises by synthesis 'de novo' in the mucosal cells, (Wilson and Reinke, 1968) and 
by continual desquamation o f these cells. Borgstrom (1960) using a method 
which enabled him to analyse the contents o f successive segments o f the human
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small in testine, showed tha t absorption o f an oral dose o f cholesterol is 
completed above the dista l end o f the jejunum. Experiments on the uptake o f 
labelled cholesterol by the sm all in testine o f the ra t in vivo (Swell e t al., 1958) 
suggest tha t in th is species also, the proxim al region o f the small in testine is the 
major site o f cholesterol absorption. Cholesterol absorbed from  the in testine is 
transported in the splenic c ircu la tion  to the live r via the thoracic duct. 
Estimates o f the recovery o f absorbed labelled cholesterol in thorac ic-duct 
lymph o f rats (Biggs et al., 1951) and human subjects (Heilman et al., 1960) 
indicate tha t in both species the in testina l lym phatic system is essentially the 
only route by which absorbed cholesterol reaches the c ircu la tion .
The sm all amount o f es te rified  cholesterol present in the d ie t (usually less 
than 5% o f the to ta l d ie ta ry cholesterol) is hydrolysed by pancreatic cho lestero l- 
ester esterase in the lumen o f the small in testine. The free cholesterol resulting 
from  th is  hydrolysis, together w ith  tha t already present in the d ie t and b ile is 
incorporated in to mixed m icelles containing conjugated bile acids, phospholipids, 
2-monoglycerides, fa tty  acids and small amounts o f 1,2-diglycerides. The 
m icelles present in the in testina l lumen during the digestion o f fa t are spherical 
partic les, less than 10my in diam eter, in which the amphipathic molecules are 
oriented w ith  the ir polar regions at the surface o f the partic les and the apolar 
regions form ing a flu id  core. Conjugated bile salts when present at 
concentrations above the ir c r it ic a l m ice lla r concentration, form  m icelles tha t 
are capable o f dissolving free cholesterol but the amount dissolved is very sm all 
- less than 1 m olelcule per 40 molecules o f bile salt (Hofmann and Small, 1967). 
The capacity o f the m icelles fo r dissolving free cholesterol is g rea tly  increased 
by the addition o f phospholipid, monoglyceride and fa tty  acid.
In testina l flu id  obtained during the digestion o f a fa t containing meal 
separates in to three layers on high-speed centrifugation , an upper layer 
containing the trig lycerides and diglycerides undergoing hydrolysis by pancreatic
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lipase, a clear supernatant layer containing the m icellar components, and an 
insoluble sediment. According to the present view as to the mechanism o f lip id  
absorption, the monoglycerides and fa tty  acids released during the enzyme 
hydrolysis o f trig lyce ride  present in the em ulsified o il phase are transferred to 
the aqueous phase, where they are incorporated in to the expanded m icelles in 
which cholesterol and other water-insoluble amphipaths are dissolved. The 
components of the m ice lla r phase are then taken in to the in te rio r o f the mucosal 
cells o f the m ic ro v illi, th is process continues un til a ll the products o f the 
digestion o f trig lyce ride  have been absorbed via the m ice lla r phase.
Although trig lycerides are absorbed com plete ly under normal conditions, 
cholesterol is incom plete ly absrobed in the in testina l lumen. Borgstrom (1960) 
has suggested tha t th is se le c tiv ity  o f absorption is pa rtly  a function o f the 
pa rtition  o f cholesterol between the o il phase and m ice lla r phase. He has shown 
tha t during the absorption o f cholesterol from  the human in testine, the p a rtit io n  
co e ffic ie n t favours solution in the o il phase. Hence, the cholesterol in the to ta l 
system is incom plete ly absorbed by the tim e tha t a ll the trig lyce ride  has been 
absorbed.
Absorbed cholesterol is used in the synthesis o f plasma lipoprote ins (8-12 
mmol/day) and bile acids (lm m ol/day) or is re-excreted in the b ile (2.5mol/day) 
(Angelin, 1977). The percentage o f cholesterol absorbed is dependent on various 
factors, namely, species, age, sex, (Lu tton  and Chevallier, 1972) the nature o f 
d ie tary fa tty  acids and ra te  o f b ile flow  (D ietschy and Wilson, 1970b). The size 
o f the bile acid pool also influences cholesterol absorption.
Cholesterol is transported in the blood as part o f a lipopro te in  complex. 
These blood lipoproteins may be subfractionated by electrophoresis or by 
u ltracen trifuga l flo ta tio n  in to four major species, chylomicrons, ve ry -low - 
density lipoprote ins (VLDL or pre B)> low-density lipoproteins (LD L or B) and 
h igh-density lipoprote ins (HDL or a). A summary o f the properties o f these
classes is given in Figure 1:3. Each o f the c ircu la ting  lipoprote in subfractions 
contain a ll o f the blood lipids, but in varying amounts. Chylomicrons and VLDL 
are the two major trig lyce ride  transport lipoproteins, carry ing respective ly 
glycerides o f e ither exogenous or endogenous orig in. Trig lycerides constitu te  
more than 90% o f chylom icron lip ids and more than 70% o f VLDL lip id , 
cholesterol esterified  and unesterified, and phospholipids constitu te  the 
remainder o f the lip ids (Levy e t al., 1966; Skipski, 1972). Both free cholesterol 
and phospholipids may be present p rim arily  in the surface coat o f the two 
lipoproteins (Yokoyama and Z ilve rsm it, 1965; Z ilve rsm it, 1968).
LD L is the major cholesterol carrying lipoprote in and cholesteryl esters 
constitu te  about ha lf o f the to ta l mass. As much as 70-80% o f the to ta l plasma 
cholesterol is associated w ith  LDL. LDL cholesteryl esters contain
predom inantly unsaturated fa tty  acids, the most prevalent being lino le ic  acid 
(18:2) which constitu tes 40% o f to ta l fa tty  acids present. The phospholipid 
composition o f LD L is found to be re la tive ly  enriched w ith  sphingomyelin as 
compared to other plasma lipoproteins (Skipski, 1972; Eisenberg, e t a l., 1973), 
however the significance o f this is not known. About ha lf o f the HDL mass is 
prote in, phospholipids and cholesterol (mainly in the es terified  form ) constitu te  
30% and 20% o f the HDL pa rtic le  respectively.
Since LD L is the major ca rrie r o f plasma cholesterol, an increase in th is 
frac tion  in the blood has been im plicated in the development o f ischaemic heart 
disease. The early work o f Barr e t al. (1951) showed tha t the cho lestero l r ich  
low-density liporo te in  frac tion  was increased in diseases tha t led to IHD, and 
tha t the ra tio  o f LD L to HDL is also increased in these disorders. Olson (1958) 
showed tha t a high LD L/H D L lipoprote in ra tio  was also seen in animals 
susceptible to atherosclerosis. These observations have been supported by 
several recent prospective tr ia ls  (Stamler, 1973), including the Framingham 
study, although in several studies the plasma VLDL concentration was found to 
be pred ictive  o f IHD (Kannel, e t al., 1971).
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In recent years however, the relationship between HDL lipoprote in levels and 
pro tection from  IHD has been rediscovered, the two have been shown to be 
inversely corre lated. This observation was made several years ago (Barr e t al., 
1951), but was not considered im portan t u n til M ille r and M ille r (1975), proposed 
tha t a decrease in high-density lipoproteins was like ly  to accelerate the 
development o f atherosclerosis by im pairing the clearance o f cholesterol from  
the a rte ria l ce ll wall. There are now a number o f reports in the lite ra tu re  
corre la ting ’p ro tection ' from  IHD w ith  serum high-density lipoprote in  levels 
(Rhoads et al., 1976; Berg et al., 1976; M ille r, e t al,. 1977; Gordon, e t al.,
1977). The mechanism by which HDL protects against heart disease is not 
known, however, i t  has been suggested tha t HDL may help transport cholesterol 
out o f peripheral erythrocytes to sites o f catabolism and excretion in the liv e r 
(Levy, 1981).
1.8.3 Cholesterol catabolism  and excretion
Under steady-state conditions, the cholesterol e lim inated in the faeces and 
urine should equal tha t derived from  synthesis and absorption. A sm all quantity  
o f cholesterol is excreted through the skin (Bhattacharyya, e t al., 1972). In man, 
the princ ipa l route o f excretion is via the faeces, which contains unabsorbed 
cholesterol from  the d iet, b ilia ry  excretion and desquamated ep ithe lia l cells 
(D ietschy and Wilson, 1970c; Lewis, 1976). In the ra t, faecal excretion o f 
cholesterol its e lf is re la tive ly  low compared w ith  tha t o f b ile acids (Lu tton , 
1976). In the large bowel cholesterol undergoes bacteria l m etabolism  largely 
through ring saturation to form  coprostanol and cholestanol (Rosenfeld, e t al., 
1954; Snog-Kjaer, e t al., 1956). Coprostanol is absent in the faeces o f rats 
treated w ith  an tib io tics (Coleman and Baumann, 1957) and in the faeces o f germ - 
free rats (Danielsson and Gustafsson, 1959). Coprostanone is another deriva tive
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which is commonly found in the faeces o f man, (Anchel and Schoenheimer, 1938; 
Rosenfeld, e t a l., 1963), but generally amounts are considerably less than those 
o f faecal coprostanol.
The second major route o f cholesterol excretion is via its  catabolism  to 
bile acids. Bloch, e t al. (1943) reported the conversion o f iso top ica lly labelled 
cholesterol to bile acids. More than 80% o f cholesterol is excreted in th is fo rm  
in the ra t (Bergstrom, 1952; Siperstein, e t al., 1952) and in man (Siperstein and 
Murray, 1955) however, Lewis and Myant (1967) state tha t b ile acids account fo r 
only 28-59% o f the net stero l loss in man.
The transform ation o f cholesterol to bile acids occurs via a series o f 
oxidative steps, involving the in troduction o f hydroxyl groups in to the steroid 
nucleus and shortening o f the side chain, (D ietschy and Wilson, 1970c) th is is 
summarised in Figure 1:4. The in it ia l reaction is the in troduction o f a hydroxyl 
group in the a-con figura tion  a t the 7-position o f cholesterol to form  cholest-5- 
ene38,7a-dio l (7a-hydroxycholesterol). In subsequent steps, the 33-hydroxyl 
group is inverted to the 3a-position via a 3-keto in term ediate, the A ^ double 
bond is saturated and the orien ta tion  o f the A and B rings is sh ifted from  a trans 
to a cis re la tion  i.e. from  a 5a-H  to a 53-H  stero l. In the pathway leading to 
cholic acid, 12a-hydroxylation also occurs. Consequently two key in te rm ed ia te  
compounds 53-cho lestane-3a ,7a ,12a-trio l and 5B-cholestane-3a,7a-d io l are 
formed.
Subsequent steps involve the loss o f the three te rm ina l carbon atoms from  
the side chain, and oxidation o f the C24 carbon to the carboxylic acid group.
This process is accomplished by w -oxidation to the corresponding 26-oic acid, 
followed by 8 -oxidation and cleavage o f the three-carbon un it in the fo rm  o f 
propionyl-CoA. In this manner, 58-cho lestane-3a ,7a ,12a-trio l and 58 - 
cholestane-3a,7a-diol are converted to cho ly l-C oA  and chenodeoxycholyl-CoA 
respectively. Each o f these compounds may then be conjugated through a
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peptide linkage to e ither o f the amino acids, glycine or taurine so tha t 
taurocholic, g lycocholic, taurochenodeoxycholic and glycochenodeoxycholic 
acids, the prim ary bile acids, are fin a lly  secreted into the bile.
Follow ing th e ir secretion in to the in testina l lumen, the conjugated prim ary 
bile acids are m odified by the action o f bacteria in the lower ileum and large 
in testine. These m odifica tions include hydrolysis o f the peptide bond o f tauro 
and glyco-conjugated b ile acids and the removal o f the 7a-hydroxyl group, 
resulting in the fo rm ation  o f deoxycholate from  cholic acid and lithocho la te  
from  chenodeoxycholic acid. These are known as the secondary bile acids.
Bile acids are e ffic ie n tly  reabsorbed by active  transport from  the d ista l 
ileum, although lithocho lic  acid is m ostly lost in the faeces. Unconjugated bile 
acids which are reabsorbed are conjugated w ith  taurine and glycine p rio r to re- 
excretion in the bile, which contains a m ixture  o f conjugated prim ary and 
secondary bile acids. Dehydroxylated bile acids on arriv ing back a t the live r 
remain so in man, but are largely re-hydroxylated in rats and m ice.
1.8.4 C haracteristics o f cholesterol 7a-hydroxylase and its  role in b ile acid 
form ation
In man and other species, b ile acid synthesis is under complex contro l. The 
ra te -lim ing  step in the fo rm ation  o f b ile acids from  cholesterol is the 7a- 
hydroxylation o f cholesterol by the m icrosomal enzyme cholesterol 7a- 
hydroxylase.
Cholesterol 7a-hydroxylase belongs to a class o f enzyme systems known as 
m ixed-function oxidases. The term  was introduced by Mason (1965) and re fe rs to 
an enzyme catalysed hydroxylation in which one atom o f a molecule o f oxygen is 
introduced in to the substrate, the other oxygen atom being reduced to w a te r by a
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reduced coenzyme usually NADPH. The stoichiometry o f the reaction shows tha t 
two electrons are taken up fo r each molecule of oxygen consumed. Hence the 
net reaction may be w ritte n :
RH + NADPH + 0 2 
where RH is the substrate.
These enzymes which are located in the hepatic endoplasmic re ticu lum  are
membrane bound, and are responsible fo r the metabolism o f a wide range of
exogenous substrates such as drugs, carcinogens and other foriegn compounds,
together w ith  endogenous substrates such as steroids and fa tty  acids. (Conney,
1967; Kuntzman, 1969; G ille tte  et a l., 1972). O rig ina lly the m icrosomal enzyme
system was thought to consist o f a t least two functiona l prote in components; a
haemoprotein called cytochrome P-450 and a flavopro te in known as NADPH-
cytochrome c reductase or NADPH-cytochrom e P-450 reductase. Cytochrom e
P-450 acts as a substrate and oxygen binding site o f the system, w h ils t the
reductase acts as an electron ca rrie r, transferring electrons from  NADPH to
cytochrome P-450. Lu and Coon (1968) solubilised the system using detergent,
and as a result were able to id e n tify  three components, cytochrom e P-450,
NADPH cytochrome c reductase and a lip id  shown to be phosphatidylcholine.
A proposed scheme fo r the series o f reactions occurring during
hydroxylation is shown in Figure 1:5. In the in it ia l reaction the substrate
combines w ith  oxidised (Fe^+) cytochrom e P-450 to form  a complex which is
2+then reduced to the Fe form  by the transfer o f one electron from  NADPH via 
NADPH-cytochrome c reductase. M olecular oxygen then combines w ith  the 
complex to form  a reduced cytochrom e-substrate 0 2 complex. A second 
electron is then transferred to the ternary complex, and the complex undergo a 
m olecular rearrangement in which one atom o f oxygen is introduced in to  the
H +—------*  ROH + NADP + HzO
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RH
ROH
[(Fe++)(0? )R H ]^ [ ( F e +++)(0 ")RH]
[(Fe+++)(02" ) R H ] ^ [ ( F e ++)(02-)RH]
e
Figure 1:5 Proposed scheme o f cytochrome P-450 reduction-oxidation 
cycle associated with hydroxylation (and oxygenation)
reducti ons
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substrate and the cytochrome P-450 is oxidised. The reaction is completed by 
expulsion o f w ater from  the complex w ith  the release o f hydroxylated substrate 
and cytochrome-P-450 in the Fe^+ form . The mechanisms of subsequent 
reactions concerned w ith  the transfer o f the second electron and the 
in troduction o f the activa ted oxygen atom is s t il l unclear. The nature o f the 
acceptor fo r the second electron remains undetermined, although H ildebrandt 
and Estabrook (1971) have postulated tha t cytochrome b<- may be im portan t in 
this respect.
Since CO combines reversib ly w ith  cytochrome P-450 at its  oxygen- 
combing site, hydroxylations requiring cytochrome P-450 are inh ib ited i f  the 
reaction is carried out in the presence o f CO as well as 0 2, and the inh ib ition  is 
reversed by m onochromatic lig h t o f wavelength 450nm. Workers in several 
laboratories have shown tha t cholesterol 7a-hydroxylase requires NADPH and O2 
fo r fu ll a c tiv ity , (Shefer, e t al., 1968; Boyd, e t al., 1969; M itropoulos and 
Balasubramaniam, 1972), and tha t the m icrosomal 7a-hydroxyla tion o f 
cholesterol is inhib ited by CO (Boyd, e t al., 1969; M itropoulos and 
Balasubramaniam, 1972; Mosbach, 1969; Wada, e t al., 1968).
More d irec t evidence tha t cytochrome P-450 is required fo r the 7a- 
hydroxylation o f cholesterol has been provided by the reconstitu tion  experiments 
o f Bjorkhem, £ t al. (1975a), who used p a rtia lly  purified  preparations o f 
cytochrome P-450 to restore the cholesterol 7a-hydroxylase a c tiv ity  o f inactive  
subfractions o f live r microsomes. The evidence im p lica ting  NADPH-cytochrom e 
c reductase in the 7a-hydroxylation o f cholesterol is la rgely in fe re n tia l, although 
Wada, e t al. (1969) have reported tha t an antibody to the flavopro te in  inh ib its  
the reaction. The 7a-hydroxylation o f cholesterol resembles other hepatic 
m icrosomal m ixed-function oxidases in not requiring the iron sulphur pro te in  
(adrendoxin) tha t is essential fo r cytochrome P-450 dependent hydroxylations 
occurring in adrenal m itochondria.
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1.8.5 D ie tary fib re  and its  relationship to cholesterol 7a-hydroxylase 
a c tiv ity
The 7a-hydroxylation o f cholesterol as the rate determ ining step in the 
synthesis o f b ile acids was suggested some years ago (Bergstrom, 1959). 
Although i t  remains possible tha t the rate o f hepatic synthesis o f cholesterol 
from  acety l CoA determines the ra te  o f form ation o f bile acids under some 
certa in  conditions. These findings have generated a great deal o f experim enta l 
work on the influence o f various factors upon the a c tiv ity  o f cholesterol 7a- 
hydroxylase. Thus much o f the evidence fo r the role o f this enzyme in b ile  acid 
synthesis is derived from  measurements o f its  a c tiv ity  under conditions known to 
a lte r the ra te  o f bile acid form ation .
I f  the 7a-hydroxyiation o f cholesterol is the ra te -lim itin g  reaction in the 
form ation o f b ile acids, then the a c tiv ity  o f cholesterol 7a-hydroxylase should 
increase se lective ly in the liv e r o f animals w ith  bile fis tu la . Danielsson, e t al. 
(1967) have shown tha t when bile acid synthesis in rats is stim ulated by making a 
b ile fis tu la , cholesterol 7a-hydroxylase a c tiv ity  increases in para lle l w ith  the 
increase in bile acid synthesis; the a c tiv itie s  o f the enzymes catalysing two o f 
the subsequent steps in the form ation o f cholic acid were not consistently 
influenced by this operation. However, a ttem pts to explain the e ffe c t o f 
cholesterol feeding on bile acid synthesis in animals in term s o f an e ffe c t on 
cholesterol 7a-hydroxylase a c tiv ity  have led to contrad ic to ry  results. Some 
workers have observed an increase in enzyme a c tiv ity  (M itropoulos, e t al., 1973; 
Balasubramaniam, e t al., 1973; Ling, e t al., 1979) a fte r cholesterol feeding, 
whereas others (Bjorkhem and Danielsson, 1975b; Story, e t al., 1976b) have 
fa iled to observe any s ign ifican t changes. These discrepancies cannot be 
explained by d ifferences in the amount o f cholesterol fed to the experim enta l 
animals since in each case cholesterol rich  diets contained 0.5% - 2.0%
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cholesterol. D ifferences in steroid synthesis and excretion have also been 
observed in two d ie ta ry groups. Serdarvich and C arro ll (1972) found tha t hepatic 
cholesterol synthesis was greater in rats fed com m ercial feed, than in those fed 
a sem isynthetic d ie t. While Johansson (1970) demonstrated th a t 7a- 
hydroxylation o f liv e r cholesterol is more rapid in rats fed the anion exchange 
resin cholestyram ine, than in those animals fed a sem isynthetic d ie t. Thus these 
animal experiments indicate many possible mechanisms of action to  explain the 
influence tha t d ie ta ry fib re  may have on lip id  metabolism. Most prom inent is 
tha t o f the influence on cholesterol absorption and bile acid synthesis and 
excretion, moreover, the two may be related.
Eastwood and Ham ilton (1968) found tha t s ign ifican t quantities o f bile 
acids were bound to non absorbable m ateria ls in the in testine. In fu rthe r 
experiments i t  was found tha t the binding o f bile salts by d ie ta ry m ateria ls could 
be duplicated in v it ro , and tha t lign in active ly  bound bile salts from  phosphate 
bu ffe r solutions. This in fo rm ation  added to ea rlie r experim enta l evidence 
indicating the possib ility  th a t d ie tary fib re  inhib ited cholesterol absorption by 
binding b ile salts. Such binding could result in fa ilu re  in m ice lla r fo rm ation , 
which is essential fo r cholesterol absorption, and this in turn would increase b ile  
acid excretion e ffe c ting  an increase in bile acid synthesis, and thus an increase 
in cholesterol 7a-hydroxylase a c tiv ity  to replace the lost b ile  salts from  
cholesterol. Both events would result in a drain o f the cholesterol pool from  the 
body.
1.9 O bjective o f the Investigation
Our understanding of the involvement o f d ie ta ry fib re  on lip id , carcinogen 
and m ineral metabolism is s t i l l  quite lim ite d . In spite o f the strong re lationships 
indicated by epidem iological observations, we s t il l know very l i t t le  concerning 
mechanisms involved, and details concerning the specific types o f d ie ta ry  fib re
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involved. One viable mechanism is the in te raction  o f some types o f d ie ta ry fib re  
w ith  b ile acids. The magnitude o f th is in te raction  appears to be su ffic ie n t to 
result in an a lte ra tion  o f bile acid excretion, and as a result an a ltered stero l 
balance. Moreover, th is a lte ra tion  may be responsible fo r the 
hypocholesterolaemic e ffects  o f certa in  d ie tary fibres. In addition, other 
mechanisms o f action must be considered. It  is apparent tha t changes in stero l 
excretion do not explain a ll the observed e ffects  o f d ie tary fib re . L it t le  is 
known concerning the e ffec ts  o f d ie ta ry fib re  on lipoprote in metabolism. 
Consequently, any study making an assessment o f plasma lipids as a risk fa c to r 
fo r vascular disease, therefore must include selective quan tifica tion  o f the 
lipoprote in classes.
The popularity o f wheat bran w ith  the general public in recent years as a 
source o f d ie ta ry fib re , together w ith  the con flic ting  reports in the lite ra tu re  o f 
its e ffe c t on lip id , carcinogen and m ineral metabolism, emphasise the need fo r 
fu rthe r research in to this pa rticu la r source o f d ie ta ry fib re . Therefore the aim 
o f th is investigation is to study in de ta il the e ffec ts  o f feeding wheat bran, and 
high fa t supplemented diets on lip id , carcinogen and m ineral metabolism. 
Integration o f a ll this in form ation should then c la r ify  the role o f wheat bran in 
th is respect, and make possible recommendations fo r d ie tary m odifica tions.
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CHAPTER 2
THE EFFECT OF WHEAT BRAN SUPPLEMENTATION ON 
THE LIPID METABOLISM OF THE RAT
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2.1 Introduction
In view of the epidem iological evidence o f the strong corre la tion  between 
plasma cholesterol, trig lycerides and coronary heart disease (Keys, 1970; Kannel, 
e t al., 1971; Carlson and B o ttige r, 1972), i t  seems appropriate to find regimens 
to decrease levels o f plasma and tissue lipids.
The studies discussed in Chapter 1 have demonstrated tha t the addition of 
certa in  p lant fibres to the d ie t o f experim ental animals is accompanied by a 
s ign ifican t decrease in plasma and tissue cholesterol concentrations. The e ffe c t 
o f wheat bran on lip id  metabolism however has been variable. In cho lestero l-fed 
animals, most studies have reported tha t wheat bran supplements fa iled  to lower 
values fo r plasma cholesterol, (Truswell and Kay, 1975; Tsai, e t a l., 1976; 
Malinow, et al., 1976; Mathe, e t al., 1977; Arvanitakis, et al., 1977) plasma 
trig lycerides (Malinow, et al., 1976; Arvanitakis, et al., 1977) and liv e r  
trig lycerides (A rvanitakis, e t al., 1977). However, Owen et al. (1975) observed 
tha t wheat bran lowered both plasma and live r cholesterol levels in cholesterol 
fed rats. When wheat bran is fed to human subjects, most studies also reported 
tha t wheat bran ingestion did not influence serum cholesterol and tr ig lyce ride  
values (Bremner, et al., 1975; Connell, e t al., 1975; Durrington, e t a l., 1975; 
Jenkins, e t al., 1975a and Jenkins, e t al., 1975b). However, serum trig lyce ride  
values were s ign ifican tly  decreased in fourteen subjects studied by Heaton and 
Pomare, (1974) and serum cholesterol was s ign ifican tly  decreased in tw en ty 
seven elderly subjects studied by Persson, e t al. (1976).
These con flic ting  reports o f the e ffe c t o f wheat bran ingestion in animals 
and humans require fu rthe r investigation. Therefore, the experiments described 
in th is chapter were designed to determ ine the long te rm  e ffe c t o f varying levels 
o f wheat bran supplementation on plasma and liv e r lip id  levels in the ra t, while 
Chapter 3 considered the short term  e ffe c t o f wheat bran supplementation o f the 
normal d ie t on plasma lip id  and carbohydrate metabolism in human subjects.
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2.2 M ateria ls and Methods
2.2.1 M ateria ls
O-Phthalaldehyde, and tr io le in  standard were obtained from  Sigma 
Chemical Company London. Cholesterol, polyethylene glycol 6000, pa lm itic  
acid, perchloric acid and vanadium pentoxide were purchased from  B ritish  Drug 
Houses L td ., Poole, Dorset. Isopropanol, sodium ethoxide and acetylacetone 
were obtained from  Cambrian Chemical Company, Croydon, Surrey. Most other 
chemicals were supplied by B.D.H. Ltd . and May and Baker L td . (May and Baker 
Ltd., Dagenham, Essex) or as specified in the tex t. A ll chemicals were an ly tica l 
grade unless otherwise stated. Gases were supplied by B.O.C. L td ., C raw ley, 
Sussex, and solvents were obtained from  May and Baker L td . and James 
Burroughs L td ., London. Water was glass-distilled and stored in polypropylene 
containers.
Heparin coated blood co llection  tubes were obtained from  Seward 
Laboratories, B lackfria rs  Road, London. LP2 and LP3 tubes were purchased 
from  Luckham Laboratories, Burgess H ill, Sussex. Syringes and needles were 
supplied by G ille tte  Surgical, Isleworth, Middlesex. F ilte r  paper was obtained 
from  Whatman Ltd ., Maidstone, Kent. Sovirel tubes were purchased from  V.A. 
Howe and Co. L td ., London. A ll other equipment used is as specified in the te x t.
2.2.2 Diets
The diets used in th is study were prepared by the F lour M illing  and Baking 
Research Association at Chorleywood. A ll the diets were isocaloric and the 
composition o f each is shown in Table 2:1. D ie t A (starch contro l d ie t) contained 
no wheat bran, D ie t F (low bran diet) contained 4.8% wheat bran, D ie t G (high 
bran diet) contained 9.6% wheat bran and D ie t H (high fa t d iet) contained no 
bran but 8.5% beef suet. D ie t J was the com m ercia lly prepared stock laboratory 
d ie t 41b (E. Dixons and Sons., Ltd., Ware). This d ie t contained 16.8% d ie ta ry  
fib re  and was included to check animal husbandry throughout the experim ent.
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2.2.3 Animals
Groups o f male and female and rats o f the Wistar stra in, weighing
approxim ately 50g at the beginning o f each experiment were maintained on diets
A, F, G, H and J fo r periods o f up to seventy-two weeks; the duration o f each 
experiment being indicated in the tables o f results. A ll animals were supplied by 
the University o f Surrey Anim al Breeding U n it, except fo r those animals which 
had been fed fo r twelve and seventy-two weeks at the laboratories o f the F lour 
M illing  and Baking Research Association. The animals were randomly assigned 
to each d ie t group, and housed . in polypropylene cages (39cm x 23 cm
x 18 cm) w ith  raised mesh floors. The temperature and re la tive  hum id ity  o f the 
animal house was regulated a t 22°C and 50% respectively, and lighted from  0700 
to 1900 hours. Water was provided ad lib itum , while food intakes and body 
weight measurements were made at regular intervals.
A t the end o f the designated feeding periods the rats were anaesthetised 
w ith  ether, and blood was w ithdrawn by cardiac puncture in to heparin tubes, 
plasma was prepared by centrifug ing  fo r 10 minutes at 2,000 rpm in an M.S.E. 
bench centrifuge; aliquots o f plasma were then placed in to LP3 tubes and stored 
a t -40°C u n til analysis. The rats were then k illed  by cerv ica l d islocation and the 
livers excised.
2.2.4 Preparation o f live r fractions
A ll animals were k illed  by cerv ica l dislocation a t approxim ate ly the same 
tim e o f day i.e. 9 am + 1 hour to avoid differences due to  d iurnal va ria tion  
(Radzialowski and Bousquet, 1968). The livers were quickly removed, and placed 
in beakers containing ice-cold 1.15% (w /v) KC1. A fte r  removal o f any adhering 
fa t or connective tissue the liv e r was b lo tted dry and weighed. An homogenate 
was prepared in ice-cold 1.15% (w /v) KC1 using a size C P o tte r-E lve jhem  type 
teflon-glass homogeniser. (A .H . Thomas and Co., Philadelphia, U.S.A.). The 
pestle was driven by a Black and Decker e le c tr ic  d r il l a t a speed of
approxim ately 2,750 rpm, three up and down strokes were used fo r each 
homogenisation. The homogenate was diluted to make a 1:4 d ilu tion  i.e. 1 ml o f 
KC1 solution contained the equivalent o f 250 mg of wet weight live r, and was 
then centrifuged in a 50 m l polypropylene centrifuge tubes at 10,000g fo r 20 
m inutes at 4°C  (MSE 'High Speed 18' x 50 m l angle ro to r, 11,000 rpm). The 
supernatant, re fe rred to as the microsomal supernatant, and comprising the 
m icrosomal and soluble ce ll fractions, was used to determ ine a number o f 
enzyme ac tiv ities .
For the preparation o f the microsomal frac tion  an aliquot (15 ml) o f the 
m icrosomal supernatant was centrifuged in a Beckman L-5 65 u ltracen trifuge  
w ith  a 8 x 25 m l angle head ro to r a t 105,000 g (40,000 rpm) fo r 60 m inutes a t a 
tem perature between 1-4°C. The supernatant was care fu lly  decanted and the 
pe lle t rinsed w ith  a few m l o f ice-cold 1.15% (w /v) KC1 to remove the adhering 
supernatant frac tion , and then resuspended in the same volume o f 1.15% (w /v) 
KC1 by gentle homogenisation; this constitu ted the m icrosomal suspension.
A ll the above procedures were perform ed as rapid ly as possible a t a 
tem perature o f 0-4°C . P rio r to use a ll fractions were stored a t -40°C.
2.2.5 Assay methods
Plasma to ta l cholesterol
Plasma to ta l cholesterol concentration was measured using the O- 
phthalaldehyde method (Rudel and M orris, 1973).
This method involves a pre lim inary saponification o f the plasma, fo llowed 
by extraction  o f the non-saponifiable lip id  w ith  hexane, and reaction o f the dried 
ex tra c t w ith  O-phthalaldehyde and concentrated sulphuric acid to fo rm  a 
cholestero l-specific  coloured product which absorbs a t 550nm.
A 0.1 m l aliquot o f plasma, 0.3 m l o f 33% (w /v) KOH and 3 m l o f 95% (v /v) 
ethanol were placed in a 15 m l sovire l tube. The tube was stoppered, and a fte r  a 
thorough m ixing was placed in a water bath at 60°C fo r 15 m inutes.
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A blank, consisting o f 0.1 m l o f absolute ethanol, and 0.1 m l o f cholesterol 
standard (1 m g/m l absolute ethanol) were saponified in para lle l. A fte r  cooling 
the tubes, 10 m l o f hexane was added fo rce fu lly  to each, followed by 3 m l o f 
d is tilled  water. The tubes were capped and shaken fo r 1 m inute on a ro ta ry  
shaker to ensure complete m ixing. A liquots (1 ml) o f the hexane layer were then 
pipetted in duplicate in to 10 m l test tubes and the solvent evaporated under 
nitrogen.
A 2 m l volume o f O-phthalaldehyde reagent (50 mg O-phthalaldehyde/100 
m l g lacia l acetic acid) was added to each tube, followed by thorough m ixing to 
dissolve the residue. Approxim ately 10 minutes a fte r this addition, 1 m l o f 
concentrated sulphuric acid was slowly added, and im m ediate ly fo llowed by 
vigorous m ixing. The absorbances o f the solutions were measured w ith in  30 
minutes a fte r the addition o f the concentrated sulphuric acid, using a Cecil U.V. 
spectrophotom eter (model CE 272) (Cambridge Instruments L td.).
Plasma hiqh-density lipoprote in cholesterol
Plasma high-density lipoprote in  cholesterol (HDL-C) concentration was 
measured using the p rec ip ita tion  method o f A llen, e t al. (1979). This method 
separates HDL-C  by selective p rec ip ita tion  o f very-low -density lipoprote ins 
(VLDL) and low-density lipoproteins (LDL) using polyethylene g lyco l 6000 (PEG 
6000). HDL-C is then measured in the clear supernatant flu id  a fte r  
cen trifugation .
Heparin treated plasma (0.2 ml) was added to 0.2 m l o f PEG 6000 solution 
(200g/l PEG 6000 in d is tilled  water) in an LP3 tube and vortex mixed 
im m ediate ly. The m ixture  was allowed to p rec ip ita te  fo r 1 hour a t room 
tem perature and then centrifuged at 3,000 rpm fo r 15 minutes in a Beckman 06 
centrifuge. The supernatant (0.1 ml) was then used fo r cholesterol determ ination 
by the method o f Rudel and M orris (1973). The HDL-C  concentration was 
calculated by the use o f a range o f cholesterol working standards (25 - 100 
mg/100 ml).
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Plasma to ta l lip id
Plasma to ta l lip id  concentration was measured using a reagent k it  
(Biochemica Test Combination No. 124.303, Boehringer Mannheim GmbH, 
Mannheim, W. Germany) based on the method o f Zollner and Krosch (1962). This 
is a sulphophosphovanillin reaction, involving the reaction of lip ids w ith  sulphuric 
and phosphoric acids and van illin  to form  a pink-coloured complex, the 
absorbance o f which is measured at 546 nm.
Plasma to ta l trig lyce ride
Plasma to ta l trig lyce ride  concentration was measured using the method o f 
Soloni (1971).
Several methods have been described tha t use d iffe ren t approaches fo r the 
determ ination o f plasma trig lycerides: by use o f phenylhydrazine or
m ercaptoacetic reactions, by oxidation to yield aldehydes which are then th in - 
layer chromatographed, and by th in -layer chromatography combined w ith  
in frared spectrophotom etry. Probably the best known and most used reactions 
however, are those between chrom otropic acid and formaldehyde, or 
acetylacetone and formaldehyde.
The disadvantage w ith  the above methods is tha t they are cumbersome and 
time-consuming. The method o f Soloni overcomes these d iffic u ltie s , by using the 
extraction  procedure o f Royer and Ko (1969). This extraction  procedure does not 
make i t  necessary to remove phospholipids by adsorbing them onto s ilic ic  acid. 
The alkoxide transeste rifica tion  w ith  sodium ethoxide is faster than the 
conventional saponification (Soloni, 1971). Sodium ethoxide ra the r than 
methoxide is used because traces o f methanol derived from  the methoxide could 
in te rfe re  w ith  the fin a l colour development.
A chloro form  wash used a fte r transeste rifica tion  reta ins the heptane, 
isopropanol, fa tty  acids and esters in the lower phase, leaving the g lycero l in the 
aqueous sulphuric acid (upper) layer. An aliquot o f this upper layer then undergo 
oxidation and fina lly  colour development w ith  acetylacetone (2,4-pentanedione),
this forms 3,5 d iacety l-1 ,4 -d ihydro lu tid ine , a yellow  product that absorbs at 415 
nm.
A 0.15 m l a liquot o f plasma, 0.5 m l o f F^SO^ (0.04 M) and 2.5 m l o f 
ex trac tion  solvent (n-heptane-isopropanol, 2: 3.5 v/v) were placed in duplicate 
in to 10 m l screw-capped sovire l tubes. Into s im ila r tubes was added 2.35 m l of 
extraction  solvent, 0.5 m l o f F^SO^ (0.04 M), 0.15 m l o f d is tilled  w ater and 0.15 
m l o f tr io le in  standard solution (2 mg/100 m l in extraction  solvent) in duplicate. 
Blanks were prepared in duplicate by adding to s im ila r tubes 2.5 m l o f ex trac tion  
solvent, 0.5 m l o f H^SO^ (0.04M) and 0.15 m l o f d is tilled  water.
Tubes were stoppered, and mixed w ith  a vortex m ixer fo r 15 seconds, and 
stood fo r 2 m inutes a t room tem perature to allow the phases to separate, 
cen trifugation  was not necessary. From each tube 0.5 m l o f the upper phase was 
pipetted in to a s im ila r tube, and 0.5 m l o f sodium ethoxide solution was added 
(0.1M sodium ethoxide in isopropanol). The tubes were stoppered, mixed, and 
then incubated fo r 15 minutes in a water bath at 60°c (M ickle Laboratory 
Engineering Co., Gomshall, Surrey).
Follow ing transeste rifica tion , 1 m l o f F^SO^ (0.8M) and 2 m l o f ch loro fo rm  
was added to each tube. Tubes were stoppered and vortex-m ixed fo r 15 seconds 
and allowed to stand fo r a fu rthe r 2 m inutes to again separate the phases. The 
upper phase (0.8 ml) was pipetted in to a set o f clean acid-washed tes t tubes, 
fo llowed by 0.1 m l o f sodium m eta-periodate solution (0.02M). Tubes were mixed 
by sw irling, and a fte r 10 m inutes 0.1 m l o f sodium arsenite solution (0.2M) was 
added to each tube, and again mixed by sw irling. A fte r  5 minutes, 2 m l o f 
freshly prepared acetylacetone reagent was added to each tube and vortex m ixed 
fo r 2-3 seconds. (Acetylacetone reagent was prepared by adding 0.25 m l o f 
acetylacetone to 25 m l o f 3M ammonium acetate solution. This reagent was 
prepared a t least 15 minutes before use, and used w ith in  one hour o f 
preparation). The tubes were then incubated fo r 10 minutes in a w ater bath a t 
60°C. The absorbance was read at 415 nm against a blank set a t zero absorbance
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in a Cecil U.V. spectrophotom eter (model CE 272).
Since soaps and detergents may contain glycerol and trig lycerides, a ll 
glassware used in th is experiment was soaked fo r 24 hr in 50% n itr ic  acid p rio r to 
use.
Plasma non-esterified fa tty  acids
Plasma non-esterified fa tty  acids were measured using a reagent k it  
(Biochemica Test Combination No. 126.055, Boehringer Mannheim GmbH, 
Mannheim, W. Germany); based on the method o f Duncombe (1964).
The non-esterified fa tty  acids are converted to chloroform  soluble copper 
salts w ith  a bu ffe r/cup ric  n itra te  solution (trie thanolam ine bu ffe r 0.45M pH 7.8 
and cupric n itra te  0.27M). The copper in the organic layer is subsequently 
measured co lo rim e trica lly  by d iethyld ith iocarbam ate (9 mM) a t 436 nm. The 
concentration o f the non-esterified fa tty  acids being proportional to  the 
absorbance o f the copper-containing ch loro form  layer.
Plasma phospholipids
Over the years many methods have evolved fo r the determ ination o f 
plasma phospholipids, tha t o f Fiske and SubbaRow being by fa r  the most 
frequently used. However, in recent years i t  has been critic ised  fo r lack o f 
reproducib ility , narrow range o f acid tolerance, poor sens itiv ity , lack o f 
linea rity , in s tab ility  o f fina l colour and tu rb id ity  form ation (N aito , 1975). 
Therefore, the method used in th is chapter fo r plasma phospholipid 
determ ination is tha t o f Naito (1975). This is a m odifica tion o f the Fiske and 
SubbaRow method, e lim ina ting most o f the above problems by using vanadium 
pentoxide as a cata lyst fo r sample digestion.
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Digestion procedure-phosphorus determ ination on trich lo race tic  acid 
p re c ip ita te : Plasma (0.1 ml) was placed in duplicate into 15 ml screw 
capped sovirel tubes, 3 m l o f trich lo ra ce tic  acid solution (100 g /L) was added, 
and the contents o f each tube care fu lly  mixed w ithout allowing the p rec ip ita te  
to adhere to the walls o f the tube above the solution. The tubes were stood a t 
room tem perature fo r 10 minutes and then centrifuged at 3,000 rpm fo r 15 
minutes in a Beckman 06 centrifuge. The supernatant flu id  was discarded, and 
the prec ip ita te  washed w ith  5 m l o f d is tilled  w ater by resuspending it ,  and then 
recentrifug ing. The supernatant was again discarded and to each tube was added 
0.5 m l o f digestion m ixture  (0.25g vanadium pentoxide / l i t r e  72% perch loric acid) 
and heated fo r 30 minutes at 240°C on a m icroK je ldahl digestion unit. 
(Gallenkhamp L td ., London). The higher the phosphorus concentration o f the 
sample the longer the digestion tim e was required. I t  is im portant tha t a fte r 
digestion, the digestion m ixture  be allowed to m ix w ith  the contents o f the walls 
o f the tube, by placing the tube in a horizonta l plane and ro lling  the tube to 
allow the digestion m ixture  to wash the sides o f the tube. D igestion was 
considered to be completed when a clear and colourless solution was obtained. 
The digest m ixture  was cooled to room tem perature and 4 m l o f d is tilled  w ater 
was added to each tube.
A fte r  the digestion procedure, a reagent blank and a range o f phosphorus 
standards were set up (phosphorus stock standard 1 g /L) in duplicate as fo llow s:
Blank Standard Test
Plasma digest (ml) 
Digestion m ixture (ml) 
Working standard (ml) 
D is tilled  water (ml) 4.0
0.5
3.0
0.5
1.0
4.0
0.5
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To a ll tubes, 1 m l o f ammonium molybdate solution (25 g ammonium 
m olybda te /litre ) was added and mixed fo r 2-3 seconds on a vortex m ixer. Then 1 
m l o f l-am ino-2-napthol-4-sulphonic acid reagent (1.587 g Fiske and SubbaRow 
reducer/100 ml d is tilled  water) was added. The tubes were again mixed, and 
placed in a boiling w ater bath fo r 10 minutes. The tubes were cooled to room 
temperature and the absorbance read a t 660 nm in a C ecil U.V. 
spectrophotom eter (model CE 272).
Plasma glucose
Plasma glucose concentration was measured using a Beckman glucose 
analyser (Stevens 1971). This is a polarographic oxygen analyser which measures 
the ra te  o f oxygen depletion from  an oxygen saturated solution o f the enzyme 
glucose oxidase, the ra te  o f which is d ire c tly  proportional to the concentration 
o f glucose in the sample. 6 -D-Glucose from  the sample combines w ith  dissolved 
oxygen from  the reagent thus:
Glucose oxidase
8-D-glucose + 0 9-------------------------- — >  gluconic acid + H90 ?
H20  l  l
In the above reaction, oxygen is consumed a t the same ra te  as glucose in the 
sample reacts to form  gluconic acid. A t a ll times during the reaction the ra te  o f 
oxygen consumption is d irec tly  proportional to the concentration o f glucose in 
the reaction cup.
E xtraction  o f live r lip ids
L iver lip ids were extracted from  live r homogenate (25%) according to the 
method o f Folch, e t al. (1956).
A 0.25 m l aliquot o f live r homogenate was p ipetted in duplicate in to  a 10 
m l sovirel tube. To this was added 4.25 m l chloro form -m ethanol (2:1 v /v ). The 
tube was stoppered and the contents mixed on a ro ta ry  m ixer fo r 10 m inutes.
-  54 -
The m ixture  was then filte re d  through a Whatman No. 1 f i l te r  paper (moistened 
w ith  chloroform -m ethanol (2:1 v/v)) in to  a fresh 10 ml sovirel tube. The 
remaining contents of the f irs t  tube was re-extracted  w ith  a fu rthe r addition o f 
3 m l o f chloroform -m ethanol (2:1 v/v) fo r 10 minutes, and then filte re d  through 
the same f i l te r  paper to give a to ta l volume of 7.5 ml in the second sovire l tube.
A 1.5 m l aliquot of 0.8% (w /v) KC1 was added, and the tube mixed fo r 5 
minutes on the ro ta ry  m ixer, followed by centrifugation  at 2,000 rpm in an MSE 
M istra l 6L centrifuge fo r 5 minutes. The upper phase was removed using a 
pasteur p ipette  attached to a w ater pump and the lower phase was then washed 
three tim es by the carefu l addition o f 1 ml of pure solvent upper phase 
(ch loro form -m ethanol-w ater 3:48:47 v /v /v ). This was removed by the w ater 
pump, and the lower phase and the remaining upper phase combined by the 
addition o f 0.5 m l of methanol.
The resulting solution was dried under nitrogen in a water bath a t 30°C. 
The lipids were redissolved in chloro form  (1 ml), and the tube was kept t ig h tly  
stoppered on ice. The lip id -ch lo ro fo rm  ex trac t was used fo r the determ ination 
o f to ta l lip id , cholesterol, and non-esterified fa tty  acids. The e x tra c t could be 
stored fo r up to two weeks a t -20°C. The e ffic iency  o f extraction  o f lip ids by 
th is method was found to be > 95%.
Measurement o f live r to ta l lip id
L ive r to ta l lip id  concentration was determined on a 50 ] i l  a liquot o f the 
lip id -ch lo ro fo rm  ex tra c t using the reagent k it  (Biochemica Test Com bination No. 
124.303, Boehringer Mannheim GmbH, Mannheim, W. Germany) described 
previously fo r plasma.
Measurement o f live r to ta l cholesterol
L ive r to ta l cholesterol concentration was determ ined on a 0.1 m l a liquot o f
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the lip id -ch lo ro fo rm  ex trac t using the method of Rudel and M orris (1973) 
described previously fo r plasma.
Measurement o f live r to ta l trig lyce ride
L iver to ta l trig lyce ride  concentration was measured on a 0.15 m l a liquot o f 
a 25% live r homogenate by the method o f Soloni (1971) described previously fo r 
plasma.
Measurement o f live r to ta l phospholipids
L iver homogenate (25%) was diluted th ree-fo ld  w ith  1.15% (w /v) KC1, a 0.1 
ml a liquot was then used fo r the determ ination o f live r phospholipids by the 
method o f Naito (1975) described previously fo r plasma.
Measurement o f live r non-esterified fa tty  acids
L iver non-esterified fa tty  acid concentration was determ ined on a 0.2 m l 
aliquot o f the lip id -ch lo ro fo rm  ex trac t using the reagent k it  (Biochemica Test 
Combination No. 126.055, Boehringer Mannheim GmbH, Mannheim, W. Germany) 
described previously fo r plasma.
Measurement o f live r glycogen
L iver glycogen was measured by the method o f P fle iderer (1963). L ive r 
homogenate (1 m l o f 25%) and 2 m l o f KOH (30% w /v) were heated in dup licate in 
a boiling water bath fo r 15 minutes. The m ixture  was then cooled before the 
addition o f 3.5 m l o f absolute alcohol, and the p rec ip ita te  containing the 
glycogen obtained by cen trifuga tion  at 2,000 rpm fo r 5 minutes in a Beckman J6 
centrifuge. The p rec ip ita te  was then hydrolysed to glucose by heating w ith  2 m l 
o f (1 M) in a boiling water bath fo r 2 hours. The solutions were cooled to
room tem perature, neutralised w ith  NaOH (1 M) and the glucose concentration o f 
a suitable d ilu tion was measured using a Beckman glucose analyser.
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2.2.6 S ta tis tica l analysis
S ta tis tica l analysis was carried out using Student's unpaired t- te s t. The 
level of significance based on this test being indicated in the tables o f results.
2.3 Results
The results o f feeding D ie t A (starch contro l diet), D ie t F (low bran d iet), 
D ie t G (high bran diet), D ie t H (high fa t d iet) and D ie t J (stock d ie t 41b) fo r four, 
six, twelve and seventy-two weeks on male and female ra t body weight, live r 
weight and food intake are presented in Tables 2:2 to 2:7. Growth curves o f ra ts 
fed these diets fo r four, twelve and seventy-two weeks are shown in Figures 2:1 
to 2:5. Inclusion o f wheat bran at a level o f 4.8% (low bran d iet, D ie t F) or 9.6% 
(high bran diet, D ie t G) did not a ffe c t body weight gain; while no s ign ifican t 
d iffe rence in food intake was observed between those animals fed diets F,G,H 
and J, and those fed the starch contro l d ie t (D ie t A) throughout the study period. 
Male rats fed the high fa t d ie t (D ie t H) fo r four weeks had a s ign ifican t decrease 
in body weight gain (p < 0.01) and live r weight (p < 0.02), when compared to those 
animals fed the starch contro l d ie t (D ie t A) (Table 2:2). This resu lt is due to the 
s ign ifican tly  lower in it ia l body weight (p < 0.02) o f this group o f animals a t the 
beginning o f the experiment and is not repeated fo llow ing six, tw e lve and 
seventy-two weeks o f feeding the high fa t  d ie t to e ither male or female ra ts; 
however, body weight gain data is not available fo r female ra ts fed the high fa t 
d ie t fo r seventy-two weeks. Male rats fed the high fa t d ie t (D ie t H) fo r tw elve 
weeks show a s ign ifican t decrease in the ir re la tive  live r weights (p < 0.02) 
compared to those animals fed the starch contro l d ie t (D ie t A) (Table 2:4). The 
stock d ie t 41b (D ie t J) had no : e ffe c t on body weights a fte r  tw e lve and
seventy-two weeks o f consumption in e ither male or female rats, but a 
s ign ifican t decrease was found in live r weights when this d ie t was fed to  male 
rats fo r twelve weeks (p < 0.02) compared to those animals fed the starch con tro l 
d ie t (D ie t A) (Table 2:4).
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The results of feeding diets A, F, G, H and J fo r four, six, twelve and 
seventy-two weeks on the mean plasma and hepatic cholesterol concentration 
are summarised in Tables 2:8 and 2:9 respectively. Those animals fed the low 
bran (D ie t F) and high bran (D ie t G) diets, had no sign ificant a lte ra tion  in th e ir 
plasma cholesterol concentration when compared to those animals fed the starch 
contro l d ie t (D ie t A). However, male rats fed the high fa t d ie t (D ie t H) had a 
s ign ifican t decrease in plasma cholesterol concentration of 11% (p < 0.05) a fte r 
four weeks (Table 2:8). A s ign ifican t decrease o f 36% (p < 0.01) in plasma 
cholesterol concentration was found a fte r feeding the stock d ie t 41b (D ie t J) to 
male rats fo r twelve weeks, compared to those animals fed the starch contro l 
d ie t (D ie t A) (Table 2:8). The low bran (D ie t F) and high fa t (D ie t H) diets had no 
s ign ifican t e ffe c t on hepatic cholesterol concentration during th is study when 
compared to the starch contro l d ie t (D ie t A) (Table 2:9). Whereas male ra ts  fed 
the high bran (D ie t G) d ie t had a s ign ifican t increase in levels (p < 0.01) fo llow ing 
seventy-two weeks o f feeding when compared to those animals fed the starch 
contro l d ie t (D ie t A). The stock d ie t 41b (D ie t J) fed to male ra ts  fo r tw e lve 
weeks caused a s ign ifican t decrease in hepatic cholesterol concentration o f 50% 
(p < 0.01) compared to those animals fed the starch contro l d ie t (D ie t A); but a 
s ign ifican t increase was found fo llow ing seventy-two weeks o f feeding (p < 0.05) 
(Table 2:9).
The results o f feeding diets A, F, G, H and J fo r four, six, tw e lve  and 
seventy-two weeks on the mean plasma and hepatic trig lyce ride  concentra tion 
are shown in Tables 2:10 and 2:11 respective ly. From these results i t  is found 
tha t the high bran d ie t (D ie t G) had no s ign ifican t e ffe c t on e ithe r male or 
female ra t plasma trig lyce ride  concentration when compared to those animals 
fed the starch contro l d ie t (D ie t A). Moreover, the low bran (D ie t F) d ie t fed to  
male rats fo r four weeks caused a s ign ifican t increase in plasma trig lyce rid e  
concentration o f 53% (p < 0.02) when compared to those animals fed the starch
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contro l d ie t (D ie t A) (Table 2:10). Both the male and female rats fed the stock 
d ie t 41b (D ie t J) had s ign ifican t decreases in the ir plasma trig lyce ride  
concentrations, a 40% decrease (p < 0.02) was observed in male rats a fte r twelve 
weeks o f feeding and a 34% decrease (p < 0.01) was found in female rats 
fo llow ing seventy-weeks o f feeding D ie t J, compared to those animals fed the 
starch contro l d ie t (D ie t A). However, male rats fed D ie t J fo r seventy-two 
weeks had a s ign ifican t increase (p < 0.01) in plasma trig lyce ride  levels compared 
to those animals fed the starch contro l d ie t (D ie t A).. Both the low bran (D ie t F) 
and high bran (D ie t G) diets produced s ign ifican t decreases in hepatic 
trig lyce ride  concentration in male rats a fte r four and six weeks o f feeding 
respectively, when compared to those animals fed the starch con tro l d ie t (D ie t 
A) (p < 0.05 a fte r four weeks, p < 0.02 a fte r  six weeks) (Table 2:11). While male 
rats fed the high fa t d ie t (D ie t H) had s ign ifican tly  higher hepatic trig lyce ride  
values a fte r four and seventy-two weeks o f feeding compared to those ra ts fed 
the starch contro l d ie t (D ie t A) (p < 0.02 a fte r four weeks, p < 0.05 a fte r  
seventy-two weeks). The stock d ie t 41b (D ie t J) had no s ign ifican t e ffe c t on 
hepatic trig lyce ride  concentration when compared to those animals fed the 
starch con tro l d ie t (D ie t A).
The mean plasma and hepatic phospholipid concentration during the study 
is shown in Tables 2:12 and 2:13 respective ly. The results o f th is experim ent 
have demonstrated tha t feeding the low bran (D ie t F) and high fa t diets (D ie t H) 
fo r four weeks, and the high bran d ie t (D ie t G) fo r twelve weeks, produce 
s ign ifican t increases in plasma phospholipid levels (p < 0.01) compared to those 
animals fed the starch contro l d ie t (D ie t A) (Table 2:12). The high fa t d ie t (D ie t 
H) produced s ign ifican t increases in live r phospholipid levels both a fte r  four 
weeks o f feeding to male rats (p < 0.02), and a fte r seventy-two weeks o f feeding 
to female rats (p < 0.02) (Table 2:13). This represented an increase in hepatic 
phospholipid concentration o f 24% and 17% respective ly when compared to those 
animals fed the starch contro l d ie t (D ie t A). Both the male and fem ale rats fed
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the stock d ie t 41b (D ie t J) fo r seventy-two weeks had s ign ifican t increases in 
the ir live r phospholipid concentrations when compared to those animals fed the 
starch contro l d ie t (D ie t A) (p < 0.05 fo r the male ra t, p < 0.02 fo r the female 
rat).
The results o f feeding diets A, F, G, H and J on the mean plasma and
hepatic to ta l lip id  concentration are shown in Tables 2:14 and 2:15 respective ly.
Plasma to ta l lip id  concentration was not a ffected  by e ither the high bran, (D ie t
G) low bran (D ie t F) or high fa t (D ie t H) diets throughout th is study when
compared to those animals fed the starch contro l d ie t (D ie t A). However, from
Table 2:14 i t  is found tha t the animals fed the high bran d ie t (D ie t G) had higher
plasma to ta l lip id  concentrations than the starch fed contro l group throughout 
but this was not s ta tis tica lly  s ign ifican t, 
the entire  study,^M ale rats fed the stock d ie t 41b (D ie t J) fo r tw elve weeks had
a s ign ifican t decrease o f 26% (p < 0.02) in plasma to ta l lip id  concentration,
however, male rats fed the same d ie t fo r seventy-two weeks had a s ign ifican t
increase o f 51% (p < 0.02) in plasma to ta l lip id  concentration compared to those
animals fed the starch contro l d ie t (D ie t A). The mean liv e r to ta l lip id
concentration was not s ign ifican tly  a ffected  in rats fed the high bran d ie t (D ie t
G) during this study, whereas rats fed the low bran d ie t (D ie t F), fo r fou r weeks 
had a s ign ifican t decrease in levels o f 43% (p < 0.01) compared to those animals 
fed the starch contro l d ie t (D ie t A) (Table 2:15). Male rats fed the high fa t  (D ie t
H) d ie t, had a s ign ifican t decrease in hepatic to ta l lip id  levels a fte r four weeks 
o f feeding, this represented a decrease o f 17% (p < 0.05) compared to those 
animals fed the starch contro l d ie t (D ie t A). The stock d ie t 41b (D ie t J) 
s ign ifican tly  decreased hepatic to ta l lip id  concentration in male ra ts by 44% (p < 
0.02) a fte r twelve weeks o f feeding, compared to those animals fed the starch 
contro l d ie t (D ie t A).
The mean plasma HDL-cholesterol concentration during the study is shown 
in Table 2:16. Throughout the study, those animals fed the high bran d ie t (D ie t
Ta
ble
 
2:1
4 
E
ffe
ct
 
of 
fe
ed
in
g 
Di
et
 
A 
(s
ta
rc
h 
co
nt
ro
l 
di
et
) 
Di
et
 
G 
(h
igh
 
br
an
 
di
et
)
Di
et
 
F 
(lo
w 
br
an
 
di
et
) 
Di
et
 
H 
(h
igh
 
fa
t 
di
et
) 
Di
et
 
J 
(s
to
ck
 
di
et
 
41
b)
 
on 
pla
sm
a 
to
ta
l 
lip
id
 
co
nc
en
tra
tio
n 
in 
ra
ts
-  77 -
*
*
* *1—
* + -
o lA CM
fA fA ON
+  1 +  1 +  1 +  1
OV
CO ov VO<r vo CO VO
co
*4—3
0
i-t
4—3c
0 __o O
c E o c
o O
2 3
■a e
4-3O
4-3
CO
E
to0
0
Q
0
4-3
0
□
<—1 CM Ov CM i—i O
fA fA 1 CO vo
+  1 +  1 +  1 + 1 +1 +
CO fA O
vo CO i—1
vo CO LA VO vo
LA
CO
+ 1
co
LA 
+ 1
CO
voorH
+1
VOOv
VO
CO<r LAVO
+ 1 +1
vo voC" vo
-H-f-
ai—i 
+ 1
oaov
4-3
0
0
Q
r ^ CM fA
fA fA Ov
+  1 +  1 + 1 i I I
LA i-H LA
1—1 CM LA
CO VO
+ -
CO Ov OV vo fA i—1
LA LA LA
+  1 +  1 +  1 +  1 +  1 +
i—1 i—1 fA vo
CM vo <± Ov o vvo LA VO
cn
c
TO
0
0
VO
* 5
VO CJ.
Of
LA LA
Of
LA
Co
4 J0£-.D
Q
vo CM CM CM CM
Ta
ble
 
2:1
5 
E
ffe
ct
 
of 
fe
ed
in
g 
Di
et
 
A 
(s
ta
rc
h 
co
nt
ro
l 
di
et
) 
Di
et
 
G 
(h
igh
 
br
an
 
di
et
)
Di
et
 
F 
(lo
w 
br
an
 
di
et
) 
Di
et
 
H 
(h
igh
 
fa
t 
di
et
) 
Di
et
 
J 
(s
to
ck
 
di
et
 
41
b)
 
on 
liv
er
 
to
ta
l 
lip
id
 
co
nc
en
tra
tio
n 
in 
ra
ts
-  78 -
CO
fA
LA
CM
VO
LAfA
CO
O
VO
fA
vo
fA
CD
OV
CM
CD
fA
OV
LA
cn
■a
VO CM
XJ0
4—)COa
Xc
0
C-.0
X
£
II
c
4 -4-
fA'
II
C
CL0ax
0
CO0
CO0
X
4 -1c0
C-c0
CL
C0>
’cn
.co
Q .
DO
C-Icn
4 -10
X
SZo00
Ci0
X I
E
D
C
X Ic0
>T0
CO
0
SZh-
0
X
■■■<O
4->coa
xa
Ci0
0
Q
sz
X
0
c_
0
C l
Eoa
i—i
CD
CD
V  
CL 
*
**
A?
CD
CD
V
CL
*
*
irTo
o
V  
CL 
*
LdCO
+1
c00
E
0X
c0
CO0
CL0
C-I
0D
0>
Xa0
Ld
Ta
ble
 
2:1
6 
E
ffe
ct
 
of 
fe
ed
in
g 
Di
et
 
A 
(s
ta
rc
h 
co
nt
ro
l 
di
et
) 
Di
et
 
G 
(h
igh
 
br
an
 
di
et
)
Di
et
 
F 
(lo
w 
br
an
 
di
et
) 
Di
et
 
H 
(h
igh
 
fa
t 
di
et
) 
Di
et
 
J 
(s
to
ck
 
di
et
 
41
b)
 
on 
pla
sm
a 
H
D
L-
ch
ol
es
te
ro
l 
co
nc
en
tra
tio
n 
in 
ra
ts
-  79 -
a
oo
oo
CM
a
o
co o  0 a oONVO CM
LT\
ON
VO
CM
O
LfN
cn
Of
LT\vo
vo
■a0
0a
TD
C,
0Ci0
JC
£
II
c
KN
II
C
4—
j-T
CL0o
X0
CO0co0
JZ
4~>
c0
C-.0
CL
C0>
CT
CO
CL
ZJO
C-4cn
0
JCa00
C
CO
"co
E
c0
Cl0JO
E
ZJ
C
TD
C0
X0
CO
0
JC
4-J0
o
C l
Coa
JCac_0
0
5
JC
TD0
C_0
CL
EOo
I—I 
CD
CD
V
CL
***
IA
CD
CD
V  
CL 
*
Ldco
+1
c00
E
0
JZ
c0co0
Ch
Q .0
C-i
0
ZJ
*0>
JCo0
Ld
-  80 -
G) had higher plasma H D L-cholesterol levels than those animals fed the starch 
contro l d ie t (D ie t A). Follow ing twelve weeks o f feeding the high bran d ie t to 
male rats, and seventy-two weeks o f feeding to female rats, s ign ifican t increases 
in plasma HD L-cholesterol concentration was observed (p < 0.05) (Table 2:16). 
This represented an increase o f 40% and 30% in HDL-cholesterol concentration 
at twelve and seventy-two weeks respective ly, when compared to those animals 
fed the starch contro l d ie t (D ie t A). Male rats fed the low bran d ie t (D ie t F) fo r 
twelve weeks had a s ign ifican t increase o f 64% (p < 0.05) in plasma HDL 
cholesterol concentration compared to those animals fed the starch contro l d ie t 
(D ie t A). Male rats fed the high fa t d ie t (D ie t H) fo r four weeks had a 
s ign ificantly  lower plasma HD L-cholesterol concentration (p < 0.01), 
however, a fte r seventy-two weeks o f adm in istra tion a s ign ifican t difference o f 
21% (p < 0.05) in plasma HD L-cholesterol concentration is noted, compared to 
those animals fed the starch contro l d ie t (D ie t A) (Table 2:16). A s ign ifican t 
increase in plasma H D L-cholesterol concentration is observed in both male and 
female rats fed the stock d ie t 41b (D ie t J) fo r twelve and seventy-two weeks (p < 
0.05). This represented an increase o f 34% fo r the twelve week fed fem ale rats, 
a 26% increase fo r the seventy-two week fed male rats and a 55% increase in 
plasma HDL cholesterol concentration fo r the seventy-two week fed fem ale rats, 
when compared w ith  those animals fed the starch contro l d ie t (D ie t A).
Feeding diets A, F, G, H and J fo r four, eight, twelve and seventy-tw o 
weeks had no consistent e ffe c t on e ither the plasma or hepatic non-esterified  
fa tty  acid concentration throughout the study (Tables 2:17 and 2:18). The high 
bran d ie t (D ie t G) produced a s ign ifican t decrease o f 50% (p < 0.05) in the plasma 
non-esterified fa tty  acid concentration o f male rats fed this d ie t fo r seventy-tw o 
weeks, compared to those animals fed the starch contro l d ie t (D ie t A) (Table 
2:17). Male rats fed the low bran d ie t (D ie t F) fo r four weeks had a s ign ifican t 
decrease in plasma non-esterified fa tty  acids (p < 0.02), while a fte r  e ight weeks 
o f feeding the low bran diet, a s ign ifican t increase (p < 0.01) was observed
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compared to those animals fed the starch contro l d ie t (D ie t A). The high fa t d ie t 
(D ie t H) produced a s ign ifican t increase (p < 0.01) in plasma non-esterified  fa tty  
acid levels in male rats a fte r e ight weeks of feeding, while seventy-two weeks of 
feeding this d ie t caused a s ign ifican t decrease (p < 0.01) in levels compared to 
those animals fed the starch contro l d ie t (D ie t A). The stock d ie t 41b (D ie t J) 
had no s ign ifican t e ffe c t on plasma non-esterified fa tty  acid concentration. 
Feeding the low bran (D ie t F), high bran (D ie t G) and stock d ie t 41b (D ie t J) to 
male rats fo r four, eight and twelve weeks had no s ign ificant e ffe c t on hepatic 
non-esterified fa tty  acid concentration when compared to those animals fed the 
starch contro l d ie t (D ie t A) (Table 2:18), however, no data is available fo r 
animals fed these diets fo r seventy-two weeks. Male rats fed the high fa t d ie t 
(D ie t H) fo r four weeks had a s ign ifican t decrease o f 50% (p < 0.01) in hepatic 
non-esterified fa tty  acid concentration compared to those animals fed the starch 
contro l d ie t (D ie t A) (Table 2:18).
The low bran (D ie t F), high bran (D ie t G) and stock d ie t 41b (D ie t J) had no 
s ign ifican t e ffe c t on live r glycogen concentration when compared to those 
animals fed the starch contro l d ie t (D ie t A) (Table 2:19). The high fa t  d ie t (D ie t
H) produced a s ign ifican t decrease o f 59% (p < 0.05) in live r glycogen levels a fte r  
four weeks o f feeding to male rats, when compared to those animals fed the 
starch contro l d ie t (D ie t A).
The results o f feeding diets A, F, G, H and J on the mean plasma glucose 
concentration are summarised in Table 2:20. The diets had no consistent e ffe c t 
on plasma glucose concentration throughout the study, however, a s ign ifican t 
increase in levels was observed in male rats fed the high fa t d ie t (D ie t H) fo r 
seventy-two weeks (p < 0.02) when compared to those animals fed the starch 
contro l d ie t (D ie t A).
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2.4 Discussion
Cereal fib re  in the form  of wheat bran is the most extensively studied type 
o f d ietary fib re . Although a t least ten human studies of its  e ffe c ts  on to ta l 
plasma cholesterol have been un ifo rm ly negative, two b rie f reports (Bremner, et 
al., 1975; O'Moore, et a l., 1978) indicate tha t bran m ight increase H D L- 
cholesterol in man. In the present study therefore , wheat bran was chosen as the 
source o f d ie ta ry fib re , and was incorporated in to  the test diets F and G a t a 
level to represent a low and high fib re  intake o f an average 70 kg man per day. 
Moreover, by incorporating the wheat bran in the diet, i t  provides the animals 
w ith  a more physiological d ie ta ry pattern  ra ther than adm inistering i t  in one 
dose.
The low bran d ie t containing 4.8% wheat bran (D ie t F) and the high bran 
d iet containing 9.6% wheat bran (D ie t G) did not a ffe c t the growth o f the ra ts or 
th e ir food intake during the study (Tables 2:1 to 2:5). These findings are in 
contrast to those o f Asp, e t al. (1981) who found tha t food in take in ra ts  
increased roughly proportiona lly to the d ie tary fib re  content o f the d ie t. The 
results o f th is study indicate tha t neither the low bran or high bran diets had any 
overall e ffe c t on plasma glucose, lip id  or hepatic lip id  levels throughout the 
tr ia l.  Failure o f wheat bran to decrease plasma cholesterol and trig lyce rid e  
values have been reported in previous studies (Truswell and Kay, 1975; Tsai, e t 
al., 1976; Malinow, e t al., 1976; Mathe, e t al., 1977; A rvan itakis, e t a l., 1977, 
Eastwood, 1969; Eastwood, e t al., 1973; Bremner, e t al., 1975). Moreover, the 
use o f the high bran d ie t was found to increase plasma phospholipid and to ta l 
lip id  levels during this study (Tables 2:12 and 2:14). Wheat bran fa iled  to 
decrease phospholipid levels, and had l i t t le  e ffe c t on plasma non-esterified  fa tty  
concentration in th is study, and agree w ith  the findings o f Vahouny, e t al. (1980a, 
1981).
The rats fed the high bran d ie t (D ie t G) show an increase in th e ir  plasma 
H D L-cholesterol concentration throughout the study compared to those animals
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fed the starch contro l d ie t (D ie t A) (Table 2:16). This increase was s ign ifican t only
a fte r tw elve weeks o f feeding the high bran d ie t to male rats, and a fte r seventy-
two weeks o f feeding to female rats. The increase in HD L-cho lestero l
concentration was also accompanied by a slight, but non-sign ificant increase in
after seventy-two weeks of feeding 
plasma to ta l cholesterol concentration^(Table 2:8). These findings agree w ith
those o f Asp, e t al. (1981) who found increases in both HDL and plasma to ta l
cholesterol concentration a fte r feeding groups o f rats diets containing 200g/kg
wheat bran fo r six, twelve and tw enty-s ix  weeks.
In the ra t, HDL carry a substantial proportion o f the to ta l plasma 
cholesterol, the increase in HD L-cholesterol w ill also be associated w ith  a 
s im ila r increase in to ta l plasma cholesterol concentration (Asp, e t al. 1981). The 
increase o f plasma H D L-cholesterol in the rats fed the high bran d ie t is in 
agreement w ith  the recent p re lim inary reports o f a s im ilar e ffe c t in man, and 
supports the findings discussed fu lly  in Chapter 3. However, since H D L- 
cholesterol represents a much sm aller proportion o f to ta l plasma cholesterol in 
man than in the ra t, (20 -  30% compared to 70 -  80%) the elevation o f H D L- 
cholesterol in man is not necessarily re flec ted  in s ign ifican t a lte ra tions in 
plasma cholesterol levels (Bremner, e t al., 1975; O'Moore, e t al., 1978). Thus, 
th is may bring in doubt the su ita b ility  o f the ra t as an experim ental model fo r 
man in th is respect. However, the bran-induced increases in plasma H D L- 
cholesterol levels is in teresting in re la tion  to the findings o f M orris, e t al. (1977), 
tha t a high cereal fib re  in take in B ritish  middle-aged men was corre la ted  w ith  a 
low incidence o f coronary heart disease. In the lig h t o f these findings i t  has been 
suggested tha t high levels o f HDLwould foster the e ffic ie n t rem oval o f 
cholesterol from  peripheral tissue, notably the a rte ria l wa ll, to  the liv e r  fo r 
catabolism and excretion. By contrast, low levels o f HDL could lead to  
excessive accumulation o f cholesterol in the tissue (M ille r and M ille r, 1975; 
Glomset, 196)3; Hsia, e t al., 1975; Schwartz, e t al., 1978). H D L-cho leste ro l has 
been shown in v itro  to promote the e fflu x  o f cholesterol out o f a therosc le ro tic
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a rte ria l tissue (Bondjers and Bjorkerud, 1974), while a subfraction o f serum HDL 
has been reported to bind crysta lline  cholesterol in v itro  (Hsia, et al., 1975). 
Glomset (1968) indicated tha t HDL altered the balance o f unesterified  
cholesterol between plasma and cells by increasing its  u tilisa tion  in the le c ith in  
cholesterol acyltransferase system to form  cholesterol ester which would move 
less slowly back in to cells. Carew, e t al. (1976), and Stein and Stein (1976) have 
reported tha t HDL binds to the surface o f a rte ria l smooth muscle cells as 
e ffe c tive ly  as LD L, but was internalised and degraded much slower. High levels 
o f HDL could compete w ith  LD L receptor site o f a rte ria l smooth muscle cells 
and thus p a rtia lly  in h ib it uptake and degradation o f LDL and also p a rtia lly  
suppress the net increase in ce il stero l content induced by LD L (Carew, e t al., 
1976).
The present study is only descriptive and gives l i t t le  support fo r 
speculations on the mechanisms behind the increased HDL concentration in the 
group given the high bran d ie t. Plasma HDL are formed partly  from  hepatic 
and in testina l tr ig lyce rid e -rich  lipoproteins (VLDL and chylom icrons), the 
surface f ilm  o f which is transferred to the HDL class during the lip o ly tic  
breakdown o f the trig lyce ride -rich  core (Nilsson-Ehle, e t al., 1980). A lte ra tions  
in the flux  o f the tr ig lyce ride -rich  partic les can thus be expected to resu lt in 
changes in plasma HDL concentrations. However, since the fa t  content o f the 
wheat bran containing diets is low, an increased production and turnover o f 
chylomicrons in th is group seems highly unlike ly as an explanation fo r  the 
elevated HDL levels.
The stock d ie t 41b (D ie t J), had no s ign ifican t e ffe c t on body w eight gain 
or food intake during the study. However, the decrease observed in plasma and 
hepatic lip id  levels in male and female rats fed this d ie t fo r tw e lve  weeks 
requires fu rth e r discussion. Unlike the other four diets in th is study, the stock 
d ie t is a com m ercia lly prepared d ie t and not sem isynthetic, consequently its  
constituents may vary period ica lly. Analysis o f th is d ie t carried out by the F lour
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M illing  and Baking Research Association a t Chorleywood established the d ie ta ry 
fib re  content to be 16.8% compared to 4.8% fo r the high bran d ie t (D ie t G), and 
2.4% fo r the low bran d ie t (D ie t F). while the major fib re  present in the stock 
d ie t (D ie t J) was found to be oat bran.
As discussed in Chapter 1, fibres from  d iffe ren t plant sources have quite 
d iffe ren t chem ical structures, physiological actions and m etabolic e ffec ts . Thus 
i t  has been established in recent years tha t the e ffec ts  o f oat bran are much 
d iffe re n t from  the e ffec ts  o f wheat bran. Both brans are fib re -rich  byproducts 
which are separated from  flou r during the m illing  process. Oat bran contains 
14.8% water soluble fib re  and is poor in cellulose containing only 0.2%. In 
contrast, wheat bran has a lower soluble fibre, content o f only 2.9% and a much 
higher cellulose content o f 6.8% (Chen and Anderson, 1980). Therefore, these 
chem ical differences may contribu te  to the ir d iffe ren t physiological and 
m etabolic e ffects , and as a resu lt be responsible fo r the s ign ifican t decrease in 
lip id  levels observed in animals fed the stock d ie t 41b (D ie t J). A number o f 
studies in recent years have reported tha t whole oat bran, or oat bran feeding 
lowers serum cholesterol levels both in humans and the ra t (Anderson, 1980; 
Chen and Anderson, 1979a; de Groot, e t al., 1963; K irby, e t al., 1981), whereas 
in most studies wheat bran has had no e ffe c t on the serum lip id  concentration.
Male rats fed the high fa t d ie t (D ie t H) fo r four weeks had a s ign ifican t 
decrease in th e ir body weight gain and liv e r weights compared to the starch fed 
contro l animals (Table 2:2). This resu lt is due to the s ign ifican t difference in the 
in it ia l weights o f the two groups o f animals at the beginning o f the experim ent, 
and not to food intake, as this was s im ila r in the two groups. Male and fem ale 
rats fed the high fa t d ie t fo r the remainder o f the study had no s ign ifican t 
a lte ra tion  in the ir body and liv e r weights when compared to the con tro l fed 
animals. The high fa t d ie t also had a variable e ffe c t on plasma and hepatic lip id  
levels both in the male and female rats throughout the study. Analysis recen tly  
carried out by the F lour M illing  and Baking Research Association a t Chorleywood
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has shown tha t the g lu ten-free  starch present in a ll the test diets except the 
stock d ie t 41b (D ie t J) contains a small quantity o f water soluble fib re . The 
exact amount present is not known and would vary from  batch to batch. The 
water soluble fibres were discussed in Chapter 1, and have a known 
hypocholesterolaemic e ffe c t (Wells and Ershoff, 1961; K iriyam a, e t al., 1969; 
Tsai, et al., 1976; Story and K ritchevsky, 1976a). Consequently, th e ir presence 
in the starch o f the test diets m ight be responsible fo r some o f the variable 
e ffects  observed w ith  these diets, both on plasma and hepatic lip id  levels o f the 
animals fed them throughout the study. Moreover, the inconsistencies o f a 
number o f the results during this study m ight be due to the use o f d iffe re n t 
animals fo r each feeding period. Consequently, i f  the same animals could have 
been used throughout the seventy-two weeks o f the study, then a more consistent 
set o f results m ight have been obtained w ith  each d ie t group.
Wheat bran markedly influenced the colonic function o f the ra ts in th is
study. The animals fed the high bran d ie t (D ie t G) and the stock d ie t 41b (D ie t J)
produced bulky granular stools compared to those fed the low bran (D ie t F), high 
fa t (D ie t H) and starch contro l diets (D ie t A). The gut tra n s it tim es o f the 
animals fed these diets were not measured, however, a lte ra tion  in the colon 
function in these animals appears to have no overall e ffe c t on plasma or hepatic 
lip id  levels during the study. However, the results from  th is study do con firm  
previous studies in the ra t reported by Kay and Truswell (1975); A rvan itak is , et 
al. (1977) and Ranhotra (1973), as w e ll as studies in the hamster (Trusw ell and 
Kay, 1975). Failure o f wheat bran to decrease blood lip id  levels have also been 
reported in man in a number o f studies (Eastwood, e t al. 1973; Jenkins, e t al.,
1975a; Connell, et al., 1975; Durrington, e t al., 1975).
In this, and most other fib re  studies reported, (Wells and E rshoff, 1961; 
Mokaday, 1973; Ershoff and Wells, 1962; K iriyam a, e t al., 1969) the laboratory 
ra t has been used as the experim ental animal. A t present, the e ffe c ts  o f d ie ta ry  
fib re  on cholesterol and lip id  levels in other animals such as rabbits, guinea pigs
and chickens is la rgely unknown. It  is probable tha t one may observe more 
pronounced e ffec ts  in these animals since the ir serum cholesterol levels usually 
change more markedly than tha t o f rats when subjected to d ie tary cholesterol 
manipulations. Therefore, fu tu re  studies in this fie ld  must make care fu l 
decisions as to the choice o f experim ental animals.
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CHAPTER 3
THE EFFECT OF WHEAT BRAN SUPPLEMENTATION ON GLUCOSE AND LIPID
METABOLISM IN HEALTHY HUMAN SUBJECTS
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3.1 Introduction
This study was perform ed in collaboration w ith  a fina l year undergraduate 
student. I t  was designed to examine the short term  e ffe c t o f wheat bran 
supplementation on lip id  and carbohydrate metabolism in normal subjects, w ith  
pa rticu la r reference to its  e ffe c t upon fasting plasma cholesterol, H D L- 
cholesterol, LDL-cholestero l, trig lyce ride , glucose and glycosylated haemolgobin 
concentrations. Thus i t  forms a complementary study to the long te rm  
investigation in rats described in Chapter 2. The possible relationships between 
d ietary fib re  and lip id  metabolism were extensively discussed in previous 
chapters, however, the possible relationships o f fib re  w ith  glucose and 
glycosylated haemoglobin metabolism requires fu rthe r consideration.
Diabetes m ellitus is defined as a state o f chronic hyperglycaemia (fasting 
blood glucose »  144 mg/lOOml) which may arise from  many environm ental and 
genetic factors, o ften acting together (W.H.O. 1980). The blood glucose 
concentration is mainly regulated by insulin, a hormone secreted by the 3 cells 
o f the islets o f Langerhans in the pancreas. Diabetes m ellitus is c lassified in to  
two major subsections, Type I, or insulin-dependent diabetes (juvenile), and Type 
II or non-insulin dependent (adult onset) diabetes. Treatm ent is e ithe r by d ie t 
alone, d ie t plus oral hypoglycaemic agents or by d ie t and insulin, the method 
depending on the type o f diabetes. A t present, the major methods used fo r 
determ ining the degree o f m etabolic contro l include random blood sugar 
estimations, in te rm itte n t measurement o f daily urinary glucose excretion , and 
24-hour blood glucose m onitoring. Recently however, there has been much 
in terest in the estim ation o f glycosylated haemoglobin (HbAj) as an ob jective  
ind icator o f the plasma glucose level over prolonged periods o f tim e  (Gonen and 
Rubenstein, 1978).
More than 90% o f the to ta l haemoglobin concentration in adu lt 
erythrocytes is haemoglobin A (HbA) which has the subunit s truc tu re  a ^ 32• The
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remaining 10% o f haemoglobin is HbAj which consists o f several m inor 
haemoglobin components (H bA jg, HbAj^, H bA jc, H b A jj and H bA j0) o f which 
H bA jc is the most abundant, comprising 4-6% o f the to ta l haemoglobin (Bunn, et 
al., 1975). H bA jc has been id en tified  as being s tructu ra lly  identica l to HbA 
except fo r the presence o f a glucose residue attached to the N-term inus o f the 3 
chain by a ketoamine linkage (Bunn, e t al., 1975). HbA jc is formed by the post- 
transcrip tiona l glycosylation o f HbA at the N -te rm ina l valine o f the 3 chain, th is 
is a slow non-enzymic process occurring in the peripheral c ircu la tion  throughout 
the 120 day lifespan o f the e ry th rocyte ; the prevailing plasma glucose 
concentration being the most im portan t fac to r governing the quantity  o f H bA jc 
formed (Gonen, e t a l., 1977). Bunn (1981) has shown tha t the aldehyde group o f 
glucose form s a reversible S ch iff base w ith  the N-term inus o f the 3 chain to 
form  p re -A jc which is lab ile  and can undergo an Amadori re-arrangem ent to the 
stable and re la tive  irrevers ib le  ketoamine H bA jc thus:
When measuring the percentage o f H bA jc by chrom atographic techniques 
which are most commonly used, not only is H bA jc detected, but also the o ther 
glycosylated haemoglobin components H bA jg and HbA j^. However, the sum o f
AmadoriHCOH
HCOH
c h 2o h  c h 2o h
GLUCOSE ALDIMINE KETOAMINE
(S ch iff base)
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these components is much less than H bA jc and consequently does not adversely 
a ffe c t the in te rp re ta tion  o f H bA jc (Bunn, 1981). G lycosylated haemoglobin 
comprises 6-10% o f the to ta l haemoglobin o f non-diabetic patients, but increases 
to 6-19% in diabetics, the highest value being found in untreated diabetics 
(Kynoch and Lehmann, 1977). Studies by Koening et al. (1976a) on the use o f 
HbAjc concentrations to m onitor the degree o f d iabetic contro l, have indicated 
tha t the concentration o f H bA jc in the blood accurately re fle c ts  the 
carbohydrate status o f the pa tien t over weeks and months. Experiments 
perform ed in m ice which have HbA jc s im ila r to the human type have supported 
this hypothesis (Koening, e t al., 1976b).
Several studies have suggested tha t foods depleted o f d ie ta ry fib re  are 
responsible fo r diabetes m ellitus in susceptible genotypes, and tha t be tte r 
contro l o f diabetes is possible w ith  diets high in unabsorbable carbohydrates 
(Ostuzz, e t al., 1978). Much of this hypothesis is based upon epidem io logical 
evidence in tha t diabetes is rare in A frican  populations consuming large 
quantities o f d ie ta ry fib re , compared to Western countries where the intake o f 
fib re  is low. However, the long term  e ffe c t o f increasing fib re  in take on glucose 
tolerance o f normal subjects is not w e ll defined (Anderson and Chen, 1979). 
Some studies suggest tha t high fib re  diets may improve glucose tolerance, 
whereas others do not achieve any s ign ifican t e ffe c t.
Jenkins e t al. (1976a, 1978a) have suggested tha t mucilaginous fib res such 
as guar have the most potent e ffe c t on glucose metabolism. In th e ir studies, 
these fibres decreased the ra te  o f glucose absorption and slowed the upper 
in testina l trans it ra te . Total malabsorption did not occur in these acute studies, 
but animal experiments have indicated tha t chronic feeding w ith  pectin  or 
cellulose im pairs je junal glucose absorption (Schwartz and Levine, 1980). 
Tasman-Jones e t al. (1978) have demonstrated a decrease in the number o f 
in testina l v il l i  in animals fed pectin . O ther reports indicate tha t guar gum
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delays gastric emptying (H o lt, et al., 1979) and lessens the release o f gastric 
inh ib ito ry  polypeptide (GIP) (Goulder, e t al., 1978). The la tte r  e ffe c t may be 
secondary to a lte ra tion  in the site o f glucose absorption. A number o f reports 
indicate tha t incorporation o f guar or pectin into a test meal resulted in a 
fla tten ing  o f the postprandial blood glucose and insulin curves (Jenkins, e t al. 
1977a). Guar was not e ffe c tive  however, unless in tim a te ly  mixed w ith  a 
carbohydrate vehicle (W illiam s, e t al., 1980). When used in the d ie tary 
trea tm ent o f diabetes, guar has been reported to decrease insulin requirem ents 
and the excretion o f urinary glucose (Jenkins, e t a l., 1978b).
Mucilaginous fibres, although e ffe c tive  modulators o f glucose absorption 
are o f lim ite d  pa la tab ility . Therefore a study was undertaken to ascertain i f  the 
high fib re-conta in ing food, wheat bran, is also e ffe c tive  in this respect.
3.2 M ateria ls and Methods
3.2.1 M ateria ls
These were as described in the previous chapter (2.2.1), w ith  the addition 
o f the fo llow ing:
Bio-rex 70 cation exchange resin (200-400 mesh Na+ form ) was obtained 
from  Bio-Rad Laboratories, Richmond, C a lifo rn ia .
3.2.2 Subjects
Seven healthy un iversity students (four females and three males) 
volunteered to take part in th is six week study. Before the s ta rt o f the study 
each volunteer completed a questionnaire giving general deta ils about 
themselves, the ir smoking habits and medications (Table 3:1). The subjects were 
asked to note in diaries illness, drug use and departure from  the d ie t during the 
study.
Table 3:1 Characteristics of subjects
Subject Age(yrs) Sex
Height
(M)
Weight
(Kg)
Smoking
Habits
FW 21 F 1.60 58 N/S
TK 21 F 1.73 58 N/S
GW 21 M 1.79 79 N/S
CS 21 M 1.76 62 N/S
FJ 21 F 1.65 60 N/S
MB 18 F 1.54 48 N/S
SW 22 M 1.78 66 N/S
N/S represents non-smoker
No m edication was taken by any subject throughout the study
Table 3:2 Composition o f bran
Energy (Kcals)
P ro te in *
(g)
F a t*
(g)
Carbohydrate*
(g)
D ie ta ry  * 
fib re
(g)
206
!
i
14.1 5.5 26.8 44.0
*  = grm/lOOg o f bran
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3.2.3 D ie t
The composition o f the wheat bran used is given in Table 3:2. The subjects 
normal d ie t was supplemented w ith  0.3g/kg body weight/day o f unprocessed 
wheat bran fo r six weeks. The bran was gradually introduced in to the d ie t over 
the f irs t week to prevent the onset o f any adverse reaction in the subjects to  it .  
The bran was taken in unchanged form , which was uncooked as dry powder, and 
could be added to normal food liquids, such as soups and desserts. The mean 
daily intake o f bran throughout the study was 18.5g/day (range, 14.3 - 23.8g/day). 
This provided an additional in take o f 8.1g o f d ie tary fibre/day (range, 6.3 - 
10.5g/day).
3.2.4 Measurement o f nu trien t intake
To establish the normal nu trien t intake o f the volunteers a four day sem i­
weighed d ie tary intake record was carried out by a ll subjects, four days p rio r to 
the s ta rt o f the study. A fu rthe r four days were recorded during the study to 
determ ine i f  the subjects had altered the ir diets in any way. Instructions fo r 
recording food and drink intakes over these periods were given (Appendix 1). 
Although a seven-day weighed intake is considered to be the best method o f 
estim ating nu trien t intake, (Black, 1981), th is entails a high degree o f co­
operation on the part o f the subject. C o llie r and Hankin (1963) analysed n u trie n t 
intakes o f pregnant women over four-day (one weekend day and three weekdays) 
and seven-day periods. They found tha t approxim ately 90% o f the in fo rm ation  o f 
a seven-day d iet record fo r each m ajor nu trien t was retained by the fou r day d ie t 
record. A four day semi-weighed d ie ta ry intake was therefore decided on as a 
compromise between accuracy and subject accep tab ility . The four days chosen 
were Sunday to Wednesday inclusive on both occasions. The inclusion o f a 
weekend day allows fo r any varia tion in d ie ta ry intake between weekdays and 
weekends.
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The d ie tary records were coded using McCance and Widdowsons 
'Composition o f Foods' (Paul and Southgate, 1978), supplementary food 
composition tables (Wiles, e t al., 1980) and manufacturer's in fo rm ation . The 
coded records were then analysed using the Hotel and Catering Super D ie t 
computer programme.
3.2.5 Assay methods
Prio r to the s ta rt o f wheat bran supplementation fasting blood samples 
were taken. A 0.5 m l a liquot o f whole blood was used fo r glycosylated 
haemoglobin determ ination, while plasma was prepared w ith  the remainder as 
described in 2.2.3. Further blood samples were then taken at two, four and six 
weeks a fte r bran supplementation. Each subject thus served as his own contro l.
Plasma cholesterol, HDL-cholesterol, trig lyceride  and glucose 
concentrations were determ ined by the methods described in 2.2.5.
Plasma low-density lipoprote in  cholesterol
Plasma low-density lipoprote in cholesterol (LDL-C) concentration was 
determ ined using the ind irec t method o f Friedewald et al. (1972), and was 
calculated fo r each person according to the fo llow ing form ula:
C LDL = C plasma - CHDL + TG x 0.45
where:
C LDL = Low-density lipoprote in cholesterol
C plasma = Tota l plasma cholesterol
C HDL = H igh-density lipoprote in cholesterol
TG = Total plasma trig lyce ride
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Glycosylated haemoglobin
G lycosylated haemoglobin was determined by a m odifica tion o f the method 
o f Kynoch and Lehmann (1977).
Reagents
(1) Isotonic saline (0.9% w /v NaCl)
(2) Haemolysing reagent; O.lg powdered saponin and 0.5g KCN 
dissolved in d is tilled  w ater to make 100m l
(3) B u ffe r N o .l pH 6.8; 0.03M Na H2PC>4 . 2H20, 0.008M Na2 H PC>4 
plus 0.01M KCN
(4) B u ffe r No.2 pH 6.4; 0.09M Na H£ PC>4 . 2H20, 0.04M Na£ H P 0 4-
(5) B io-rex 70 cation exchange resin (200 - 400 mesh Na+ form )
Preparation o f resin: B io-rex 70 cation exchange resin (200-400 mesh Na+ form ) 
was suspended in bu ffe r 1 in a large beaker and stirred using a magnetic s tir re r  
fo r 5 minutes. The resin was allowed to settle  and the supernatant discarded. 
This procedure was repeated 5 tim es to ensure adequate washing o f the resin. A 
fu rth e r quantity  o f bu ffe r 1 was poured onto the resin and s tirred  fo r 5 m inutes, 
the resin was then allowed to equ ilibrate w ith  the bu ffe r fo r 48 hr a t room 
tem perature.
A im er columns were assembled (Figure 3:1), and the resin s lu rry poured 
in to each u n til the desired volume was reached. Each column was then washed 
and equ ilibrated by passing through 100ml o f bu ffe r 1, followed by 50ml o f bu ffe r 
2, and fin a lly  100 m l o f bu ffe r 1. In order to establish a su ffic ie n tly  rapid e lu tion  
rate , the height o f the head o f the bu ffe r reservoir was adjusted to 54cm above 
the top o f the column in each case. This gave a flow  ra te  o f approxim ate ly 
100ml/3hr.
Preparation o f blood samples: A 0.5ml a liquot o f anticoagulated whole blood was 
pipetted into a test tube containing 10ml o f isotonic saline. The contents o f the
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Figure 3:1
■ i
i i
Buffe r rese rvo ir
i > 
i i
%
25 cm glass column, 1 cm in te rn a l 
diameter containing 20 cm o f 
B io-rex 70 ca tio n ic  exchange 
res in  (200-400 mesh Na+ form)
Ion exchange chromatography apparatus fo r  the determ ination 
o f glycosylated haemoglobin
tube were mixed, and centrifuged at 3,000 rpm fo r 3 minutes in a Beckman 36 
centrifuge. The supernatant was removed by suction, and the washed red blood 
cells haemolysed by the addition o f 0.8m l o f haemolysing reagent. The tube was 
mixed and stood a t room tem perature fo r 1 m inute, 9ml o f b u ffe r 1 was then 
added, the tube was again mixed and centrifuged at 3,000 rpm fo r 3 m inutes. 
The clear haemoglobin solution was then used fo r analysis. I t  was found tha t 
storage o f th is solution a t -40°C  fo r up to 1 month had no e ffe c t upon the 
glycosylated haemoglobin a c tiv ity .
Measurement o f glycosylated haemoglobin: A 2 m l aliquot o f the haemoglobin 
solution was transferred to the top o f each column. The aliquot was allowed to 
drain into the resin, bu ffe r 1 was then applied to the top o f the resin column, and 
the reservoir containing bu ffe r 1 attached. B u ffe r 1 elutes HbAj, and a 100ml o f 
eluate was collected in a vo lum etric  flask.
B u ffe r 1 was then removed from  the column and a reservoir containing 
bu ffe r 2 attached. This bu ffe r elutes the remainder o f the haemoglobin (HbA + 
HbA2), and a fu rth e r 100m l a liquot was collected in a vo lum etric  flask.
The optica l density o f each eluate was then determ ined by reading against 
the appropriate bu ffe r as blank a t 413nm in a C ecil U.V. spectrophotom eter 
(model CE272). The percentage o f glycosylated haemoglobin was calculated 
using the form ula:
% HbA, = -------— -------  x 100
1 OD1 + OD2
where:
OD1 = optica l density o f f irs t  eluate
OD2 = optica l density o f second eluate
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The resin was re-equ ilib ra ted fo r reuse by passing 130ml o f bu ffe r 1 through the 
column.
3.2.6 S ta tis tica l analysis
S ta tis tica l analysis was perform ed using Student’s paired t- te s t. The level 
o f significance based on this tes t being indicated in the tables o f results.
3.3 Results
In general the wheat bran supplements were well to lerated. However, 
increased fla tus production and abdominal distension- were commonly 
experienced, and a ll subjects commented on the increased frequency o f bowel 
movements during the study. A t the beginning o f the study, two subjects 
complained o f headaches, nausea and constipation, which may have been caused 
by dehydration due to in su ffic ien t flu id  intake.
There were only m inor differences in the intake o f prote in , fa t, 
carbohydrate, alcohol and cholesterol during the study periods (Table 3:3, Figure 
3:2). Energy intakes varied from  individual to individual, these varia tions were 
s im ila r fo r a ll subjects except subject M.B. The mean d ietary fib re  in take before 
bran supplementation was 19.8g/day (range, 7.5 - 36.6 g/day) th is is consistent 
w ith  the 19.9 g/day o f d ie ta ry fib re  consumed in the average B ritish  d ie t 
(Bingham, e t al., 1979). During wheat bran supplementation the mean d ie ta ry  
fib re  intake was 26.7 g/day (range, 16.3 - 38.7 g/day) which represents a mean 
increase o f 34% in d ie ta ry fib re  consumption.
The mean plasma to ta l cholesterol concentration during the study is shown 
in Table 3:4. No s ign ifican t change in plasma cholesterol concentration was 
found a fte r wheat bran supplementation, however, a s light increase o f 4% over 
the contro l value was noted a fte r six weeks o f bran supplementation. Plasma 
trig lyce ride  concentration did not change s ign ifican tly  during the study, although
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a 28% decrease compared to the contro l value fo llow ing the supplementation o f 
the normal d ie t w ith  bran fo r six weeks was observed (Table 3:4). The mean 
plasma H D L-cholesterol concentration increased steadily during the period o f 
wheat bran supplementation (Table 3:4), from  a mean contro l o f 72 mg/100 m l + 
3 mg/100 m l to a mean value o f 103 mg/100 m l + 7 mg/100 m l a fte r six weeks o f 
bran supplementation. This represented a s ign ifican t increase o f 47%, (p < 0.05), 
in HD L-cholesterol concentration over the contro l unsupplemented value. 
Plasma LD L-cho lestero l concentration decreased s ign ifican tly  (p < 0.05) to 64 
mg/100 ml + 6 mg/100 m l from  an in it ia l contro l value o f 85 mg/100 m l, + 7 
mg/100 m l a fte r six weeks o f wheat bran supplementation (Table 3:4), th is 
represented a decrease o f 33%.
The mean plasma glucose, and blood glycosylated haemoglobin 
concentrations throughout the experiment are recorded in Table 3:5. Wheat bran 
supplementation had no s ign ifican t e ffe c t on plasma glucose concentration 
during the six week study. However, the mean concentration o f glycosylated 
haemoglobin showed a s ign ifican t decrease throughout the period o f wheat bran 
supplementation, from  a mean value o f 11% + 0.6% during the con tro l period to a 
mean o f 6% + 0.2% a fte r six weeks o f bran supplementation. This represents a 
mean fa ll in the percentage o f glycosylated haemoglobin o f 44% which was 
highly s ign ifican t (p < 0.001).
3.4 Discussion
There were no s ign ifican t changes in the nu trien t intake o f the subjects 
during the six week study (Table 3:3 Figure 3:2). By using a 4-day semi-weighed 
d ie ta ry record i t  was found th a t the food intake o f the subjects during the course 
o f the study were s im ila r to  the ir normal diets. The w ith in  ind iv idual co e ffic ie n t 
o f varia tion (CV) o f daily nu trien t intake (Table 3:3) compared
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favourably w ith  those achieved by Black (1981) over a much longer period, and 
Acheson e t al. (1980) over a 7-day period. Therefore the 4-day semi-weighed 
intake recorded fo r this study was able to account fo r the daily va ria tion  in 
intakes o f the major nutrien ts. Consequently, i t  can be concluded from  the 
analysis o f d ie ta ry intakes before and a fte r wheat bran supplementation (Table 
3:3), tha t bran supplementation had no s ign ifican t e ffe c t upon the subjects 
nu trien t intakes. Therefore the e ffe c ts  seen on glucose and lip id  metabolism 
during the study are not like ly  to be the resu lt o f a lterations in d ie ta ry intakes, 
and any change w ill probably be due to the bran itse lf.
In th is study the daily supplements o f 0.3g/kg body weight/day o f 
unprocessed wheat bran were not associated w ith  any s ign ifican t changes in 
plasma to ta l cholesterol concentration (Table 3:4). Baseline con tro l values o f 
186 + 7 mg cholesterol/100 m l increased by 4% a fte r six weeks o f wheat bran 
supplementation to give a mean plasma cholesterol concentration o f 193 + 11 
mg/100 ml.
The e ffe c t o f wheat bran on to ta l plasma cholesterol concentration in man 
has shown no significant e ffe c t (Truswell and Kay 1976). A lthough there 
have been numerous studies in to the e ffe c t o f bran on plasma cholesterol 
concentrations, the varia tion  in experim enta l design makes comparisons between 
d iffe re n t studies more d iff ic u lt.  Some studies simply supplement the subjects 
normal d ie t w ith  bran (Connell e t al., 1975; Heaton and Pomare, 1974; W einrich, 
et al., 1977), while others s tr ic tly  con tro l the composition o f the diets (Kay and 
Truswell, 1977b; Jenkins, et a l., 1975a). Bran decreased plasma cholestero l by a 
mean of 7% in elderly people given 20g o f bran/day fo r six weeks (Persson e t al., 
1975). Heaton and Pomare (1974) found tha t when 38g o f unprocessed wheat 
bran was added to subjects normal diets, plasma cholesterol concentrations were 
decreased by a mean o f 3%, but this was not s ta tis tic a lly  s ign ifican t. Van Berge- 
Henegouwen, e t al. (1979) demonstrated tha t supplements o f 0.5g/kg body
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weight/day o f unprocessed wheat bran to a subjects normal d ie t caused a 
s ign ifican t decrease in plasma cholesterol concentration. In several other 
studies (Connell, e t al., 1975; Kay and Truswell, 1977b; Weinrich, e t al., 1977; 
O'Moore e t al., 1978), no s ign ifican t changes in plasma cholesterol concentration 
a fte r wheat bran supplementation were reported. Thus i t  appears tha t the 
results o f the present study are in agreement w ith  the m a jo rity  o f previous 
studies, i.e. tha t wheat bran does not s ign ifican tly  a lte r to ta l plasma cholesterol 
concentration in man. However, some o f the biochem ical components o f bran, 
have been shown to have hypocholesterolaemic e ffec ts  (Keys, e t al., 
1961; Jenkins, e t al., 1975b).
A s ta tis tica lly  s ign ifican t increase in plasma H D L-cholestero l
concentration was found a fte r six weeks o f wheat bran supplementation in th is 
study (p < 0.05) (Table 3:4). This represented an increase o f 47% over the con tro l 
values, and is in agreement w ith  Bremner, e t al. (1975) who found tha t 50g o f
unprocessed wheat bran/day, s ign ifican tly  increased H D L-cholestero l
concentration by 50% (p < 0.01) a fte r two months, and 30% (p < 0.01) a fte r  three 
months, in patients w ith  Type IV hyperlipoproteinaem ia. O'Moore e t a l. (1978) 
also found a 10% increase (p < 0.02) in plasma HDL-cholesterol concentration 
a fte r one month o f wheat bran supplementation. In contrast however, a study by 
van-Berge Henegouwen, e t al. (1979) found s ign ifican t decreases in plasma H D L- 
cholesterol concentration a fte r four weeks o f wheat bran supplementation to 
seven healthy male volunteers.
Plasma LD L-cholestero l concentration was s ign ifican tly  decreased in the 
present study by 33% (p < 0.05) a fte r six weeks o f wheat bran supplem entation 
(Table 3:4). These findings are supported by the recent study o f Dodson, e t al. 
(1981) who reported tha t a high fib re  d ie t increased plasma H D L-cho leste ro l 
concentration, while simultaneously decreasing plasma LD L-cho lestero l
concentration in fo rty -fo u r subjects w ith  hypertension. Thus, these results
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indicate a positive e ffe c t fo r bran by increasing plasma HD L-cholestero l 
concentration while decreasing the potentia l atherogenic plasma LD L- 
cholesterol frac tion . The fa c t tha t the s ign ifican t increase in plasma H D L- 
cholesterol concentration is not re flected  in a lterations in to ta l plasma 
cholesterol in th is study may be due to the fa c t tha t in man, H D L-cholestero l 
accounts fo r less o f the to ta l plasma cholesterol than i t  does in the ra t (20 - 30% 
in man compared to 70 - 80% in the ra t) (Asp, e t al., 1981). The cause o f the 
increase in HDL-cholesterol concentration is not clear. I t  is possible th a t i t  
could be the result o f increased breakdown o f VLDL and chylom icrons (T a ll and 
Small, 1978). A lcohol consumption and exercise can also influence plasma H D L- 
cholesterol concentrations.
The mean plasma trig lyce ride  concentration decreased during this study by 
28% (Table 3:4). This decrease was not s ta tis tica lly  s ign ificant, and may be due 
to the high varia tion between the individual subjects in the study. Therefore i f  a 
larger number o f subjects had been used, then a more de fin ite  response o f plasma 
trig lycerides to wheat bran supplementation m ight have emerged. However, the 
fa ilu re  to find any s ign ifican t response in plasma trig lyceride  concentration to 
wheat bran supplementation is consistent w ith  the results obtained by several 
other workers (Jenkins, e t al., 1975b; Connell, e t al., 1975; Kay and Truswell, 
1977b; Weinrich, e t al., 1977). However, Heaton and Pomare (1974) and van- 
Berge Henegouwen, e t al. (1979) found s ign ifican t decreases in plasma 
trig lycerides (p < 0.01) w ith  wheat bran supplements. The decrease o f plasma 
trig lyce ride  concentration would be o f considerable benefit because o f the strong 
corre la tion between plasma trig lyce ride  concentration and the risk o f coronary 
heart disease. It  is possible tha t wheat bran may decrease the ra te  o f absorption 
o f trig lycerides and fa tty  acids, therefore decreasing post-prandia l 
hyperlipidaem ia. Anderson and Chen (1979) carried out a study in which they 
showed high carbohydrate, high fib re  diets caused lower post-prandia l
trig lyce ride  levels, and tha t the post-prandial peak values were lower than 
fasting levels. Thus from  these observations i t  appears that plasma tr ig lyce ride  
concentrations are a ffected  by high fib re  diets in man.
The wheat bran supplements did not s ign ifican tly  e ffe c t plasma glucose 
concentrations over the six week period o f the study (Table 3:5). This find ing 
agrees w ith  the results o f Jenkins e t al. (1975b) and Ostuzz e t al. (1978) who 
found tha t wheat bran fa iled  to s ign ifican tly  a lte r fasting blood glucose levels in 
normal subjects. The e ffe c t o f high fib re  diets on fasting plasma glucose 
concentrations in diabetic patients are con flic ting . Rivellese, e t al. (1980) found 
tha t high fib re  diets decreased fasting plasma glucose concentrations in d iabetic 
patients. S im ila rly, Ostuzz, e t al. (1978) found tha t bran supplements decreased 
fasting plasma glucose concentrations, while Cohen, e t al. (1980) fa iled  to  
produce such a response.
Wheat bran supplementation in this study caused a s ign ifican t decrease in 
the mean glycosylated haemoglobin concentration a fte r two, four and six weeks 
(Table 3:5). The level o f glycosylated haemoglobin is a . reliable index of 
diabetic control. ;, (Gonen, e t al., 1977). As the amount o f glycosylated 
haemoglobin was decreased in a ll subjects during the wheat bran 
supplementation, i t  would appear th a t the to ta l plasma glucose concentrations 
during the period o f the study are lower than beforehand. This could be the 
result o f bran slowing down the ra te  o f glucose absorption, and thus lowering the 
post-prandial hyperglycaemia. I t  is possible tha t insoluble fib re , including wheat 
bran may decrease in testina l trans it tim e, thus allow ing less tim e fo r 
carbohydrate absorption in the upper jejunum. Consequently available 
carbohydrates may be absorbed fu rth e r down the jejunum, or ileum , and so 
m inimise the increase in plasma glucose concentration (Anderson and Chen, 
1979). Thus an e ffe c t o f bran would be seen on blood glycosylated haemoglobin 
levels and not on fasting plasma glucose concentrations. A recent study by
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Monnier e t al. (1981) showed tha t d ie tary supplementation w ith  fib re  decreased 
the percentage o f glycosylated haemoglobin in diabetics, and this was associated 
w ith  an improved glucose tolerance. Thus, these results indicate tha t wheat bran 
supplements in man do influence glucose haemostasis. Consequently, wheat bran 
supplementation m ight be useful in the long term  trea tm ent o f diabetes by 
improving glucose tolerance, and thus decreasing the insulin requirem ents o f 
people w ith  this disease.
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CHAPTER 4
THE EFFECT OF WHEAT BRAN SUPPLEMENTATION ON BILE AC ID
METABOLISM AND THE OMEGA HYDROXYLATIO N OF FATTY ACIDS
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4.1 Introduction
The role tha t d ie ta ry fib re  may have in the regulation o f cholesterol and 
bile acid metabolism was discussed in Chapter 1, the findings o f which are 
summarised below.
In most species o f laboratory animals, the balance between the in take o f 
cholesterol in to the body and its  removal by excretion and catabolism  is 
maintained by two regulatory mechanisms. F irs t, increased d ie tary intake leads 
to decreased hepatic synthesis by repression o f HMG-CoA reductase. Second, 
increased d ietary intake leads to increased conversion o f cholesterol in to bile 
acids. In man, d ie ta ry cholesterol represses hepatic HMG-CoA reductase, but 
the e ffic iency  o f this contro l mechanism varies from  one individual to another 
(Myant, 1975). Man lacks the a b ility  to increase his output o f b ile acids in 
response to increase absorption o f cholesterol. However, when cholesterol 
absorption is increased in man, the amount excreted in the bile and subsequently 
lost in the faeces is also increased.
Bile acids returning to the live r from  the intestine in h ib it th e ir own 
synthesis by repression o f cholesterol 7a-hydroxylase, the enzyme catalysing the 
ra te -lim itin g  step in the conversion o f cholesterol in to bile acids. Hence, i f  the 
reabsorption o f bile acids is in te rfe red  w ith , th is enzyme becomes de-repressed 
and the degradation o f cholesterol to bile acids is stim ulated. Thus in recent 
years i t  has been suggested tha t increased intakes o f certa in  d ie ta ry  fib res or 
fib re  isolates may have hypocholesterolaemic properties in humans (Keys e t al., 
1961; Jenkins, e t al., 1979) and experim ental animals (Cookson and Fedoro ff, 
1968; Leve ille  and Sauberlich, 1966). These include fibres which tend to 
sequester bile acids in v itro  (K ritchevsky and Story, 1974; Vahouny, e t a l., 
1980b), and may exh ib it hypocholeterolaem ic properties by increasing the faecal 
excretion o f these acid steroids (Leve ille  and Sauberlich, 1966). Binding o f b ile 
acids in vivo by d ie ta ry fib re  would resu lt in fa ilu re  o f m ice llu la r fo rm ation  
which is essential fo r cholesterol absorption, and in an increase in cholesterol
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7a-hydroxylase. Both events would lead to a decrease in the cholesterol pool in 
the body, and thus decrease the chances o f developing hypercholesterolaem ia. 
For example, a lfa lfa  fib re  has been reported to be hypocholesterolaemic, 
(Cookson and Fedoroff, 1968) to increase faecal excretion o f bile acids (Reddy, 
e t al., 1980) and to bind these substances in v itro  (Kritchevsky and Story, 1974; 
Vahouny, e t al., 1980b). However, the action o f wheat bran in th is respect is 
controversia l and requires fu rth e r investigation.
Oxidation o f fa tty  acids occurs via three pathways in mammalian tissue i.e. 
a, 6 and w-oxidation. Recently however, evidence has been obtained fo r the 
existence o f a ^-ox ida tion  pathway in the mammary gland o f the goat (D im ick, 
e t al., 1969). In a -oxidation a hydroxyl group is inserted at carbon atom 2, the a 
carbon atom o f the fa tty  acid. Subsequently, the a-hydroxy acid is 
decarboxylated to a fa tty  acid containing one carbon atom less than the orig ina l 
substrate (Mead and Levis, 1963). An enzyme bound a -ke to  acid is an 
in term ediate in the decarboxylation step and the fo llow ing reaction sequence 
occurs.
Monooxygenase ^
“ ----------------------- > R - C - COOH
Fe Ascorbate I
OH
NADH - Specific
------------------------ ------- > R - C C O O H
Dehydrogenase ||
O
Decarboxylase
 ------------------------- > R - COOH + C 0 2
ATP, NADH, Ascorbate
In the above pathway, a-hydroxy acids and odd number carbon atom acids are 
formed. These are im portan t constituents o f brain and the reaction is catalysed 
by brain m icrosomal preparations.
8 -O xidation is the main catabolic pathway o f free fa tty  acids, and derives
R - CH2 - COOH + 0 2 
H
R - C - COOH
I
OH
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its  name from  the oxidative a ttack tha t occurs at carbon atom 3 o f fa tty  acids, 
the 8 carbon atom. An acylcoenzyme A is degraded by successive cleavage o f 2- 
carbon atom fragments from  the carboxyl end o f the fa tty  acid chain. The 
acetylcoenzyme A units thus generated can be oxidised to C 0 2 and water via the 
c it r ic  acid cycle (which is also found w ith in  the m itochondria), the com plete 
oxidation o f fa tty  acids is thus achieved.
a)-Oxidation refers to an oxidative a ttack on the carbon atom o f the a lky l 
chain tha t is fu rthest removed from  the carboxyl end. Evidence was obtained fo r 
the existence o f this pathway from  studies w ith  free fa tty  acid analogues. F a tty  
acids tha t contain d im ethyl substitu tion on carbon 3, the 8 carbon atom, cannot 
be degraded from  the carboxyl end by 8 -oxidation. I f  the co-end o f the chain is 
also blocked such as in 3 ,3 ,12 ,12-te tram ethylm yris tic  acid or 3,3-dim ethyl-14- 
phenylm yristic acid, the analogue cannot be catabolised (Challoner and 
Steinberg, 1966; Goodman and Steinberg, 1938; Spector, e t al., 1963). However, 
i f  the co-end is not blocked, such as in 2,2-d im ethylstearic  acid, the fa t ty  acid is 
degraded to  2,2-dim ethyladip ic acid (Bergstrom, e t al., 1954). In it ia lly ,  the 
m ethyl group a t the co-end is hydroxylated to a hydroxym ethyl group and is then 
oxidised to a carboxyl group, the resulting d icarboxylic acid being degraded by 8- 
oxidation.
A combination o f the m icrosomal and supernatant fractions from  a ra t 
live r homogenate converts saturated fa tty  acids and oleic acids to  co-hydroxy 
acids and dicarboxylic acids (Preiss and Block, 1964). A small amount o f hydroxy 
acid containing the hydroxyl group on the penultim ate (co-1) carbon atom  is also 
formed in this system. The in it ia l product is the w-hydroxy acid, w hile  in 
subsequent steps the co-hydroxy acid is converted to a d icarboxylic acid thus:
Monooxygenase
FAA + 0 2 + NADPH + H+  ----------------------------- > id -OH-FA + NADP + H20
w -OH-FA D icarboxylic  acid
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As in a-oxidation, the fa tty  acid and not the coenzyme A th ioester is the
substrate in th is pathway. I t  is found tha t medium-chain fa tty  acids such as
laurate, are oxidised at a faster rate than pa lm ita te  or stearate by the co - 
oxidation system prepared from  bacteria (Kusunose, e t al., 1964a). NADPH was
found to be the co facto r fo r the mammalian enzyme system (Ichihara, e t al.,
1969) while NADH is u tilised by the bacteria l enzyme system (Kusunose, e t al., 
1964b).
The in it ia l reaction o f w -hydroxylation takes place in the m icrosomal 
frac tio n  o f ra t live r, and the highest enzymic a c tiv itie s  are present in the liv e r 
and kidney (Ichihara, e t al., 1969). The enzyme co-hydroxylase, is a mixed 
function oxidase, and has been solubilised and resolved in to fractions containing 
cytochrome P-450, a cytochrome P-430 reductase, and a heat stable frac tio n  
shown to be a lip id  (Lu, e t al., 1969).
The role tha t co-hydroxylation has in the body remains unclear, however, a 
number o f hypotheses as to its  action have been forwarded. I t  has been 
suggested tha t the im portance o f w -oxidation is tha t 8 -oxida tion o f the 
d icarboxylic acid to com pletion may yie ld succinic acid, and thus could resu lt in 
the net form ation o f carbohydrate from  fa tty  acid (B lixenkrone-M oller, 1938). 
While E llin  (1975) has suggested tha t co-oxidation functions to de tox ify  fa tty  
acids tha t m ight otherwise poison cells by uncoupling the m itochondria l 
respiratory chain. Wada and Usami (1977) administered even carbon-containing 
fa tty  d icarboxylic  acids to d iabetic and starving rats and found a decrease in the 
concentration o f ketone bodies in the blood o f these animals. From these results 
they suggested tha t co-oxidation may be im portan t fo r production o f succinyl- 
CoA from  fa tty  acids.
Therefore, because o f the im portance o f b ile acids and hepatic cholesterol
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7a-hydroxylase in the contro l o f cholesterol metabolism, the present study was 
designed to investigate the e ffe c t o f wheat bran supplementation on these 
parameters, and on the m icrosomal w-hydroxylation o f fa tty  acids.
4.2 M ateria ls and Methods
4.2.1 M ateria ls
NAD, NADH, glucose-6-phosphate, glucose-6-phosphate dehydrogenase 
(E.C. No. 1.1.1.49), semicarbazide hydrochloride, sodium glycocholate, 8 - 
m ercaptoethylam ine and Tris (hydroxymethyl) aminomethane were purchased 
from  Sigma Chemical Company, London. NADP and NADPH were obtained from  
Cambrian Chemical Company, Croydon, Surrey. 3a-Hydroxysteroid 
dehydrogenase (0.3 units/m g from  Pseudomonas testeroni) was obtained from  P-L 
Biochemicals Inc., (In ternational Enzymes L td ., Windsor, Berks.) Tween 80, 
Folin -C ioca lteu reagent and bovine serum albumin (98% pure) were purchased 
from  B ritish  Drug Houses L td ., Poole, Dorset. Thixotrop ic gel powder 'Cab-O- 
Sil', 2,5 diphenyloxazole (PPO) and 2,2l-p-Phenylene-bis (5-phenyloxazole) 
(POPOP) were supplied by the Packard Instrum ent Company, London. Laurie 
acid was obtained from  A ld rich  Chemical Company L td ., G illingham , Dorset.
[ 4 - ^ C ]  Cholesterol, specific  a c tiv ity  o f 58 m C i/m m ol and radiochem ical 
pu rity  o f 99% was purchased from  the Radiochemical Centre Amersham, and 
stored in toluene under nitrogen at 4°C  un til required. [ 1 - ^ C ]  Laurie  acid, 
specific  a c tiv ity  o f 32 m C i/m m ol and radiochem ical pu rity  o f 99% was purchased 
from  the Radiochemical Centre and stored in hexane at 4°C . 12-and 11- 
H ydroxylauric acid standards were generously donated by Dr. T. Fenell. 7a- 
Hydroxycholesterol (cholest-5-ene-3a,-7a diol) was purchased from  Research 
Plus Laboratories Inc., Bayonne, New Jersey, U.S.A. XAD-7 Resin was obtained 
from  Rohm and Haas L td ., Croydon, Surrey.
Most other chemicals used were supplied by BDH Ltd , and May and Baker 
L td . as described in 2.2.1 or as specified in the te x t, a ll were o f ana ly tica l grade
unless otherwise stated. Solvents and d is tilled  water used in this study were as 
described in 2.2.1. A ll other m ateria ls used were as described in 2.2.1 or as 
specified in the tex t.
4.2.2 Diets
The diets used in this study were as described in 2.2.2.
4.2.3 Animals
Weanling male and female rats o f the Wistar stra in were housed 
as described in 2.2.3, and fed the starch contro l (D ie t A), low bran 
(D ie t F), high bran (D ie t G), high fa t (D ie t H) and the stock d ie t 41b (D ie t J) fo r 
periods o f up to seventy-two weeks; the duration o f each experim ent being 
indicated in the tables o f results. A t the end o f the designated feeding period, 
plasma and live r samples were taken, and prepared as described in 2.2.3.
4.2.4 Preparation o f live r fractions
L iver m icrosomal fractions were prepared by the method described in
2.2.4.
4.2.3 Assay methods
Cholesterol 7a-hydroxylase 
r -14I f  L4 CJ cholesterol is incubated w ith  a suspension o f liv e r microsomes 
under suitable conditions, the radioactive cholesterol is converted in to  7a- 
hydroxy [ ^ C ]  cholesterol a t a ra te  re lated to the a c tiv ity  o f the cholestero l 7a- 
hydroxylase in the microsomes. The rad ioactive  7a-hydroxycholesterol may then 
be isolated from  the incubation system by th in  layer chromatography (T .L .C .) 
and assayed fo r ra d io ac tiv ity . This is the princip le  underlying the method used 
fo r assaying cholesterol 7a-hydroxylase a c tiv ity  in th is work.
In any assay system based on measurement o f the incorporation o f [ ^ d
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from  labelled cholesterol in to 7a-hydroxycholesterol in the presence o f live r 
microsomes, certa in  conditions must be satisfied in addition to those required fo r 
enzymic hydroxylations. The form ation o f 7a-hydroxycholesterol in the
incubation m ixture by nonenzymic autoxidation o f cholesterol is m inim ised by 
adding the su lfhydryl reagent 8-m ercaptoethylam ine to the incubation m ixture . 
Moreover, an add itional correction fo r nonenzymic fo rm ation  o f 7a- 
hydroxycholesterol is made by including contro l incubations containing boiled 
microsomes.
As a resu lt o f the in fo rm ation  provided above, and from  work carried out in 
the Departm ent o f B iochem istry at the University o f Surrey in recent years 
(Gray, 1979; Rush, 1981); the fo llow ing incubation system was set up in duplicate 
in 23 m l acid washed conical flasks.
Test C ontro l
M icrosomal supernatant 25% w /v (ml) 3.0
Boiled m icrosomal supernatant 25% w /v (ml) - 3.0
8-M ercaptoethylam ine 140 mM (ml) 0.05 0.05
Substrate (ml) 2.0 2.0
C ofactor solution (m l) 1.0 1.0
Substrate: [ 4 - ^ C ]  Cholesterol 0.5 y C i/m l stabilised in 7.2 mg o f Tween 80 
(polyoxyethylene sorbitan monoleate), and dissolved in 2 m l o f 0.1 M potassium 
phosphate bu ffe r pH 7.4..
C ofactor solution: NADP (5 ym ol) and glucose-6-phosphate (50 ym ol) dissolved in 
1 m l o f d is tilled  water.
The f irs t  three constituents were pre-incubated a t room tem perature fo r 
10 minutes before the reaction was in itia ted  by the addition o f the co fac to r 
solution. The flasks were subsequently incubated a t 37°C fo r 60 m inutes.
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Extraction  procedure: The reaction was term inated by the addition o f 5 m l o f 
methanol, the m ixture  transferred to a 15 ml screw-capped sovire l tube and the 
flask washed out w ith  a fu rthe r 5 ml o f methanol. Neutra l lip id  was subsequently 
extracted according to the method o f Hattersley (1975) (Figure 4:1). E xtraction  
recovery was o f the order o f 80-90%, being checked by sampling a t each stage o f 
the extraction  procedure.
The combined lip id  e x tra c t was then transferred to a 25 m l 'pear-shaped1 
flask and evaporated to dryness in vacuo using a ro ta ry  evaporator a t 40°C.
Thin-layer chromatography o f e x tra c t: Analysis o f the radioactive products 
formed was carried out by th in -layer chromatography (TLC) using s ilica  gel G, 
(Scheicher and Schull, W. Germany) on plates measuring 20 cm x 20 cm w ith  a 
gel layer 0.25 mm th ick . The solvent system used was toluene - e thy l acetate 
(7:13 v/v). Ascending chromatography in saturated a ir was used, allow ing 
approxim ate ly 50 minutes fo r development at room tem perature, or u n til the 
solvent had reached a distance o f 17-18 cm from  the edge o f the p late (15 -16 
cm from  the orig in). Duplicate plates were set up as fo llow s: The residue
obtained from  the extraction  o f test and contro l incubation m ixtures were 
redissolved in 250 y l o f choloroform , and a 25 y l a liquot o f each applied as a 
narrow band to the orig in o f both plates. To the second plate only was applied a 
s im ila r band o f 7a-hydroxycholesterol so tha t the two bands (standard + e x tra c t) 
overlapped s ligh tly , thus allow ing more certa in  iden tifica tio n  o f the product.
A fte r  chromatography, the second plate was visualised by spraying w ith  a 
20% (w /v) solution o f dodecomolybdophosphoric acid in absolute ethanol, 
fo llowed by gentle heating. The m etabolites generated in the incubation 
m ixtures were detected by th in -layer rad ioactive  scanning on a Berthold th in  
layer radioactive scanner (model LB 2723). A fte r  scanning, each chrom atopla te 
was divided in to approxim ately 0.5 cm x 2.0 cm zones from  0.5 cm below the 
orig in  to the solvent fron t. Each zone was then removed in to  a polypropylene
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Incubation medium
Add 2 x 5 m l methanol, e x tra c t 10 
minutes, centrifuge 2,000 rpm 10 
minutes
Supernatant -> Pe lle t
M ix 10 minutes 
centrifuge 5 minutes
2,000 rpm, discard 
upper layer
•Supernatant <r
Add 10 ml 
ch loro form , 
ex tra c t 
10 minutes, 
centrifuge 
2,000 rpm 
10 m inutes
Chloroform  ex trac t
v
Pelle t
Add 5ml F^O, mix 
5 minutes, centrifuge
2,000 rpm 10 
minutes. Discard 
upper layer
“Supernatant <-
L ip id  ex tra c t
Add 5m l hot 
e thy l acetate, 
e x tra c t 10 
m inutes, 
centrifuge 
2,000 rpm 10 
m inutes
Pe lle t discarded
Figure 4:1 E xtraction  procedure fo r cholesterol 7a-hydroxylase assay
'm ini v ia l' (S te rilin  Products Ltd., Teddington, Middlesex) and counted 
ind iv idually.
Radioactive-counting procedure: The segments o f s ilica gel removed in to the 
m in i-v ia ls  from  the th in  layer chromatography plates were shaken vigorously 
w ith  5 m l o f 'Cab-O-Sil' sc in tilla n t (5.5g PPO, lOOmg POPOP, 45g 'Cab-O-Sil' in 
1 lit re  o f toluene).
Each v ia l was 'counted' using a LKB Wallac 1210 u ltrabe ta  liqu id  
sc in tilla tion  counter fo r a period o f 5 minutes. The sc in tilla tion  counter was 
programmed to co rrec t au tom atica lly  fo r quenching by the external standard 
channels ra tio  method. The counting e ffic iency  was 94%.
Laurie acid hydroxylation
The method used fo r the measurement o f m icrosomal lau ric  acid 
hydroxylation is a m od ifica tion  o f the method o f Fan, e t a l. (1976), whereby the 
hydroxylated m etabolites are separated from  lauric  acid by s ilica  gel th in  layer 
chromatography. Throughout the procedure, a contro l incubation m ixtu re
containing boiled microsomes is included to correct fo r any 12- and 11- 
hydroxylaurate formed non enzym ically.
The fo llow ing incubation system was set up in duplicate in 10 m l acid 
washed sovirel tubes.
Test C ontro l
B u ffe r: T ris-H C L 200 mM pH 7.4 (ml) 0.5 0.5
M gC ^ 50 mM (ml) 0.2 0.2
C ofactor solution (ml) 0.2 0.2
Substrate (ml) 0.4 0.4
Microsomal suspension 25% w /v (ml) 0.2 -
Boiled microsomal suspension 25% w /v (ml) - 0.2
D is tilled  water (ml) 0.4 0.4
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C ofactor so lution: Giucose-6-phosphate 40 mM
Glucose-6-phosphate dehydrogenase 10 un its /m l
14Substrate: LI- CJ Lauric acid was d iluted to give a specific a c tiv ity  o f 0.5 
m C i/m m ol and added to the incubation system to give a fina l concentration o f 
100 pm.
The above constituents were preincubated at 37°C fo r 3 minutes in a 
shaking w ater bath, the reaction was then in itia ted  by the addition o f 0.1 m l o f 
NADPH (20 mM). The tubes were subsequently incubated fo r 8 m inutes in a 
shaking w ater bath at 37°C.
E xtraction  procedure: The reaction was term inated by addition o f 0.8 m l o f 2M- 
h^SO^. The aqueous phase was then extracted three times w ith  5 m l o f d ie thy l 
ether fo r 10 minutes on a ro ta ry  ex trac to r, and centrifuged fo r 10 m inutes in a 
Beckman J6 centrifuge a t 2,000 rpm. The combined ether phase e x tra c t was 
washed once w ith  5 m l o f d is tilled  w ater in a 25 m l screw capped tube. The 
combined lip id  ex trac t was then transferred to a 25 m l 'pear shaped1 flask and 
evaporated to dryness 4n vacuo1 on a ro ta ry  evaporator a t 37°C. E xtrac tion  
recovery was o f the order o f 90-95%.
Thin-layer chromatography o f e x tra c t: Analysis o f the rad ioactive  products 
form ed was carried out by th in  layer chromatography using s ilica  gel G, 
(Scheicher and Schull, W. Germany) on plates 20 cm x 20 cm w ith  a gel layer 0.25 
mm th ick . The solvent system used was hexane - d ie thyl ether - ace tic  acid 
(70:28.5:1.5 v /v /v ). Ascending chromatography in saturated a ir was used, 
allow ing approxim ately 50 minutes fo r development a t room tem perature, or 
u n til the solvent had reached a distance o f 17-18 cm from  the edge o f the p la te  
(15-16 cm from  the origin).
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The residue obtained from  the extraction  o f the test and contro l incubation 
m ixtures were redissolved in 0.1 m l o f methanol, and a 50 p i a liquot o f each was 
applied as a streak to the orig in  o f each plate. Duplicate plates were set up, and 
to the second plate was applied 10 p i each o f the pure 12-hydroxylauric and 11- 
hydroxylauric acid standards in methanol (1 m g/m l).
Following chromatography, the plates containing the standards were 
visualised by spraying w ith  concentrated sulphuric acid and heating to 100°C in 
an oven. The 12- and 11-hydroxylauric acid metabolites generated in the 
incubation system were iden tified  by th in  layer radioactive scanning using a 
Berthold th in  layer rad ioactive  scanner (model LB 2723). Each plate was then 
divided in to  1.0 cm x 2.0 cm zones from  0.5 cm below the orig in to the solvent 
fro n t. Each zone was then removed in to polypropylene 'm ini via ls' (S te rilin  
Products L td., Teddington, Middlesex) to be counted individually.
Radioactive-counting procedure: Segments o f the s ilica  gel removed in to m in i- 
v ia ls from  the th in  layer chromatography plates were shaken vigorously w ith  5 
m l o f 'Cab-O-Sil' sc in tilla n t (5.5g PPO, 100 mg POPOP, 45g Cab-O-Sil in 1 l i t re  
o f toluene).
Each v ia l was 'counted' using a LKB Wallac 1210 u ltrabe ta  liqu id  
sc in tilla tion  counter, fo r a period o f 5 minutes. The sc in tilla tion  counter was 
programmed to correc t au tom atica lly  fo r quenching by the externa l standard 
channels method. The counting e ffic iency  was 94%.
Plasma to ta l b ile acids
A m odifica tion  (Barnes and Chitranukroh, 1977) o f the assay system o f 
Murphy, e t al. (1970) was used. Bile acids are isolated from  plasma by a liq u id - 
solid extraction  and measured by an enzym ic -fluo rim e tric  method. The enzyme 
used is 3a-hydroxysteroid dehydrogenase derived from  Pseudomonas tes te ron i,
which was orig ina lly  used fo r the quan tita tive  assay o f androgenous steroids w ith  
a 3a-hydroxyl substituent (Hurlock and Talalay, 1957). The bile acids (cholic 
acid, deoxycholic acid and chenodeoxycholic acid) are also 3a-hydroxysteroids 
and w ill react w ith  3a-hydroxysteroid dehydrogenase. The reaction may be 
represented as:
Steroid alcohol + N A D *" "  NSteroid ketone + NADH + H+
The reaction is encouraged to proceed to the rig h t by the addition o f a ketone- 
trapping agent semicarbazide hydrochloride, and the NADH is determ ined 
flu o rim e trica lly .
E xtraction  procedure: The resin, XAD-7 (a non-ionic polymer) was purchased 
from  Rohm and Haas Ltd ., Croydon, Surrey, as 350-500 ym beads. It  was soaked 
overnight in 5 volumes o f d is tilled  water to remove NaCl and ^ £ 0 0 ^  added as 
preservatives. The fine partic les were removed by repeated sw irling  and 
decanting, so tha t the remaining beads sedimented in 20-30 seconds. The resin 
was then extracted fo r 1 hour each, f irs t ly  w ith  methanol followed by ch loro fo rm  
- methanol (1:1 v/v) and fin a lly  w ith  methanol. Thorough washing w ith  w ater 
was then required u n til the ch loro form  was removed. The resin was stored under 
w ater u n til required. A fte r  use the resin was soaked in aqueous methanol (1:1 
v /v) and regenerated by repeating the solvent extraction  procedure.
XAD-7 Resin ( lg )  was placed in a glass 10 m l sovirel tube f it te d  w ith  a 
screw cap. A 1 m l a liquot o f plasma was then added to each tube, fo llowed by 
0.1 M NaOH, to give a fina l volume o f 9 m l. An extraction  blank was set up 
using lg  o f XAD-7 resin and 9 m l o f 0.1M NaOH only.
The tubes were capped, and mixed on a ro ta ry  m ixer fo r 60 m inutes at 
room tem perature. A fte r  m ixing, the supernatant was removed by aspiration on
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a water pump. In order to m aintain a pH o f 10 a t a ll stages throughout the 
washing procedure, a 2ml volume of 0.0Q4M NaOH was added. The tubes were 
then mixed b rie fly  on a vortex m ixer, and the supernatant was removed by 
aspiration w ith  a water pump. A 6 m l volume of methanol was added to the resin 
and the contents o f the tubes were mixed fo r a fu rthe r 20 minutes on a ro ta ry  
m ixer. The m ethanolic supernatant was transferred to a 25 m l 'pear-shaped' 
flask, the resin extracted in to a second 6 m l o f methanol and the supernatant 
solutions combined. The methanol was removed in vacuo using a ro ta ry  
evaporator at 50°C. The residue was then redissolved in 1 m l o f 50% (v/v) 
aqueous methanol p rio r to enzymic analysis.
Enzymic assay: The fo llow ing reagents were prepared on ice im m ediate ly before 
use.
Reagent A/100 ml
95.0 m l 0.1M sodium pyrophosphate bu ffe r pH 10.2
5.0 ml methanol
4 mg semicarbazide hydrochloride 
6 mg NAD
Reagent B/100 m l
95.0 m l 0.1 M sodium pyrophosphate bu ffe r pH 10.2
5.0 ml methanol
4 mg semicarbazide hydrochloride 
6 mg NAD
0.5 mg (0.25 IU) 3a-hydroxysteroid dehydrogenase
The incubation system shown in Table 4:1 was then set up in duplicate.
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Standards were prepared by d ilu ting  a stock solution o f sodium glycocholate in 
50% aqueous methanol (1 m g/m l) to cover a range o f concentrations from  10.25 
to 205 y m o l/ litre  (5-100 yg /m l). Tubes were then mixed on a vortex m ixer and 
incubated a t 37°C  in a shaking water bath (M ickle Laboratory Engineering Co. 
Gomshall, Surrey) fo r 45 minutes.
The reaction was term inated by plunging the tubes in to an ice -w ate r slurry 
(0°C). The tubes were subsequently maintained at this tem perature w h ils t the 
fluorescence in tensity was measured. The fluorescence o f the solutions was read 
using a Perkin Elmer spectro fluorim eter (model MPF3), w ith  a xenon lamp, 2 
monochromators and quartz cuvettes o f 1 cm lig h t path, exc ita tion  wavelength 
365 nm, emission wavelength 457 nm.
Measurement o f prote in concentration
Protein concentration was measured by the method based on tha t o f Lowry, 
e t a l. (1951).
To 0.5 m l aliquots o f tissue d ilu ted w ith  0.5M NaOH (usually a 1.20 d ilu tion  
fo r 25% w /v microsomes) was added 5 m l o f freshly prepared Lowry reagent (2% 
sodium carbonate, 1% copper sulphate and 2% sodium potassium ta rtra te  100:1:1 
v /v /v ) and mixed w e ll. A fte r  a t least 10 minutes, 0.5 m l o f Fo lin -C ioca lteu  
Phenol reagent (diulted 1:2 w ith  water) was added, and im m ediate ly vortex 
m ixed. A fte r  allow ing 30 minutes fo r development, the blue colour was 
measured a t 720 nm in a Cecil UV spectrophotom eter (model CE272). A ll 
determ inations were perform ed in duplicate, and blanks (0.5M NaOH) and 
standards (0-300 yg bovine serum albumin in 0.5M NaOH) were trea ted  
iden tica lly .
4.2.6 S ta tis tica l analysis
S ta tis tica l analysis was carried out using Student's unpaired t- te s t. The
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level o f significance based on this test being indicated in the tables o f results.
4.3 Results
The e ffe c t o f feeding D ie t A (starch contro l diet), D ie t F (low bran diet), 
D ie t G (high bran diet), D ie t H (high fa t d iet) and D ie t J (stock d ie t 41b) fo r four, 
e ight and twelve weeks on ra t body weight, live r weight and food intake is shown 
in Tables 4:2, 4:3 and 4:4 respective ly. Growth curves fo r the animals used in 
these experiments are not shown as they were s im ila r to those given in Chapter 
2. The body weight and food intake data fo r the animals used in the 
determ ination o f cholesterol 7a-hydroxylase a c tiv ity  are summarised and 
discussed in 2.3.
The low bran (D ie t F), high bran (D ie t G), high fa t (D ie t H) and stock d ie t 
41b (D ie t J) had no s ign ifican t e ffe c t on food intake during this study when 
compared to those animals fed the starch contro l d ie t (D ie t A). The results 
support the ea rlie r findings o f the e ffec ts  o f these diets on food intake described 
in Chapter 2. However, in those animals fed the high fa t d ie t (D ie t H) fo r eight 
weeks, s ign ifican t decreases o f 15% (p < 0.001) in live r weight, and 13% (p < 
0.02) in re la tive  liv e r weight was observed when compared to  the animals fed the 
starch contro l d ie t (D ie t A) (Table 4:3). Moreover, the animals fed the low bran 
d ie t (D ie t F) fo r eight weeks had a s ign ifican t decrease o f 11% (p < 0.05) in th e ir  
re la tive  live r weight compared to those animals fed the starch con tro l d ie t (D ie t 
A) (Table 4:3). Animals fed the stock d ie t 41b (D ie t J) fo r twelve weeks had a 
s ign ifican t decrease o f 8% (p < 0.01) in re la tive  live r weight compared to  those 
animals fed the starch contro l d ie t (D ie t A) (Table 4:4).
The results o f feeding the starch con tro l (D ie t A), low bran (D ie t F), high 
bran (D ie t G), high fa t (D ie t H) and stock d ie t 41b (D ie t J) on cholestero l 7a- 
hydroxylase a c tiv ity  are summarised in Table 4:5. Under the conditions 
employed in this experiment, 7a-hydroxycholesterol was the only detectable 
m etabolite  o f cholesterol as illus tra ted  by the typ ica l th in layer scan shown in
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Figure 4:2. The low bran (D ie t F) and high bran diets (D ie t G) fed to rats fo r up 
to seventy-two weeks had no s ign ifican t e ffe c t on hepatic cholesterol 7a- 
hydroxylase a c tiv ity , when compared to those animals fed the starch con tro l d ie t 
(D ie t A) fo r the same period o f tim e (Table 4:5). However, male rats fed the 
high fa t d ie t(D ie t H) fo r twelve and seventy-two weeks had a s ign ifican t 
decrease in cholesterol 7a-hydroxylase a c tiv ity  o f 72% (p < 0.01) a fte r  tw elve 
weeks, and a 25% decrease (p < 0.01) a fte r seventy-two weeks compared to those 
animals fed the starch contro l d ie t (D ie t A) (Table 4:5). Male and female rats 
fed the stock d ie t 41b (D ie t J) fo r twelve weeks had s ign ificant increases in th e ir 
hepatic cholesterol 7a-hydroxylase a c tiv ity  compared to those animals fed the 
starch contro l d ie t (D ie t A) (p < 0.02 fo r male rats, p < 0.05 fo r female rats) 
(Table 4:5).
The low bran (D ie t F), high bran (D ie t G), high fa t (D ie t H) and stock d ie t 
41b (D ie t J) fed to male rats fo r four, eight and twelve weeks had no s ign ifican t 
e ffe c t on the omega hydroxylation o f lauric  acid when compared to those 
animals fed the starch contro l d ie t (D ie t A) (Table 4:6). Under the conditions 
employed in this experiment, a m ixture  o f 12- and 11-hydroxylaurate were the 
only detectable m etabolites o f lau ric  acid as illus tra ted  by the typ ica l th in  layer 
scan shown in Figure 4:3.
A typ ica l ca lib ra tion  curve used in the determ ination o f plasma to ta l b ile  
acids is shown in Figure 4:4. The low bran (D ie t F), high bran (D ie t G) and stock 
d ie t 41b (D ie t J) had no s ign ifican t e ffe c t on the plasma to ta l b ile  acid 
concentration o f male rats throughout th is study, when compared to those 
animals fed the starch contro l d ie t (D ie t A). However, male rats fed the high fa t 
d ie t (D ie t H) fo r four weeks had a s ign ifican t decrease o f 58% (p < 0.02) in 
plasma to ta l b ile acid levels compared to those animals fed the starch con tro l 
d ie t (D ie t A) (Table 4:7).
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4.4 Discussion
The present study was designed to investigate the e ffe c t o f the long term  
intake o f defined diets containing various amounts o f wheat bran on cholesterol 
metabolism, b ile acid metabolism and omega hydroxylation o f fa tty  acids. 
Moreover, i t  attem pts to re la te  these changes to the e ffe c t o f wheat bran on 
lip id  metabolism per se. Unlike previous studies which measure the faecal bile 
acid concentration, (K irby, e t al, 1981) the present study m onitored changes in 
plasma to ta l b ile acid concentration as an indication o f bile acid binding by 
d ietary fib re .
The feeding o f wheat bran to rats in sem i-purified diets at 4.8%, (low bran 
d iet, D ie t F) and at 9.6% (high bran d iet, D ie t G) had no s ign ifican t e ffe c t on 
hepatic cholesterol 7a-hydroxylase a c tiv ity , or plasma to ta l b ile acid
concentration throughout the study, when compared w ith  those animals fed the 
starch contro l d ie t (D ie t A) (Tables 4:5 and 4:7 respectively). The results o f this 
study are largely consistent w ith  those o f an ea rlie r study using wheat bran as a 
fib re  source fed to male rats fo r six weeks (Vahouny, e t al., 1980a). In v itro  
binding experiments w ith  b ile acids indicate tha t certa in  d ie ta ry fib res such as 
pectins derived from  f ru it  and vegetables adsorb b ile acids, whereas wheat bran 
has l i t t le  e ffe c t (K ritchevsky and Story, 1974; Story and Kritchevsky, 1976a). 
Therefore, the results from  this in vivo study support the in v itro  observations 
reported by Kritchevsky and Story (1974) and Story and Kritchevsky (1976a). The
negative e ffe c t o f feeding the low bran (D ie t F) and high bran diets (D ie t G) on
hepatic cholesterol 7a-hydroxylase a c t iv ity  and plasma to ta l b ile  acid
concentration supports the earlie r findings discussed in Chapter 2; where both 
diets had l i t t le  or no hypocholesterolaemic e ffe c t in animals fed them, as 
assessed by th e ir plasma and liv e r cholesterol concentrations.
The s ign ifican t increase in hepatic cholesterol 7a-hydroxylase a c tiv itie s  in 
male and female rats fed the stock d ie t 41b (D ie t J) fo r twelve weeks may be
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due to the higher d ie ta ry fib re  content o f this d iet, in that i t  contained 16.8% 
d ie tary fib re  compared to 2.4% fo r the low bran d ie t (D ie t F), and 4.8% fo r the 
high bran d ie t (D ie t G). Moreover, unlike the other experimental diets used in 
th is study the stock d ie t 41b (D ie t J) contained a high quantity o f oat bran. Oat 
bran as discussed previously has a known hypocholesterolaemic e ffe c t, and has 
been found recently to increase the daily faecal b ile acid excretion, but not 
cholesterol and neutra l steroid excretion (K irby, e t al., 1981). In addition to its  
e ffe c t on cholesterol 7a-hydroxylase a c tiv ity  reported in this chapter, the stock 
d ie t fed to male rats fo r twelve weeks also s ign ifican tly  decreased the plasma 
to ta l cholesterol concentration in these animals as reported in Chapter 2. 
Consequently, the stock d ie t 41b (D ie t J) may be exerting a 
hypocholesterolaemic e ffe c t in these animals by binding bile acids, thus causing 
a de-repression o f cholesterol 7a-hydroxylase a c tiv ity , which in tu rn  decreases 
plasma to ta l cholesterol concentration. However, in the present study the stock 
d ie t 41b (D ie t J) had no s ign ifican t e ffe c t on plasma to ta l b ile acid concentration 
when compared to those animals fed the starch contro l d ie t (D ie t A) (Table 4:7).
The stock d ie t 41b (D ie t J) unlike the other four experim ental diets used in 
th is study is a com m ercia lly prepared d ie t. Thus unrefined d ie ta ry  fib re  
components in this d ie t may contain traces o f pesticides, the quan tity  o f which 
would vary from  one d iet batch to another. As discussed in Chapter 1, the 7a- 
hydroxylation o f cholesterol involves, like  the metabolism o f ce rta in  drugs, and 
other fore ign compounds, cytochrome P-450 and the electron transport system 
associated w ith  it .  The adm in istra tion o f phenobarbitone in doses s u ffic ie n t to 
induce hypertrophy o f the hepatic endoplasmic re ticu lum  and cytochrom e P-450 
increases bile acid output in man (M ille r and Nestel, 1973), rhesus monkeys 
(Redinger and Small, 1973a) and hamsters (Schoenfield, e t al., 1973). The 
a c tiv ity  o f cholesterol 7a-hydroxylase was found to be increased in hamster liv e r 
microsomes fo llow ing this trea tm ent (Schoenfield, e t a l., 1973). Therefore, 
pestic idesjjjresent in the stock d ie t 41b (D ie t J) may be s u ffic ie n t to induce
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cytochrome P-450 and the electron transport system associated w ith  it ,  and thus 
cause the concurrent increase in hepatic cholesterol 7a-hydroxylase a c tiv ity  
observed in male and female rats fed this d ie t fo r twelve weeks.
Male rats fed the high fa t d ie t (D ie t H) fo r twelve and seventy-two weeks 
had s ign ifican t decreases in the ir hepatic cholesterol 7a-hydroxylase a c tiv ity  
(Table 4:5), while rats fed the high fa t d ie t fo r four weeks had a s ign ifican t 
decrease in plasma to ta l b ile acid concentration (Table 4:7). Unlike diets A, F, G 
and J the high fa t d ie t (D ie t H) contained 8.5% beef suet, which is high in 
saturated fats. However, the mechanism by which d ietary saturated and 
unsaturated fa ts e ffe c t cholesterol 7a-hydroxylase a c tiv ity  remains unclear and 
can only be speculated at.
A d ie t rich in unsaturated fa tty  acids is known to decrease the cholesterol 
concentration in plasma (Ahrens, e t al., 1957). I t  has been suggested tha t th is  
e ffe c t m ight be due to increased fo rm ation  o f b ile acids from  cholesterol. 
D iffe re n t results however, have been obtained in studies concerned w ith  the 
e ffe c t o f unsaturated d ie tary lip ids on b ile acid biosynthesis and metabolism . In 
some studies (Avigan and Steinberg, 1958; Haust and Beveridge, 1958; Goldsm ith, 
e t a l., 1960; Lewis, e t al., 1961; Antonis and Bersohn, 1962; Wood, e t al., 1966, 
Sodhi, e t al., 1967; Connor, e t al., 1969; Campbell, e t al., 1972; Redinger, e t 
al., 1973b) a small or moderate increase in bile acid biosynthesis has been found. 
In other studies (Bloom fie ld, 1964; Grundy and Ahrens, 1970; Mayer and Mayer,
1974) e ither no e ffe c t on bile acid biosynthesis has been found, or d iffe re n t 
e ffec ts  in d iffe re n t individuals has been observed. In most studies, the 
unsaturated d ie t has been found to increase accumulation o f cholesterol in the 
live r. This increase has been ascribed e ither to an increased biosynthesis o f 
cholesterol, (Avigan and Steinberg, 1958) or a red is tribu tion  between plasma and 
tissue pools o f cholesterol (B loom fie ld, 1964; Grundy and Ahrens, 1970).
The endoplasmic re ticu lum  in the liv e r is responsible fo r the oxidative  
metabolism o f a wide varie ty  o f drugs and carcinogens, and membrane in te g rity
is essential fo r oxidative metabolism (Lu, e t al., 1969; Strobel, et al., 1970). 
Moreover, the s ta b ility  and perm eab ility  o f membranes in the endosplasmic 
re ticu lum  depends on the phospholipids, and these are markedly influenced by the 
nature, extent o f unsaturation and arrangement o f the ir constituent fa tty  acids 
(Lucy, 1972; Chapman, 1973). W ills (1971) has shown tha t lip id  peroxidation, 
which causes fragm entation o f polyunsaturated fa tty  acids o f membrane 
phospholipids, leads to a marked decrease in mixed function oxidase a c tiv ity . 
Thus the conform ation o f the fa tty  acyl chains o f membrane phospholipids in the 
live r may be im portan t in holding the cytochrome P-450 complex in an active  
conform ation in the endoplasmic re ticu lum  membrane, or in form ing a flu id  
environment which fa c ilita te s  electron transfer from  NADPH to cytochrome P- 
450 (Ingelman-Sundberg and Gustafsson, 1975; Ingelman-Sundberg, 1977). 
Therefore the nature o f the d ietary lip id , and especially the content o f 
polyunsaturated fa tty  acids regulates oxidative drug and carcinogen metabolism  
in the live r endoplasmic re ticu lum ; (Rowe and Wills, 1976; Lam bert and W ills, 
1977a,b) and i t  is thus possible tha t the d ie ta ry lip id  alters the ra te  o f oxidative  
metabolism by m od ifica tion  o f the fa tty  acid composition o f the endoplasmic 
re ticu lum .
Many o f the studies re ferred to above are d if f ic u lt  to compare due to 
differences in species, and composition o f d ie ta ry fa t as w e ll as experim enta l 
technique. In recent work, the d irec t e ffe c t o f a d ie t rich in unsaturated fa tty  
acids on cholesterol 7a-hydroxylation has been determ ined in anim al 
experiments. Mayer and Mayer (1974) found tha t feeding a polyunsaturated d ie t 
to rats fo r fourteen days increased 7a-hydroxyla tion o f cholesterol, whereas 
feeding o f a saturated d ie t decreased the a c tiv ity . In contrast, K ritchevsky, e t 
al. (1977) found tha t a d ie t rich  in unsaturated lipids decreased the 7a - 
hydroxylation o f cholesterol. Thus the results from  the present study support 
those o f Mayer and Mayer (1974) in tha t the saturated fa t present in the high fa t  
d ie t (D ie t H) may a ffe c t the s ta b ility  o f the endoplasmic re ticu lum , and thus
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cause the s ign ifican t decrease in cholesterol 7a-hydroxylase a c tiv ity  found a fte r 
twelve weeks o f feeding this d ie t. However, the differences observed in a ll 
these studies m ight be due to differences in composition o f fa t, or to the 
presence o f d iffe re n t amounts o f lip id  peroxides in the unsaturated fa t, or to 
d ifferences in the incubation procedures used.
The wheat bran diets used in this study also had no s ign ifican t e ffe c t on the 
omega hydroxylation o f lauric  acid (Table 4:6). This study was based on the 
hypothesis tha t wheat bran may contain natura l enzyme-inducers o f the mixed 
function oxidase system such as indoles. Cruciferous vegetables, including 
Brussel sprouts, cabbage and cau liflow er are re la tive ly  potent in th is regard. 
From these vegetables three indoles w ith  inducing a c tiv ity  have been iden tified . 
These are indo le -3 -ace ton itrile , indole-3-carbinol, and 3,3'-diindolylm ethane 
(Loub, e t al., 1975) and a ll result from  the hydrolysis o f a parent compound 
indo ly lm ethyl glucosinolate. The parent compound along w ith  the enzyme 
myrosinase which hydrolyses the compound occur in plants in th e ir viable states. 
W ith ce llu la r disruption, the enzyme and substrate are brought together and 
hydrolysis occurs. The re la tive  amounts o f the hydrolysis products being 
dependent upon the conditions o f the reaction (Loub, e t al., 1975). Thus as omega 
hydroxylation takes place via the cytochrome P-450 mixed function  oxidase 
system, the presence o f these in itia to rs  may induce the m icrosomal omega 
hydroxylase enzyme, and thus cause an increase in omega hydroxylation in those 
animals fed the wheat bran d ie t. Moreover, the presence o f indoles in the stock 
d ie t 41b (D ie t J) may be responsible fo r the s ign ifican t increase in cholesterol 
7a-hydroxylase a c tiv ity  in male and female rats a fte r twelve weeks o f feeding 
(Table 4:5) as discussed previously.
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CHAPTER 5
THE EFFECT OF WHEAT BRAN SUPPLEMENTATION ON THE
BINDING OF CARCINOGENS
-  148 -
5.1 Introduction
The mode of action o f d ie tary fib re  in the etiology o f colon cancer was 
extensively discussed in Chapter 1. Studies designed to ascertain the role of 
d ie ta ry fib re  in colon carcinogenesis have shown tha t any p ro tective  e ffe c t by 
fib re  may depend on the type o f fib re  and the pa rticu la r carcinogen present. 
Consequently, animal model studies examining the role o f various fibres in colon 
carcinogenesis have provided con flic ting  results. Therefore, the experiments 
described in this chapter were designed to fu rthe r investigate these reports, by 
examining the binding o f carcinogens to d ie ta ry fib re  in v itro  as w e ll as in vivo in 
rats fed wheat bran diets. Because o f the ir ubiquitous nature, and thus a possible 
risk to health, the carcinogens chosen fo r this study were safro le, and the 
po lycyc lic  arom atic hydrocarbons benzo(a)pyrene, and 3-methylcholanthrene, the 
properties o f which are considered below.
Safrole (4-a lly l-l,2m ethylenedioxybenzene) is one o f the f irs t  re la tive ly  
pure compounds to be used as a spice flavour (Figure 5:1). I t  is the princ ipa l 
component (80-90%) from  the roots and bark o f the sassafras tree, Sassafras 
albidum . Safrole is thus a natural ingredient o f sassafras tea, and was quite 
extensively used as a flavouring agent in so ft drinks, pa rticu la rly  roo t beer and in 
certa in  pharm aceutical preparations, u n til its  use as such was prohib ited by the 
United States Food and Drug A dm in istra tion in 1960. Safrole also occurs as a 
major component o f oils from  the Heterotropa genus (Borchert, e t al., 1973a), as 
a m inor component (1 to 4%) o f some other essential oils, and as a very m inor 
component (0.1%) o f oils o f nutmeg, mace and cinnamon (Guenther, 1948; 
Guenther and Aithausen, 1949). Thus small amounts o f safro le are ingested by 
humans in spiced foods.
Safrole is a weak carcinogen when fed to adu lt male or female rats or male 
m ice, d ie tary concentrations o f up to 0.5% - 1% fo r one year or more are 
required to induce appreciable incidences o f live r tumours (M ille r, e t al., 1979).
The metabolism of safrole both in vivo and in v itro  using live r homogenates and
cultures has been w idely studied (Borchert, et al., 1973b; Janiaud, et al., 1977;
S tillw e ll, e t al., 1974), and a single study dealing w ith  its  metabolism in humans
has also been reported (Benedetti, e t al., 1977). Safrole is extensively
metabolised giving rise to a large number o f m etabolites. Metabolism involves
essentially two major routes, oxidation o f the a lly l side chain, and oxidation o f
the methylenedioxy group w ith  subsequent cleavage to form  the catechol. The
number o f such derivatives is increased by the possibility o f m igra tion o f the
double bond from  the 1,2- to the 2,3-position o f the side-chain (Solheim and
Scheline, 1973; W illiams, 1959). Reactions involving the a lly l group o f safro le
has been described by Borchert, e t al. (1973b), Fishbein, et al. (1967), Kamienski
and Casida (1970), and Oswald, e t al. (1971), w h ils t Solheim and Scheline (1973)
have discussed the metabolism of 4-methoxyallybenzene in deta il. The role o f
these m etabolites in the carcinogenic ity o f safrole is unknown, although Borchert
/
e t al. (1973a) have shown tha t 1-hydroxysafrole present to the extent o f 1-3% in 
the urine o f sa fro le -trea ted  rats is very much more carcinogenic in rats and m ice 
than safro le its e lf. The proposed fu rthe r metabolism o f l'-hyd roxysa fro le  to 
form  a reactive  ester m etabolite  is in agreement w ith  the cu rren tly  favoured 
view tha t the u ltim a te  carcinogenic fo rm  o f most, i f  not a ll, chem ical 
carcinogens are strong e lec troph ilic  reactants which are able to bind covalently 
to tissue macromolecuies (M ille r, 1970). Safrole its e lf has no such a b ility  
(Borchert, e t al., 1973a).
3-M ethylcholanthrene (3-MC) and benzo(a)pyrene (BP) Figure (5:1) belong 
to a class o f compounds known as po lycyclic  arom atic hydrocarbons (PAH). They 
are prevalent contaminants o f air, water, and soil, and are the m ajor products o f 
alkene free -rad ica l conjugation during the incomplete combustion o f fossil fuels. 
The observations by Perciva l Po tt in 1775 tha t scro ta l cancer in chimney sweeps 
in B rita in  was re lated to the ta r and soot in the chimney a fte r coal burning, was 
the f irs t  tim e the environment was considered as a fac to r in the development o f
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Safrole
8
3-Methylcholanthrene
Benzo(a )pyrene
Figure 5:1 Structural representation o f safrole, 3-methylcholanthrene
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human cancer (Pott, 1775). Yamagiwa and Ichikawa confirm ed this hypothesis 
when they produced the f irs t laboratory tumour by chemicals using m u ltip le  
treatm ents o f coal ta r extracts on rabbits ear (Yamagiwa and Ichikawa, 1915). 
This experiment demonstrated the presence o f tumourigenic substances in coal 
ta r.
The recognition tha t po lycyclic  arom atic hydrocarbons were major 
environm ental contam inants led to numerous studies to elucidate the animal 
species and tissue susceptib ilities fo r these compounds, including the biochem ical 
pathways fo r activa tion  and detoxication, and the ir ro le in human carcinogenesis. 
One o f the problems in these studies concerns the in trace llu la r ta rge t site(s) w ith  
which the carcinogen reacts to induce m alignant transform ation. The working 
hypothesis is based on the fa c t tha t PAH covalently bind to ce llu la r 
macromolecules such as DNA (deoxyribonucleic acid), RNA (ribonucle ic acid) and 
prote in (Baird and Brookes, 1973a; Brookes and Lawley, 1964; Gelboin, 1969; 
Kuroki, e t al., 1971; M ille r, 1951; Selkirk, e t al., 1976), the amount o f 
hydrocarbon bound being proportional to the concentration o f macromolecule in 
the tissue, w ith  ce llu la r prote in binding most o f the hydrocarbon, fo llowed by 
RNA then DNA. Although there is no unequivocal evidence th a t carcinogenesis 
is a mutagenic event, and epigenetic mechanisms are theo re tica lly  feasible 
(P ito t and Heidelberger, 1963), much o f the current research fo r the c r it ic a l 
ta rge t site(s) is w ith  DNA.
Early studies showed tha t the PAH were probably bound cova lently, as 
rigorous solvent extraction  fa iled to remove a ll the hydrocarbons from  the 
macromolecule (Brookes and Lawley, 1964; Goshman and Heidelberger, 1967). 
C urren tly , there is much research in to the com parative binding o f hydrocarbons 
to macromolecules to ascertain which compounds are more re levant to 
carcinogenesis (Baird and Brookes, 1973a; Baird, e t al., 1973b; Baird, e t al.,
1975). The lip id  soluble PAH are chem ically ine rt compounds, and are 
metabolised by the m icrosomal bound m ixed-function oxidase, ary l hydrocarbon
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hydroxylase (AHH) to more water soluble forms. The conversion proceeds via 
transient chem ica lly -reactive  interm ediates whereby the molecule form s 
reactive  epoxide species (Selkirk, 1977; Sims and Grover, 1974a). A second 
microsomal enzyme epoxide hydrase, converts epoxides in to v ic ina l glycols 
(Oesch, et al., 1977) and as epoxides are more active carcinogens than the parent 
hydrocarbon, th is enzyme may play a c r it ic a l ro le in carcinogenesis by rapid 
removal o f the reactive  in term ediate epoxides (Huberman, e t al., 1972) before 
in te raction  w ith  a ta rge t site. However, i t  is now known tha t in some cases, 
diols o f arom atic hydrocarbons can undergo another cycle o f m etabolic 
activa tion  and become even more carcinogenic, as diol epoxides, than the 
epoxide its e lf  (Huberman, et al., 1976; Sims, e t al., 1974b; Slaga, e t al., 1976; 
Slaga, e t al., 1977; W olf and Jackson, 1963).
Unlike the cytochrome P-450 from  untreated or phenobarbital-(PB) trea ted 
rats, the adm in istra tion o f PAH and safrole is associated w ith  the fo rm ation  o f a 
spectra lly d is tinc t form  o f cytochrome P-450, cytochrome P^-450 (or P-448) in 
the live r and other tissues o f the ra t (Sladek and Mannering, 1966; Alvares, et 
al., 1967). The induction o f this cytochrome is associated w ith  the specific  
induction o f a number o f hepatic m icrosom al monoxygenases i.e. 
ethoxyresorufin-O -deethylase, biphenyl-2-hydroxylase and to a lesser extent 
biphenyl-4-hydroxylase. Therefore, the induction o f this cytochrom e produced 
on adm inistering these carcinogens may be used as a model fo r studying the in 
vivo binding o f carcinogens to wheat bran, by m onitoring changes in the specific  
enzymes associated w ith  i t  in the presence and absence o f bran. Thus using 
these carcinogens, the present study was designed to evaluate the ro le  o f wheat 
bran in pro tecting animals against carcinogenesis by in it ia lly  examining the 
binding o f these carcinogens in v itro  and then in vivo by the methods described in 
the tex t.
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5.2 M ateria ls and Methods
5.2.1 M ateria ls
These were as described in the previous chapter (4.2.1), w ith  the addition 
o f the fo llow ing.
3-Methylcholanthrene and cytochrome c were purchased from  Sigma 
Chemical Company, London. Isoamyl alcohol, sodium d ith ion ite , heparin and 
hydrogen peroxide were obtained from  B ritish  Drug Houses Ltd., Poole, Dorset. 
Safrole, biphenyl, 2-hydroxybiphenyl and 4-hydroxybiphenyl standards were 
purchased from  Hopkins and W illiams, Chadwell Heath, Essex. E thoxyresorufin, 
and resorufin standard were supplied by Pierce Chemicals, Rockford, Illino is, 
USA.
■^C-Safrole, specific a c tiv ity  o f 15 m C i/m m ol and radiochem ical pu rity  o f 
99% was purchased from  Commissariat a l'Energie Atom ique, Service des 
Molecules Marquees, G il-su r-Y ve tte , France; and was stored in d is tilled  w a te r- 
ethanol (1:1 v/v) a t 4°C  u n til required. [G -^ H ] Benzo(a)pyrene, specific  a c t iv ity  
o f 20 Curies/m m ol and radiochem ical pu rity  o f 99% was purchased from  the 
Radiochemical Centre, Amersham, and was stored in toluene at -20°C . 'Insta 
gel', 'D im ilum e 30' and 'Soluene 350* were supplied by the Packard Instrum ent 
Company, London. 'Hydrocount' was obtained from  J.T. Baker Chemical 
Company, Phillipsburg, N.J., U.S.A.
Most other chemicals used were supplied by BDH Ltd. and May and Baker, 
L td ., as described in 2.2.1 or as specified in the te x t. Solvents and gases used in 
this study were as described in 2.2.1.
5.2.2 Assay methods fo r the in v itro  binding o f carcinogens to wheat bran
E ffe c t o f pH on the in v itro  binding o f ^ C -s a fro le  to wheat bran: The 
capacity o f wheat bran to bind the carcinogen safrole was determ ined by an 
adaptation o f the method described by Smith-Barbo, et al. (1981).
14 /A 50 p i a liquot o f C-safro le containing approximately 880,000 dpm /m l
was added to screw-capped tubes containing 5 m l o f 0.1M potassium phosphate
bu ffe r a t pH values ranging from  1 to 12. The tubes were mixed, and a 0.5 m l
aliquot was removed and added to 5 m l o f 'Hydrocount' sc in tilla tio n  flu id .
Samples o f wheat bran (0.25 g) were then added to the remainder o f the
14potassium phosphate bu ffe r - C -safro le m ixture in the screw-capped tubes. 
The tubes were capped and placed on a ro ta ry  m ixer at 37°C fo r 2 hours. A fte r  
incubation the tubes were centrifuged at 2,000 rpm fo r 15 minutes in an MSE 
M is tra l 6L centrifuge, and a fu rthe r 0.5 m l a liquot o f the supernatant was 
removed and added to 5 ml o f 'Hydrocount1. Supernatant ra d io a c tiv ity  was used 
as an ind ica tor o f unbound carcinogen. R ad ioactiv ity  was determ ined by use o f a 
LKB Wallac rackbeta liqu id sc in tilla tion  counter (model 1216) w ith  a counting 
e ffic iency  o f 90%.
14E ffe c t o f incubation tim e on the in v itro  binding o f C -safro le to wheat 
bran: A fixed amount o f wheat bran (0.25 g) was incubated w ith  5 m l o f 
the potassium phosphate bu ffe r -^ C -s a fro le  m ixture , fo r 30, 60, 90, 120, 150 
and 180 minutes at 37°C and pH 6.7 by the method described above.
14E ffe c t o f wheat bran concentration on the in v itro  binding o f C -sa fro le :
Wheat bran at concentrations ranging from  10 m g/m l to 100 m g/m l were
14incubated w ith  5 m l o f the potassium phosphate bu ffe r -  C -safro le m ix tu re  a t 
pH 6.7 and 37°C fo r 2 hours by the method described above.
14E ffe c t o f safrole concentration on the in v itro  binding o f C -safro le  to
wheat bran: A fixed amount o f wheat bran (0.25 g) was incubated a t pH
o 146.7 and 37 C fo r 2 hours w ith  5 m l o f the potassium phosphate b u ffe r - C -
safrole m ixture , containing safrole a t the fo llow ing concentrations, 1 mM, 100
pM, 1 pM, 500 nM and 100 nM, by the method described above.
Preparation o f desolubilised wheat bran
Wheat bran was defatted J by incubating w ith  acetone in a shaking w ater 
bath a t 20°C fo r 4 hours. The procedure removes fa tty  acids together w ith  any 
soluble fibres present in the bran; and was carried out under oxygen free 
nitrogen to prevent peroxidation and degradation o f the bran components. The 
desolubilised wheat bran was then placed in muslin and washed thoroughly w ith  
d is tilled  water u n til the acetone was removed, and then dryed in a ir at room 
tem perature.
E ffe c t o f pH on the in v itro  binding o f ^ C -s a fro le  to desolubilised wheat 
bran: This experiment was perform ed as described above fo r whole wheat
bran.
E ffe c t o f desolubilised wheat bran concentration on the in v itro  binding o f 
~^C -safro le : This experiment was perform ed as described above fo r whole 
wheat bran, w ith  desolubilised wheat bran concentrations ranging from  10 m g/m l 
to 80 m g/m l in the incubation system.
E ffe c t o f pH on the in v itro  binding o f [G - H 1 -benzo(a)pyrene to wheat 
bran; A 10 y l a liquot o f [G -^ H ] -benzo(a)pyrene, containing approxim ate ly
3.3 x 10^ dpm /m l was added to the incubation system described previously fo r 
"^C -sa fro le . The supernatant ra d io ac tiv ity  was then determ ined using a LKB 
Wallac rackbeta liquid sc in tilla tion  counter (model 1216) w ith  a counting 
e ffic iency  o f 31%.
5.2.3 Assay methods fo r the in v itro  binding o f carcinogens to g lu ten-free  
wheat starch
E ffe c t o f pH on the in v itro  binding o f ^ C -s a fro le  to g lu ten-free  
wheat starch: This experiment was perform ed as described in 5.2.2 
fo r wheat bran.
E ffe c t o f g lu ten-free  wheat starch concentration on the in v itro  
binding o f ^ C -s a fro le : This experiment was perform ed as described 
in 5.2.2 fo r wheat bran.
5.2.4 Animals and diets fo r the in vivo binding of carcinogens to wheat
bran
The e ffe c t o f feeding D ie t A (starch contro l) D ie t G (high bran) D ie t F (low bran) 
and D ie t H (high fa t) on the in vivo absorption o f 3-m ethylcholanthrene given to 
male rats by gastric in tubation
Twenty male rats o f the W istar stra in weighing approxim ately 125 g were 
randomly assigned in equal numbers to one o f the four d ie t groups. A ll animals 
were housed as described in 2.2.3 and fed diets A, G, F and H fo r five  days p rio r 
to being given a single dose o f 3-methylcholanthrene (25 mg/kg in corn o il) by 
gastric in tubation. Throughout th is study, a carcinogen con tro l group o f five  
animals fed the starch contro l d ie t (D ie t A) and given a single ora l dose o f corn 
o il was included. Tw enty-four hours a fte r dosing, a ll animals were k illed  by 
cerv ica l dislocation, and the livers excised as described in Chapter 2. Food and 
w ater was provided ad lib itum .
The e ffe c t o f feeding D ie t A (starch contro l) D ie t G (high bran) D ie t F (low bran) 
and D ie t H (high fa t) on the in vivo absorption o f safrole incorporated in to  these 
diets
D ie t preparation: For d ie ta ry adm in istra tion, safrole was mixed in to the starch 
con tro l (D ie t A), high bran (D ie t G), low bran (D ie t F) and high fa t diets (D ie t H) 
using a Horbart m ixer (model A200). Safrole a t a concentration o f 0.25% (w /w) 
in each d ie t was prepared by adding the compound dissolved in a quan tity  o f corn 
o il such as to raise the fa t content o f the d ie t by 2% (w /v); a con tro l d ie t was
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prepared by adding 2% (w/w) corn o il to the starch contro l d ie t (D ie t A). Each 
d iet was mixed fo r 30 minutes at the slowest speed on the Horbart m ixer. Corn 
o il solutions were in it ia lly  mixed fo r three minutes in to 23% o f the to ta l 
quantity  o f d ie t, and this prem ix subsequently dispersed in to the remainder. On 
account o f the v o la tility  o f safro le, i t  was added to the diets a t a level 10% 
higher than the desired concentration (Borchert, 1973a; Hagan, 1967). A ll diets 
were then stored in t ig h tly  sealed dark glass containers at 4°C  p rio r to use.
Anim als: Twenty male rats o f the W istar stra in weighing approxim ate ly 147g 
were randomly assigned in equal numbers to each d ie t group, and housed 
ind iv idua lly as described in 2.3.3. Animals were then fed the starch con tro l (D ie t 
A), high bran (D ie t G), low bran (D ie t F) and high fa t diets (D ie t H) fo r five  days, 
p rio r to being given the diets containing 0.23% (w/w) safrole, which were fed fo r 
a fu rthe r seven days. Throughout the study a carcinogen contro l group o f five  
animals fed the starch con tro l d ie t (D ie t A) containing corn o il fo r seven days 
was included. A ll animals were then k illed  by cerv ica l d islocation and the livers  
excised as described in Chapter 2. A t a ll tim es during the study animals were 
allowed access to the d ie t and water, while measurement o f body weight and 
food intake was made at regular in tervals.
The e ffe c t o f feeding D ie t A (starch contro l) D ie t G (high bran) D ie t F (low bran) 
and D ie t H (high fa t) on the in vivo absorption o f 3-m ethylcholanthrene 
incorporated in to these diets
D ie t preparation: These diets were prepared as described fo r safro le. The 3- 
methylcholanthrene was dissolved in corn o il and incorporated a t a concentration 
o f 0.04% (w/w) into each test d ie t. A carcinogen contro l d ie t was prepared 
containing only corn o il by the method described previously.
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Anim als: Sixteen male rats o f the Wistar strain weighing approxim ately 145g 
were randomly assigned in equal numbers to each d ie t group and housed 
ind iv idua lly as described in 2.2.3. Animals were then fed the starch contro l (D ie t 
A), high bran (D ie t G), low bran (D ie t F) and high fa t diets (D ie t H) fo r five  days. 
The animals were then transferred to cages containing s te rlite  bedding, and 
placed in a negative pressure iso lator (Plate 1); where they were fed diets A,G,F 
and H containing 0.04% (w/w) 3-m ethylcholanthrene fo r fourteen days. 
Throughout the study, a carcinogen contro l group o f four animals fed the starch 
contro l d ie t (D ie t A) containing corn o il fo r fourteen days was also included. A ll 
animals were then k illed  by cerv ica l dislocation and the livers excised as 
described in Chapter 2. A t a ll times during the study animals were allowed 
access to the diets and water.
The e ffe c t o f feeding D ie t A (starch contro l) D ie t G (high bran) D ie t F (low bran)
14and D ie t H (high fa t) on the in vivo absorption and excretion o f C -safro le given 
to male rats by gastric in tubation
Twelve male rats o f the Wistar s tra in  weighing approxim ately 250g were 
randomly assigned in equal numbers to one o f the four d iet groups. A ll animals 
were housed as described in 2.2.3, and fed diets A,G,F and H fo r five  days p rio r 
to being given a single dose o f 3yC i ^ C -s a fro le  (equivalent to 200 nmol o f 
safrole) by gastric in tubation. Blood samples were then taken a t ten m inute 
in tervals fo r one hour from  the ta il o f the ra t in to polyethylene tubes pre-coated 
w ith  heparin (300 un its /m l); plasma was then prepared by the method described 
in 2.2.3. The animals were then transferred in to individual glass metabolism  
cages (Metabowls, Jencon S cien tific  L td., Hemel Hempstead, Herts.) where they 
were fed diets, A,G,F and H fo r a fu rthe r four days; tw en ty -fou r hour urine and 
faecal samples were then collected. Food and w ater was provided ad lib itum , 
and body weight and food intake were recorded at regular in tervals.
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P la te  1
N egative  pressure iso la to r used fo r feeding D ie t A (starch  
co n tro l) D ie t G (high bran) D ie t F (low  bran) and D ie t H (high fa t)  
conta in ing  0.04% 3 -m ethy lcho lan th rene  to male ra ts fo r 14 days
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The e ffe c t o f feeding D ie t A (starch contro l) D ie t G (high bran) D ie t F (low bran) 
and D ie t H (high fa t) on the in vivo absorption and excretion o f [G - -H ]  
benzo(a)pyrene given to male rats by gastric in tubation
The experim ental conditions o f this study were as described previously fo r
safrole, each animal however received 15 yC i [G -^ H ] benzo(a)pyrene
(equivalent to 250 nmol o f benzo(a)pyrene) by gastric intubation.
5.2.5 Preparation o f live r fractions
L iver m icrosomal fractions were prepared by the method described
in 2.2.4.
5.2.6 Assay methods fo r the in vivo binding o f carcinogens to wheat bran
Biphenyl hydroxylase
Biphenyl undergoes hydroxylation a t a number o f positions, but in
the ra t the major m etabolite is 4-hydroxybiphenyl. Smaller amounts o f 2-
hydroxybiphenyl are also produced, and both can be measured simultaneously, as 
at pH 5.5 they exh ib it d iffe re n t fluorescence spectra.
Biphenyl
2-Hydroxybiphenyl
An assay system based on Creaven, e t al. (1965) was used, com prising the 
fo llow ing incubation system:
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Test TestBlank Blank
40H
Biphenyl
Standard
20H
Biphenyl
Standard
Buffer, T ris-H C l 0.05M 
pH 8.1 (ml) 0.5 0.5 0.5 0.5 0.5
MgCl2 0.05M (ml) 0.2 0.2 0.2 0.2 0.2
Homogenising medium 
1.15% w /v KC L (ml) 0.3 0.3 0.3 0.3 0.3
NADP+ 0.006M (ml) 0.25 0.25 0.25 0.25 0.25
Substrate (ml) 0.25 0.25+ 0.25+ 0.25t 0.25+
Microsomal supernatant 
25% w /v (ml) 0.5 0.5 - - -
20H  Biphenyl standard 
(ml)
- - - - 0.035+
40H  Biphenyl standard 0.176+
f  represents addition a fte r incubation
Substrate: 0.012M Biphenyl in d is tilled  water containing 4% (w /v) Tween
80 (polyoxyethylene sorbitan monoleate)
Standards: 2-Hydroxybiphenyl 6 ug /m l in 96% (v/v) aq ethanol
4-Hydroxybiphenyl 30 pg /m l in 96% (v/v) aq ethanol
The above incubation system was prepared in duplicate on ice in 15 m l 
sovire l tubes, and incubated a t 37°C fo r 10 minutes in a shaking w ater bath. The 
reaction was term inated by the addition o f 0.5 m i o f HCL (2M). A fte r  placing 
the tubes on ice, substrate and standard were then added to the appropriate 
tubes. A fte r the addition o f 10ml o f heptane containing 1.5% (v/v) isoamyl 
alcohol (isoamyl alcohol decreases the form ation o f emulsions) a ll tubes were
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extracted fo r 10 m inutes on a ro ta ry  ex trac to r. Any emulsion formed was 
broken by cen trifuga tion  a t 2,000 rpm fo r 5 minutes. A 2 ml a liquot o f each 
heptane layer was transferred to clean tubes, 10 ml o f NaOH (0.1M) was added, 
and the tubes extracted fo r a fu rthe r 10 minutes on the ro tary ex trac to r. A fte r  
cen trifuga tion  at 2,000 rpm fo r 5 minutes, the heptane layer was aspirated o ff  
using a water pump. Hydroxybiphenyls in the NaOH phase are stable in the dark 
at 4°C , fo r at least 24 hours.
A 2 m l a liquot o f the NaOH phase was pipetted in to a fluo rim e te r cuvette , 
and the pH brought to 5.5 by the addition o f 0.5 m l of succinic acid (0.25M); 2- 
and 4-hydroxybiphenyls were then determ ined using a Perkin E lmer 
Spectro fluorim eter MPF3 at 295 nm (excita tion) and 415nm (emission) and 275 
nm (excita tion) and 338 nm (emission) respective ly. Under these conditions, 4- 
hydroxybiphenyl fluoresces s ligh tly  at the wavelength maxima o f 2- 
hydroxybiphenyl. It is thus necessary to account fo r the contribu tion  o f 4- 
hydroxybiphenyl at th is wavelength.
Ethoxyresorufin-O-deethylase
Ethoxyresorufin-O-deethylase was measured by a m od ifica tion  o f the 
method o f Burke and Mayer (1974).
L ive r microsomes from  the ra t catalyse the O -deethylation o f 
ethoxyresorufin to resorufin (7-hydroxyphenoxazone) in an NADPH and oxygen- 
dependent reaction involving the flavopro te in , NADPH-cytochrome c reductase 
and cytochrome P-450. The reaction may be represented thus:
NADPH
Ethoxyresorufin Resorufin
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The fo llow ing were placed in to a fluo rim e te r cuvette, 2 m l o f Tris bu ffe r 
(0.1 M pH 7.6), 50 p i o f m icrosomal suspension (25% w/v) and 10 p i o f 
ethoxyresorufin (50 pm in ethanol). A baseline o f fluorescence was recorded at 
an exc ita tion  wavelength o f 510 nm and an emission wavelength o f 586 nm w ith  a 
Perkin Elmer Spectro fluorim eter MPF3. A 10 p i aliquot o f NADPH (50 mM) was 
then added to the m ixture  to s ta rt the reaction, and the progressive increase in 
fluorescence was recorded as the de-ethylation o f ethoxyresorufin to resorufin 
progressed. The reaction was carried out at 37°C and fo llowed fo r 
approxim ately 2 minutes. The fluo rim e te r was calibrated w ith  10 p i o f resorufin 
standard (10 pM in ethanol), and a ll determ inations were made in duplicate.
Cytochrome b^
Cytochrome b^ was measured as the d ifference spectrum o f NADH- 
reduced microsomes against oxidised microsomes. The method is tha t o f Omura 
and Sato (1964).
M icrosomal suspension (25% w /v) was diluted ten-fo ld  w ith  0.1 M phosphate 
bu ffe r pH 7.4, 2.5 m l was then pipetted in duplicate into each o f two 1 cm 
cuvettes. A 0.1 m l a liquot o f NADH (1 m g/m l) was added to the sample cuvette  
and the reduced minus oxidised d iffe rence spectrum recorded between 390 nm 
and 500 nm using a Pye Unicam SP1800 scanning UV spectrophotom eter. The 
cytochrome b^ content was calculated using an extinction  c o e ffic ie n t o f 185 
m M '^ cm ’ ^ fo r the ex tinc tion  differences between 410 nm and 426 nm (Omura 
and Sato, 1964).
Cytochrome P-450: carbon monoxide ligand
In its  reduced form  the cytochrom e P-450-CO complex absorbs strongly a t 
450 nm. Measurement o f this spectral maximum perm its determ ination o f the 
cytochrome (Omura and Sato, 1964).
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A 2.5 m l aliquot o f a 25% (w /v) m icrosomal suspension diluted ten -fo ld  
w ith  0.1M phosphate bu ffe r pH 7.4 was pipetted in duplicate in to each o f two 1 
cm cuvettes, and reduced w ith  a few m illig ram s of sodium d ith ion ite . A baseline 
was drawn, and CO was then bubbled through the contents o f the sample cuvette  
fo r 30 seconds, the d iffe rence spectrum was then recorded between 390 nm and 
500 nm using a Pye Unicam SP1800 scanning UV spectrophotom eter. The 
cytochrome P-450 concentration was calculated from  the ex tinc tion  d ifferences 
between 450 nm and 490 nm. In the absence of an accepted ex tinc tion  
co e ffic ie n t fo r ra t cytochrome P-450 the orig ina l value calculated from  rabb it 
live r cytochrom e P-450 of 91 mM~^ cm"'*' was used (Omura and Sato, 1964).
NADPH-cytochrom e c reductase
Microsomal NADPH-cytochrom e c reductase a c tiv ity  was measured by the 
method o f W illiam s and Kamin (1962), by fo llow ing the ra te  o f reduction o f 
cytochrome c a t ambient tem perature. The fo llow ing were placed in duplicate 
in to 1 cm cuvettes:
Test Blank
Potassium phosphate bu ffe r:
0.05M pH 7.6 containing ImM KCN (ml) 1.7 1.8
Cytochrome c 0.1 mM (ml) 1.0 1.0
Microsomal suspension 25% (w /v) (ml) 0.2 0.2
NADPH 0.03M (ml) 0.1 -
A fte r  establishing a baseline a t 550 nm, the reaction was in itia te d  by the 
addition o f the NADPH to the test cuvette, and the reaction fo llowed fo r 
approxim ately 2 m inutes using a Pye Unicam SP1800 scanning UV 
spectrophotom eter. The in it ia l ve loc ity  was taken as a measure o f cytochrom e c 
reduction. The NADPH-cytochrom e c reductase a c tiv ity  was calculated using an 
ex tinc tion  co e ffic ie n t o f 18.5 mM"^ cm"'*'.
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Measurement o f prote in concentration
Microsomal prote in concentration was determined by the method o f Lowry, 
e t a l. (1951) as described in 4.2.5.
Measurement o f ra d io ac tiv ity  in plasma
A 30 p i a liquot o f plasma from  animals treated w ith  ^ C -s a fro le , and a 40 
y l a liquot from  animals treated w ith  [G -^H  ] benzo(a)pyrene were placed into 
polypropylene sc in tilla tio n  vials (Hughes and Hughes L td., Romford, Essex) 
containing 5 m l o f 'Insta gel1 sc in tilla tion  flu id . R ad ioactiv ity  was then 
determ ined by use o f a LKB Wallac rackbeta liqu id sc in tilla tion  counter (model 
1216). A counting e ffic iency  o f 90% fo r ^ C -s a fro le  and 37% fo r [G -^ H ] 
benzo(a)pyrene was observed.
Measurement o f rad io ac tiv ity  in urine
A 0.4 m l a liquot o f urine from  "^C -sa fro le  treated animals, and a 0.25 m l 
a liquot from  [G -^H  ] benzo(a)pyrene treated animals was placed in to 
polypropylene sc in tilla tio n  vials (Hughes and Hughes L td., Romford, Essex) 
containing 5 m l o f 'Insta gel1 sc in tilla tio n  flu id . R ad ioactiv ity  was then 
determ ined by use o f a LKB Wallac rackbeta liqu id sc in tilla tion  counter (model 
1216). A counting e ffic iency  o f 89% fo r "^C -sa fro le  and 27% fo r tG -^H ] 
benzo(a)pyrene was observed.
Measurement o f rad io ac tiv ity  in faeces
A 5% (w /v) faecal homogenate from  the ^ C -s a fro le  and [G -^ H ] 
benzo(a)pyrene treated animals was prepared in d is tilled  w ater. D uplicate 
aliquots (0.5 ml) were then transferred to glass sc in tilla tion  vials and digested 
w ith  3 ml o f 'Soluene 350' a t 50 - 60°C fo r 6 hours. On cooling, the samples were 
decolourised overnight at room tem perature w ith  100 vol H2O2 (0.25 ml).
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'D im ilum e 30' sc in tilla tio n  flu id  (10 ml) was then added to each v ia l and the
ra d io ac tiv ity  determ ined by use o f a LKB Wallac u ltrabeta liqu id sc in tilla tio n
/ \ 14counter (model 1210). A counting e ffic iency o f 85% fo r C -safro le, and 25%
fo r [G -^H  ] benzo(a)pyrene was observed.
5.2.7 S ta tis tica l analysis
S ta tis tica l analysis was carried out using Student's unpaired t -  
test. The level o f s ignificance based on this test being indicated in the tables o f 
results.
5.3 Results
5.3.1 In v itro  binding studies
14In v itro  binding o f C -safro le to wheat bran and desolubilised 
wheat bran
14The percentage o f C -safro le bound to wheat bran in v itro
increased w ith  the duration o f incubation (Figure 5:2), and w ith  increasing bran
concentration to a maximum o f 73% a t a bran concentration o f 100 m g/m l
14(Figure 5:3). The percentage o f C -safro le bound by wheat bran increased from
61% a t pH 1 to a maximum o f 76% at pH3. The sharp decrease in carcinogen
binding tha t occurred between pH 7 and pH 8 continued as the pH values became
14more basic u n til a t pH 11, 42% o f the C-safro le was bound to the wheat bran 
(Figure 5:4). A t the chosen standard assay conditions (0.25g wheat bran
incubated w ith  5 ml phosphate b u ffe r-^ C -s a fro le  m ixture  pH 6.7 fo r 2 hours at 
37°C) the percentage o f safrole bound to the wheat bran increased w ith
increasing safrole concentration, to a maximum o f 73% a t a concentra tion o f 
safro le in the incubation system o f Im M  : (Figure 5:5).
The percentage o f "^C -sa fro le  bound to desolubilised wheat bran increased 
w ith  increasing concentration o f desolubilised wheat bran to a maximum o f 60% 
at a concentration o f 60 m g/m l (Figure 5:6). Moreover, the
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Figure 5:2 E ffec t o f incubation time on the binding o f C-safrole 
to wheat bran. A ll  measurements were made a t pH 6.7 
fo llow ing the incubation o f wheat bran (50 mg/ml) w ith 
14C -s a fro le (2 6 -4 f iM )  at 37°c.
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Figure 5:3 E ffec t o f wheat bran concentration on the binding o f 
l4C-safro1e. A l l  measurements were made at pH 6.7 
fo llow ing the incubation o f wheat bran with '^C-safrole(26-4i 
fo r  2 hours at 37°C.
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Figure 5 :4  E ffect o f pH on the binding o f ^C -sa fro le  to wheat bran 
A l l  measurements were made fo llow ing the incubation o f 
wheat bran (50 mg/ml) w ith 14c-safrole(26-4^J\/i)for 2 hours
at 37 °C.
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Figure 5:5 E ffect o f safro le concentration on the binding o f ^C -s a fro le  
to wheat bran. A ll measurements were made at pH 6.7 fo llow ing 
the incubation o f wheat bran (50 mg/ml) w ith l^C -sa fro le  fo r  
2 hours at 37°C.
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Figure 5:6 E ffec t o f desolubilised wheat bran concentration on the 
binding o f ^C -sa f ro l e . A l l  measurements were made at 
pH 6.7 fo llow ing the incubation o f desolub ilised wheat 
bran with ^^'C-sa’f r o le ( 26 ‘4 |*.M) for 2  hours at 37°c .
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14/Figure 5:7 E ffec t o f pH on the binding o f C-safrole to desolub ilised
wheat bran. A ll measurements were made fo llow ing the 
incubation o f desolubilised wheat bran (50 mg/ml) w ith
1 C -s a f r o le (26-4^M ) for 2 hours at 3 7 °C .
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desolubilised wheat bran show a lower a ff in ity  fo r binding "^C -sa fro le  
throughout the entire  pH range used in this experiment than whole bran (Figure 
5:7).
E ffe c t o f pH on the in v itro  binding o f [G -^H  ] benzo(a)pyrene to wheat bran
This experiment was carried out under the standard incubation conditions 
reported in the te x t. The percentage o f [G -^ H ] benzo(a)pyrene bound to wheat 
bran increased from  44% at pH 1, to a maximum of 64% at pH 3 (Figure 5:8). 
However, a marked decrease in the percentage binding o f [G -^H ] 
benzo(a)pyrene to wheat bran occurred between pH 7 and pH 8, which continued 
as the pH o f the incubation became more basic, u n til a t pH 10 19%, and a t pH 11 
21% of the [G -^ H ] benzo(a)pyrene was bound to the wheat bran (Figure 5:8).
14In v itro  binding o f C-safro le to g lu ten-free wheat starch
These experiments were carried out under the standard incubation
14conditions previously reported fo r wheat bran. The percentage o f C -safro le 
bound to the g lu ten-free  wheat starch increased w ith  starch concentration, to a 
maximum o f 31% a t a starch concentration o f 100 m g/m l (Figure 5:9). 
Moreover, the percentage o f ^ C -s a fro le  bound to the g lu ten-free  wheat starch 
varied w ith  the pH from  24% at pH 1, to 21% a t pH 12, w ith  a maximum binding 
o f 27% a t pH 5. (Figure 5:10).
5.3.2 In vivo binding studies
The e ffe c t o f feeding D ie t A (starch contro l) D ie t G (high bran) D ie t F (low bran) 
and D ie t H (high fa t) on the hepatic mixed function oxidase system o f male ra ts 
given a single dose o f 3-methylcholanthrene by gastric in tubation
3-Methylcholanthrene adm in istra tion by gastric in tubation (25 mg/kg in 
corn o il) to male rats fed the starch contro l (D ie t A), low bran (D ie t F), high bran
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(D ie t G) and high fa t (D ie t H) diets, had no s ign ifican t e ffe c t on body weight or 
live r weights compared to those animals given the corn o il and fed the starch 
contro l d ie t (D ie t A) (Table 5:1). However, the food intake o f the animals on the 
various d ie t groups were not measured during this experiment. The 
adm in istra tion o f 3-m ethylcholanthrene (25 mg/kg in corn o il) by gastric 
in tubation to male rats fed diets A, F, G and H resulted in s ign ifican t increases 
in the hepatic drug metabolising enzymes, compared to those animals fed the 
starch contro l d ie t (D ie t A) and ora lly  dosed w ith  corn o il (Table 5:2). Moreover, 
a marked enhancement o f biphenyl-2-hydroxylation and ethoxyresorufin-O - 
deethylation a c tiv ity , cytochrome P-448 mediated enzyme reactions was evident 
in the 3-m ethylcholanthrene treated d ie t groups, compared to those animals 
given the corn o il and fed the starch contro l d ie t (D ie t A) (Table 5:2). However, 
no s ign ifican t increase in NADPH-cytochrome c reductase a c tiv ity  or 
m icrosomal prote in concentration was noted in those animals given 3- 
methylcholanthrene when compared to those animals given the corn o il.
Animals fed the low bran d ie t (D ie t F) and given 3-m ethylcholanthrene (25 
mg/kg in corn o il) by gastric  in tubation had a s ign ifican t increase (p < 0.05) in 
ethoxyresorufin-O -deethylase a c tiv ity , and a s ign ifican t increase (p < 0.05) in 
cytochrome b,. compared to those animals fed the starch con tro l d ie t (D ie t A) 
and given 3-m ethylcholanthrene (25 mg/kg) (Table 5:2). Moreover, those animals 
given the 3-m ethylcholanthrene and fed the high bran (D ie t G) and high fa t  diets 
(D ie t H) had s ign ifican t increases in cytochrome b^, (p < 0.05) and NADPH- 
cytochrome c reductase a c tiv ity  (p < 0.05) respective ly, when compared to  those 
animals fed the starch contro l d ie t (D ie t A) and given 3-m ethylcholanthrene (25 
mg/kg) by gastric in tubation (Table 5:2).
Ta
ble
 
5:1
 
E
ffe
ct
 
of 
fe
ed
in
g 
Di
et
 
A 
(s
ta
rc
h 
co
nt
ro
l 
di
et
) 
Di
et
 
G 
(h
igh
 
br
an
 
di
et
)
Di
et
 
F 
(lo
w 
br
an
 
di
et
) 
Di
et
 
H 
(h
igh
 
fa
t 
di
et
) 
on 
m
ale
 
ra
t 
bo
dy
 
w
ei
gh
t 
an
d
-  177 -
0c0S->
JZ
c0
o
j o0
j z
4 -40
E1m
0
COO•a
"toCho
0
"ctc
'co
0
Ci0
0
4-1
JZCJl
’0
£
Ch0>
in
a
o
CM
CD
rn
a
o
in
CD
cm
CD
CM
a o
CM
CM VO
CM
CD O
0 Q
CM
cn cn cn
CDa
r—I
4->
cn jc
44 .21 
■£ ®
cn
JCcncn cncn
anT>
JO > *0
S0 -O
cnc.
w
0
c
0>
'01
CO
"0
E
c
<
4^
4—
•
C
.2
4 4
0
JOD
•- .2
“  n  0 J3cn 3
>s c 
jo • —. a
0 h
c  to 
c-i 0  
o  cn
0 >, cn jo
^  a)cn c
E S
m £  
cm c
<4— 0
0 o0 JC
CO O
* £
0  4 -4
J=i 0
£ $  
CO rn
0 cn 
c ^  
®  on
I . E
JS S5CO
E o  
c ©
<1 O  
4 -  TD
CO 0 
CO 0 
JC
4-4c 0 
f - i 0 
CL
5 C
c0>
’cn
Vi
a.ooCxcn
4-4
0
JCo00
0
JO
EZ3
C
0
JZ Ea
ch
 
va
lue
 
re
pr
es
en
ts
 
the
 
me
an
 
+ 
SE
M
.
Ta
ble
 
5:2
 
E
ffe
ct
 
of 
fe
ed
in
g 
Di
et
 
A 
(s
ta
rc
h 
co
nt
ro
l 
di
et
) 
Di
et
 
G 
(h
igh
 
br
an
 
di
et
)
Di
et
 
F 
(lo
w 
br
an
 
di
et
) 
Di
et
 
H 
(h
igh
 
fa
t 
di
et
) 
on 
the
 
he
pa
tic
 
m
ixe
d 
fu
nc
tio
n 
ox
id
as
e 
sy
ste
m 
of 
ma
le 
ra
ts 
af
te
r 
a 
sin
gle
 
or
al
 
do
se
 
of 
3-
m
et
hy
lc
ho
la
nt
hr
en
e
OD
CD
CD
m
CD
CD CD
O
CD
CD
CD
fA
CN
CD
m
CD
CD
CD
CD
KV
CD•
CD
m
VO O
CD CDCD
CD
CDfA
O n
CN
CD
CO
CD
LA
cn
CN
CD
CD
CAO
CD
CD
CD
CD
CD
VO
CD
CD CO
CD
fA
CD
CD
fA
On
CO
CD
CD
CD
CD
CD
CO
O•
VO
VO
OnOn
VO•
CD
fA
CD CD
VO
CD
CD
On
CD
CD
VO
CD
(A
CN
O
o
CD
CDO
CD CO
CN•
CD
CN
CDCO
□L
CJ>
CL CL
cn cn
cn
JZ TJ
4->  0
CL
>. °~ 
x cnx cn
TJ •CD JD Q .
Q .
t* sz>% o
Q .
cnZJ
cn
E
lA
CN
0
CO
o
TJ
cnc.
‘co
0
c0>
‘Eh
CO
"co
£
c
<4—
co
4J0
JD
D
O
"Z>
4—> 
CO 0 
cn
XJD
CL*
oo
cn
ZJ
cn
E
m
CN
0co
o•O
JD
"cn
£"co
0
c0
>
'Eh
CO
*0
£
c
<
3-
m
et
hy
lc
ho
la
nt
hr
en
e 
by 
ga
st
ric
 
in
tu
ba
tio
n.
Th
e 
nu
m
be
r 
of 
an
im
al
s 
in 
ea
ch
 
di
et
 
gr
ou
p 
is 
giv
en
 
in 
pa
re
nt
he
se
s.
Ea
ch
 
va
lue
 
re
pr
es
en
ts
 
the
 
me
an
 
+ 
SE
M
f 
* 
p 
< 
0.
05
, 
**
 
p 
< 
0.
02
, 
**
**
 
p 
< 
0.0
01
 
co
m
pa
re
d 
wi
th
 
Di
et
 
A
tt
.
-  179 -
The e ffe c t o f feeding D ie t A (starch contro l) D ie t G (high bran) D ie t F (low bran) 
and D ie t H (high fa t) containing 3-methylcholanthrene on the hepatic mixed 
function oxidase system o f male rats
The e ffe c t o f feeding diets A, F, G and H containing 0.04% (w/w) 3- 
m ethylcholanthrene fo r fourteen days on body weight and liv e r weight is shown 
in Table 5:3. Those animals fed the starch contro l d ie t (D ie t A) containing corn 
o il had a s ign ifican t increase (p < 0.02) in the ir mean body weight compared to 
those animals fed the starch contro l d ie t (D ie t A) containing 0.04% (w/w) 3- 
m ethylcholanthrene (Table 5:3); however, food intakes during this experim ent 
were not recorded. The rats fed diets A,F,G and H containing 0.04% (w/w) 3- 
m ethylcholanthrene fo r fourteen days had s ign ifican t increases in th e ir hepatic 
drug metabolising enzymes, compared to those animals fed the starch contro l 
d ie t (D ie t A) containing corn o il (Table 5:4). As reported previously, no 
s ign ifican t increase in NADPH-cytochrom e c reductase a c tiv ity , or m icrosomal 
pro te in  concentration was found in those animals fed the diets containing 3- 
m ethylcholanthrene, compared to those animals fed the starch contro l d ie t (D ie t 
A) containing corn o il. However, a marked enhancement o f b iphenyl-2- 
hydroxylase and ethoxyresorufin-O -deethylase a c tiv ity  was observed in those 
animals given the diets containing 3-methylcholanthrene, compared to those 
animals fed the starch contro l d ie t (D ie t A) containing corn o il (Table 5:4).
The rats fed the low bran d ie t (D ie t F) containing 0.04% (w /w) 3- 
methylcholanthrene fo r fourteen days had s ign ifican tly  lower cytochrom e P-450 
(p < 0.001), and cytochrome b^ levels (p < 0.02), compared w ith  the animals fed 
the starch contro l d ie t (D ie t A) containing 0.04% (w/w) 3-m ethylcholanthrene 
(Table 5:4). The high bran d ie t (D ie t G) containing 0.04% (w /w ) 3- 
m ethylcholanthrene s ign ifican tly  decreased the cytochrome b^ concentration (p 
< 0.05) in those animals receiving this d ie t compared to those animals fed the 
starch contro l d ie t (D ie t A) containing 0.04% (w/w) 3-m ethylcholanthrene. 
Moreover, the rats fed the high fa t d ie t (D ie t H) containing 0.04% (w /w ) 3- 
m ethylcholanthrene fo r fourteen days, had a s ign ifican t decrease in cytochrom e
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P-450 (p < 0.01), and NADPH-cytochrom e c reductase a c tiv ity  (P < 0.01) 
compared to those animals fed the starch contro l d ie t (D ie t A) containing 0.04% 
(w/w) 3-methylcholanthrene (Table 5:4).
The e ffe c t o f feeding D ie t A (starch contro l) D ie t G (high bran) D ie t F (low bran) 
and D ie t H (high fa t) containing safrole on the hepatic mixed function oxidase 
system of male rats
The e ffe c t o f feeding the starch contro l (D ie t A), low bran (D ie t F), high 
bran (D ie t G) and high fa t (D ie t H) diets containing 0.25% (w/w) safro le fo r seven 
days on ra t body weight, live r weight and food intake is shown in Table 5:5. 
Growth curves o f the animals fed these diets are shown in Figure 5:11. The 
animals fed the starch contro l d ie t (D ie t A) containing corn o il had a s ign ifican t 
increase in body weight (p < 0.001), but a s ign ifican t decrease in liv e r weight 
(p < 0.01), and re la tive  live r weight (p < 0.001) compared to those animals fed the , 
starch contro l d ie t (D ie t A) containing 0.25% (w/w) safrole. However, no 
s ign ifican t d ifference in food intake was observed (Table 5:5). The rats fed diets 
A, F, G and H containing 0.25% (w /w) safrole had s ign ifican t increases in 
cytochrome P-450, cytochrome b^, NADPH-cytochrom e c reductase a c t iv ity  and 
m icrosomal prote in, compared to those animals fed the starch con tro l d ie t (D ie t 
A) containing corn o il. Moreover, s ign ifican t increases in the cytochrome P-448 
mediated enzymes biphenyl-2-hydroxylase and ethoxyresorufin-O -deethylase 
was observed in the safrole treated animals, compared to those animals fed the 
starch contro l d ie t (D ie t A) containing corn o il (Table 5:6).
Rats fed the high bran d iet (D ie t G) containing 0.25% (w /w) safro le fo r 
seven days had a s ign ifican t decrease in biphenyl-2-hydroxylase (p < 0.02), and a 
s ign ifican t increase (p < 0.02) in cytochrome b^ levels, compared to those 
animals fed the starch contro l d ie t (D ie t A) containing 0.25% (w /w ) safro le. 
While animals fed the high fa t d iet (D ie t H) containing 0.25% (w /w) safro le had
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Figure 5:11 Growth curves o f male rats fed Diet A (starch control
d ie t ,  + 0.25% corn o i l ,  •  ) Diet A (starch control d ie t ,
+ 0.25% safro le , a  ) Diet G (high bran d ie t ,  + 0.25% 
sTfro le, □ ) Diet F (low bran d ie t ,  + 0.25% sa fro le , a ) 
and Diet H (high fa t  d ie t ,  + 0.25% sa fro le , ■ ) fo r  7 days.
Diets containing safro le and corn o i l  
introduced
sign ifican t increases in biphenyl-4-hydroxylase (p < 0.05), cytochrome P-450 (p < 
0.01) and cytochrome (p < 0.001) levels, compared to those animals fed the 
starch contro l d ie t (D ie t A) containing 0.25% (w/w) safrole (Table 5:6).
The e ffe c t o f feeding D ie t A (starch contro l) D ie t G (high bran) D ie t F (low bran)
and D ie t H (high fa t) on the absorption and excretion o f ^ C -s a fro le
administered to male rats by gastric intubation
The feeding o f the high bran (D ie t G), low bran (D ie t F) and high fa t (D ie t 
H) diets had no s ign ifican t e ffe c t on the plasma level (Figure 5:12, and Table IA :  
Appendix 2) or faecal excretion (Figure 5:13, and Table 2A: Appendix 2) o f "^ C -  
safrole, in rats given 3yC i "^C -sa fro le  by gastric in tubation, when compared to 
those animals given 3yC i "^C -sa fro le  and fed the starch con tro l d ie t (D ie t A). 
However, those animals fed the high fa t d ie t (D ie t H) had a s ign ifican t increase 
in "^C -sa fro le  excretion in the urine throughout the four days o f the study 
compared to those animals fed the starch contro l d ie t (D ie t A) (Figure 5:14, and 
Table 3A: Appendix 2).
The mean daily faecal production was s ign ifican tly  increased in animals fed 
the high bran d ie t (D ie t G), compared to those animals fed the starch con tro l 
d ie t (D ie t A) throughout the experim ent (Figure 5:15, and Table 4A: Appendix 2). 
However, the low bran (D ie t F), high bran (D ie t G) and high fa t (D ie t H) diets had 
no s ign ifican t e ffe c t on the mean daily urine production when compared to those 
animals fed the starch con tro l d ie t (D ie t A) (Figure 5:16, and Table 5A: Appendix 
2). Moreover, the food intake and body weights o f the animals in each d ie t group 
were s ta tis tica lly  s im ila r (data not shown).
The e ffe c t o f feeding D ie t A (starch contro l) D ie t G (high bran) D ie t F (low  bran) 
and D ie t H (high fa t) on the absorption and excretion o f [G -^ H ] benzo(a)pyrene
administered to male rats by gastric in tubation
The feeding o f the high bran (D ie t G), low bran (D ie t F) and high fa t  (D ie t 
H) diets had no s ign ifican t e ffe c t on the plasma level (Figure 5:17, and Table 6A:
Pl
as
ma
 
co
nc
en
tra
tio
n 
of 
C
-s
af
ro
le
 
(d
pm
/3
0 
y
l)
-  187 -
440-
420
400
380
360
340
320
300
280
260
240
220
200
180
160
140
120
100| Jx
60504020 3010
Time a f te r  ^ C -s a fro le  administration (min)
Figure 5:12 E ffec t o f feeding Diet A (starch control d ie t ,  a  ) ,
Diet G (high bran d ie t ,  □ ) ,  Diet F (low bran d ie t ,  a )
and Diet H (high fa t  d ie t ,  ■ ) on plasma sa fro le  levels
in  rats given 3 yCi T4C-safrole by ga s tr ic  in tu b a t io n . 
Each po int represents the mean of 3 animals. ~
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Figure 5:13 E ffect o f feeding Diet A (starch control d ie t ,  a  ) ,
Diet G (high bran d ie t ,  □ ), Diet F (low bran d ie t ,  *  ) 
and Diet H (high fa t  d ie t ,  ■ ) on safro le excretion in 
the faeces o f rats given 3 yCi I^C-safrole by g a s tr ic  
In tuba tion . Each po int represents the cumulative mean 
of 3 animals, . ' ; :
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Figure 5:14 E ffec t o f feeding Diet A (starch control d ie t ,  a ) ,
Diet G (high bran d ie t ,  □ ) ,  Diet F (low bran d ie t ,  a ) 
and Diet H (high fa t  d ie t ,  ■ ) on safro le  excretion in  the 
urine o f rats given 3 yCi ^C -sa fro le  by ga s tr ic  in tuba t ion  
Each po in t represents the cumulative mean o f 3 animals.
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Figure 5:15 E ffec t o f feeding Diet A (starch control d ie t ,  a  ) ,
Diet G (high bran d ie t ,  □ ) ,  Diet F (low bran d ie t ,  a  ) 
and Diet H (high fa t  d ie t ,  ■ ) on faeces production in 
rats given 3 pCi ^C -s a fro le  by ga s tr ic  in tubation^
Each point represents the cumulative mean o f 3 animals^
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Figure 5:16 E ffec t o f feeding Diet A (starch control d ie t ,  a  ) ,
Diet G (high bran d ie t ,  □ ) ,  Diet F (low bran d ie t ,  *  ) 
and Diet H (high fa t  d ie t ,  ■ ) on urine production in 
rats given 3 uCi ^C -sa fro le  by gas tr ic  in tu b a t io n .
Each po int represents the cumulative mean o f 3 animals.
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Figure 5:17 E ffec t o f feeding Diet A (starch control d i e t ,  a  ) ,
Diet G (high bran d ie t ,  □ ) ,  Diet F (low bran d ie t ,  a ) 
and Diet H (high fa t  d ie t ,  ■ ) on plasma benzo(a)pyrene 
levels in  rats given 15 yCi [G-^H] benzo(a)pyrene by 
gas tr ic  in tubation. Each po int represents the mean o f 
3 animals, ! ‘ ’
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Figure 5:18 E ffec t o f feeding Diet A (starch control d i e t , a ),
Diet G (high bran d ie t ,  □ ) ,  Diet F (low bran d ie t ,  a ) 
and Diet H (high fa t  d ie t ,  ■ ) on benzo(a)pyrene excretion 
in  the faeces of rats given 15 yCi [G-^H] benzo(a)pyrene 
by gas tr ic  in tu ba t io n . Each point represents the cumulative 
mean o f 3 animals* . '
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Figure 5:19 E ffec t o f feeding D iet A (starch contro l d ie t ,  a  ) ,
Diet G (high bran d ie t,  □ ) ,  D iet F (low bran d ie t ,  *  ) 
and D iet H (high fa t  d ie t,  ■ ) on benzo(a)pyrene excre tion  
in  the urine o f ra ts .g iven  15 yCi [G-^H] benzo(a)pyrene
by g a s tric  in tu ba tio n . Each po in t represents the cumulative 
mean o f 3 animals. ~ f -
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Figure 5:20 E ffec t o f feeding D iet A (starch control d ie t ,  a  ) ,
Diet G (high bran d ie t ,  □ ) ,  D iet F (low bran d ie t ,  *  ) 
and D iet H (high fa t  d ie t,  ■ ) on faeces production in  
rats given 15 yCi [G-3H] benzo(a)pyrene by g a s tr ic  
in tu b a tio n . Each po in t represents the cumulative mean
o f 3 animals, : . : ; - :
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Figure 5:21 E ffec t o f feeding Diet A (starch contro l d ie t , a ) ,
Diet G (high bran d ie t ,  □ ) , D iet F (low bran d ie t ,  a ) 
and D iet H (high fa t  d ie t,  ■ ) on urine production in  
rats given 15 yCi [G-3H] benzo(a)pyrene by g a s tr ic
in tu b a tio n . Each po in t represents the cumulative mean o f 
3 animals, .
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Appendix 2) or faecal and urine excretion (Figures 5:18, 5:19 and Tables 7A, 8A: 
Appendix 2 respective ly) o f [G -^ H ] benzo(a)pyrene in rats given 
15yC i [G -^H ]benzo(a)pyrene by gastric intubation, when compared to those 
animals given 15]iC i [G -^H  ] benzo(a)pyrene and fed the starch contro l d ie t 
(D ie t A). However, the results shown in Figure 5:19 indicate tha t the excretion 
o f benzo(a)pyrene in the urine o f the rats fed diets A, F, G and H has not reached 
a plateau four days a fte r adm in istra tion. Therefore, i f  i t  had been possible to 
continue this experiment fo r a longer period o f tim e, then a more clear response 
to the e ffe c t o f feeding diets A,F,G and H on the excretion o f [ G- ] 
benzo(a)pyrene in the urine o f these animals m ight have emerged.
The mean daily faecal production was s ign ifican tly  increased in animals fed 
the high bran d ie t (D ie t G), compared to those animals fed the starch con tro l 
d ie t (D ie t A) throughout the experiment (Figure 5:20 and Table 9A: Appendix 2). 
However, the low bran (D ie t F), high bran (D ie t G) and high fa t  (D ie t H) diets had 
no s ign ifican t e ffe c t on the mean daily urine production compared to those 
animals fed the starch contro l d ie t (D ie t A) (Figure 5:21 and Table 10A: 
Appendix 2). Moreover, the food intake and body weights o f the animals in each 
d ie t group were s ta tis tic a lly  s im ila r throughout the experiment (data not shown).
5.4 Discussion
In recent years, several hypotheses have been put forward to explain f ib re - 
colon cancer in teractions (B u rk itt, 1971; B u rk itt, e t al., 1972; Reddy, e t al., 
1978; Eastwood and Mowbray, 1970; Freeman, e t al., 1978). I t  has been 
suggested tha t d ie tary fib re  acts to shorten trans it tim e, thus decreasing the 
tim e tha t a po ten tia l carcinogen can come in to  contact w ith  the colon mucosa 
(B u rk itt, 1971; B u rk itt, e t al., 1972; Reddy, e t al., 1978). A second, and la rge ly 
unexamined hypothesis is tha t certa in  types o f d ie ta ry fib re  are able to bind 
carcinogens making them unavailable fo r contact w ith  the colon mucosa, and
thus preventing absorption. Therefore to investigate this hypothesis, p re lim inary 
investigations were undertaken to examine the in v itro  binding properties o f 
safrole and benzo(a)pyrene to wheat bran. The results from  this study lead to 
the design o f fu rthe r experiments in which the in vivo binding and excretion o f 
these carcinogens were studied in rats fed wheat bran supplemented diets.
The results o f the in v itro  study show tha t at the pH of the colon (6.4 - 
6.7), "^C -sa fro le  and [G -^ H ] benzo(a)pyrene were bound to wheat bran, 
therefore wheat bran may decrease the a va ila b ility  o f these carcinogens fo r 
contact w ith  the colon mucosa and thus absorption a t colonic pH. The wheat 
bran bound "^C -sa fro le  and [G -^H  ] benzo(a)pyrene at acidic, neutra l and basic 
pH values throughout the experiment, although the percentage binding decreased 
as the pH became more basic. Wheat bran contains the pu rified  fib re  
components cellulose, hemicellulose and lignin, as well as non-fib re components 
such as vitam ins and minerals. Moreover, the vitam ins and m inerals present in 
wheat bran may be responsible fo r the binding o f the carcinogens by a lte ring  the 
ionic exchange po ten tia l o f the wheat bran fo r these substances, thus enabling 
the bran to bind the carcinogens at acidic and neutra l pH values. Freeman e t al. 
(1978) in a study using 1,2-dim ethylhydrazine (DMH), has suggested tha t the 
cellulose frac tion  o f wheat bran was the active  component th a t p ro tected 
against DMH induced colon carcinomas.
Wheat bran desolubilised w ith  acetone, and its  subsequent washing w ith  
w ater resulted in a decrease in the percentage o f ^ C -s a fro le  bound to the bran 
a t colon pH. The chem istry o f a pa rticu la r fib re  w ill a lte r its  absorptive 
capacity by a ffec ting  the number o f ionised groups, which are in tu rn  a ltered by 
the pH o f the environment (Kay and Strasberg, 1978). Therefore, carcinogens 
may bind to the carboxylic acid groups o f fa tty  acids, and carboxyl groups o f the 
free sugar residues o f water-soluble fibres , present in bran, which are
capable o f acting as cation exchange units. Thus the rem oval o f these 
substances from  wheat bran may be responsible fo r the decrease in the binding o f
carcinogens observed w ith  the desolubilised bran. However, a t the pH o f the 
colon, the carboxyl groups would be in a re la tive ly  unionised state and would not 
bind the carcinogens. Moreover as the pH of the environment becomes more 
basic, a greater number o f carboxyl groups would become available fo r the 
binding o f the carcinogen. However, this phenomenon was not observed during 
the present study.
Although the studies carried out in v itro  gave an indication o f the a b ility  o f 
wheat bran to bind carcinogens, i t  does not represent the conditions th a t would 
be found in v ivo . As described in the in troduction to this chapter, the 
p re lim inary in vivo experiments were based on the a b ility  o f 3- 
methylcholanthrene and safrole to specifica lly  induce cytochrome P-448. Hence, 
i f  binding o f these carcinogens to wheat bran occurred then a decrease in the 
levels o f cytochrome P-448 would be observed in those animals fed the high bran 
d ie t. Thus the in it ia l experiment involved the adm in istra tion o f 3- 
methylcholanthrene by gastric in tubation. However, the adm in istra tion o f 
carcinogens by gastric in tubation may not be representative o f the conditions 
found in v ivo , in tha t the amount o f fib re  in the stomach and in testine  o f the 
animals a t the tim e o f adm in istra tion o f the carcinogen may be very sm all, and 
as a result any binding e ffe c t w ith  the wheat bran may not be observed in these 
animals. Therefore, the carcinogens were subsequently incorporated in to  each
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test d ie t at the m inimum concentration tha t would produce a detectable 
induction o f cytochrom e P-448 (i.e. 0.25% (w/w) safrole fed to rats fo r seven 
days, and 0.04% (w /w) 3-methylcholanthrene fed to rats fo r fourteen days).
From the results presented in Tables 5:2, 5:4 and 5:6, the induction o f 
biphenyl-2-hydroxylase was lower in the high bran (D ie t G) fed animals 
throughout the study; but was only s ign ifican t in those animals fed this d ie t 
containing 0.25% (w /w) safrole fo r seven days (Table 5:6). However, the high 
bran d ie t (D ie t G) had no s ign ifican t e ffe c t on ethoxyresorufin-O-deethylase 
a c tiv ity  throughout the study. The overall in ab ility  o f the high bran d ie t (D ie t G) 
to decrease the induction o f cytochrome P-448 on the adm in istra tion o f 3- 
m ethylcholanthrene and safrole in vivo indicates tha t binding o f these 
carcinogens to wheat bran is not occurring, or i f  i t  is, then to a very much 
sm aller extent than in v itro  studies suggest.
Therefore to confirm  these results a fu rthe r series o f experiments were 
designed to determ ine the e ffe c t o f wheat bran supplementation on the 
absorption and excretion o f ^ C -s a fro le  and [G -^H  ] benzo(a)pyrene in the 
plasma, urine and faeces o f rats given these carcinogens by gastric in tubation. 
In th is study, the high bran d ie t (D ie t G) g reatly  increased the daily production o f 
faeces in both the safrole and benzo(a)pyrene treated animals. This may provide 
a measure o f pro tection  in tha t i f  carcinogens are bound to wheat bran in vivo 
then they would be excreted from  the body more readily, and thus have less tim e 
to exert th e ir e ffects . Moreover, those animals fed the high bran d ie t (D ie t G) 
had a higher level o f ^ C -s a fro le  and [G -^ H ] benzo(a)pyrene excretion in the 
faeces compared to those animals fed the starch contro l d ie t (D ie t A), but was 
not s ign ifican t. The large standard errors reported in these results aredue to the 
daily physiological varia tion  in faecal and urine production, therefore i f  a la rger 
number o f animals had been used, then the varia tion  would have been decreased 
and s ign ifican t differences between the high bran (D ie t G) and starch con tro l 
(D ie t A) diets m ight have been observed (Appendix 2).
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The gastric in tubation o f ^ C -s a fro le  and [G -^H ] benzo(a)pyrene had no 
s ign ifican t e ffe c t on urine production throughout this study. However, those 
animals fed the high fa t d ie t (D ie t H) had a s ign ifican t increase in the excretion 
o f "^C -sa fro le  in the urine compared to those animals fed the starch con tro l d ie t 
(D ie t A). Moreover, a s ign ifican t increase in the drug metabolising enzymes 
cytochrome P-450, cytochrom e b^ and biphenyl-4-hydroxylase in the liv e r o f 
these animals fed the high fa t d ie t containing 0.25% (w/w) safrole was observed 
(Table 5:6). This resu lt may be re lated to the lip id  so lub ility  o f the safro le. In 
both the "^C -sa fro le  and [G -^ H ] benzo(a)pyrene treated animals fed the high 
fa t d ie t (D ie t H), higher plasma levels o f these carcinogens between 20-30 
minutes a fte r adm in istra tion was noted, which again may be re lated to the lip id  
so lub ility  o f these carcinogens. However, these increases were not s ign ifican t 
when compared to the starch contro l fed animals, administered these 
carcinogens.
According to Remmer (1969), induction o f the drug metabolising enzymes 
requires an inducing agent o f high lip id  so lub ility  which enables the inducer to 
reach lipoph ilic  membranes o f the endoplasmic re ticu lum . Thus the a b ility  o f a 
high fa t d ie t to absorb certa in  carcinogens may be detrim enta l to the body in 
tha t i t  may aid th e ir carcinogenic ity by increasing the rate , and the ; amount at 
which they are introduced in to the cells where they can become activa ted  to  
highly reactive  e lec troph ilic  compounds the proxim ate carcinogens, by the mixed 
function oxidase system. A number o f studies support the find ing o f the 
carcinogenic e ffe c t o f h igh -fa t diets, and indicate tha t consequent increased 
excretion o f bile acids may contribu te  to colon tumour form ation (Reddy, e t al., 
1976b; Reddy, e t al., 1976c; Reddy, e t al., 1977). The increase in b ile  acid 
synthesis in response to a high fa t d ie t m ight a lte r the uptake or m etabolism  o f 
carcinogens by changing the s truc tu ra l and functiona l characteris tics  o f the 
in testine through the ir detergent properties. Such a role m ight be possible in
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view o f the known e ffe c ts  o f bile acids on separating components o f the 
ep ithe lia l ce ll membrane (Thomas, e t al., 1972, F rizze ll and Schultz, 1970), and 
disrupting the gastric mucosa (Davenport, 1968) w ith  consequent a ltera tions in 
ep ithe lia l perm eability  properties.
In conclusion, the results o f the in v itro  investigation indicates tha t wheat 
bran m ight a lte r the incidences o f chem ically induced carcinogenesis by binding 
carcinogens and thus making them unavailable fo r absorption. However, the in 
vivo studies are equivocal and do not fu lly  support these observations, and as 
previously discussed may be the result o f the metabolic a lte ra tion  o f the wheat 
bran by the in testina l m icro flo ra .
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CHAPTER 6
THE EFFECT OF WHEAT BRAN SUPPLEMENTATION ON PLASMA
M INERAL CONCENTRATION AND THE BINDING OF INORGANIC IRON IN VITRO
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6.1 Introduction
Although disturbances o f m ineral metabolism are prevalent in many parts 
o f the world they have a ttrac ted  less a tten tion  than the e ffec ts  o f deficiencies 
o f certa in  other nutrients, perhaps because m ineral deficiencies ord inarily  are 
not life -th rea ten ing . They may however be an im portant source o f ill-hea lth , 
and o f pa rtia l, or even to ta l d isab ility  (Reinhold, e t al., 1976). Moreover, 
deficiencies o f calcium  (Ca), magnesium (Mg), zinc (Zn), iron (Fe) and other 
trace metals, o ften develop insidiously in the presence o f seemingly adequate 
intakes o f these elements in the d ie t. The high dietary phytate content o f the 
bread consumed by people liv ing  in the Middle East and India has been suggested 
by many investigators to be a causative fac to r in th is kind o f m a lnu trition  
(Reinhold, 1971; Reinhold, e t al., 1973; Wills, e t al., 1972, Pecoud, e t al., 1975). 
However, others have shown tha t phytic  acid had no inh ib ito ry  e ffe c t on m inera l 
b ioava ilab ility , (Ranhotra, e t al., 1974; Liebman and D riske ll, 1979) and some 
authors suggest tha t phytate could be an e ffe c tive  ca rrie r o f n u tr it io n a lly  
im portant metals (M orris and Ellis, 1976; M ocilovic and Shah, 1976).
The in te raction  o f m inerals w ith  d ie tary fib re , and the possible ro le  tha t 
fib re  has on inorganic iron absorption was discussed in Chapter 1. The work 
reviewed in tha t chapter underlines the controversy tha t s t i l l  remains regarding 
d ie tary fib re  research and m ineral metabolism. Much o f this confusion has 
resulted from  the various techniques and the experim ental design used by 
d iffe re n t investigators, together w ith  the assumption tha t a ll fib re  exerts a 
s im ila r e ffe c t. Therefore, the experiments described in this chapter a tte m p t to 
c la r ify  the s ituation by examining the binding characteristics o f wheat bran, and 
dephytinised wheat bran to inorganic iron in v it ro . The e ffe c t o f varying wheat 
bran concentrations on plasma m ineral status was also investigated in v ivo , 
although a complete m ineral balance study was not carried out.
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6.2 M ateria ls and Methods
6.2.1 M ateria ls
Cyanomethaemoglobin standard, lanthanum chloride, Drabkin's reagent and 
standard solutions o f iron, sodium, zinc, potassium, calcium and magnesium were 
obtained from  B ritish  Drug Houses L td., Poole, Dorset. Imidazole was purchased 
from  Sigma Chemical Company, London.
A ll other chemicals used were obtained from  BDH Ltd. and May and Baker 
Ltd ., or as specified in the te x t, and were o f ana lytica l grade unless otherwise 
stated. Deionised water was prepared in the Department o f B iochem istry o f the 
U niversity o f Surrey and stored in polypropylene containers, and a ll glassware 
was soaked in 50% (v/v) n itr ic  acid fo r 24 hr p rio r to use. Solvents and a ll other 
m ateria ls used were as described in 2.2.1, or as specified in the te x t.
6.2.2 Diets
The diets used in this study were as described in 2.2.2.
6.2.3 Animals
Weanling male and female rats o f the Wistar stra in were housed 
• /  as described in 2.2.3, and fed the starch contro l (D ie t A), low bran 
(D ie t F), high bran (D ie t G), high fa t (D ie t H) and stock d ie t 41b (D ie t J) fo r 
periods o f up to seventy-two weeks, the duration o f each experim ent being 
indicated in the tables o f results. A t the end o f the designated feeding periods, 
animals were anaesthetised w ith  ether and blood w ithdrawn by cardiac puncture 
in to heparin tubes, Plasma was then prepared as described in 2.2.3.
6.2.4 Assay methods
Plasma m ineral determ ination
Plasma sodium, zinc, potassium, calcium  and magnesium were determ ined 
by atom ic absorption spectrophotom etry (Instrum entation Laboratory A tom ic
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Absorption Spectrophotometer model 357, W ilm ington, U.S.A) on samples 
suitably diluted w ith  0.25% (w /v) lanthanum chloride.
Plasma and live r phosphorus determ ination
Plasma and live r phosphorus concentration was measured by the method o f 
Naito (1975) described in 2.2.5.
Blood haemoglobin determ ination
Haemoglobin was determ ined by the cyanomethaemoglobin method. Whole 
blood was treated w ith  a reagent containing potassium ferricyanide, potassium 
cyanide and potassium dihydrogen phosphate (Drabkin's reagent). The 
ferricyanide reacts w ith  the haemoglobin to form  methaemoglobin which in turn  
reacts w ith  the cyanide to form  cyanomethaemoglobin, the ex tinc tion  o f which 
can be measured.
A 20 y l a liquot o f whole blood was added to 4 m l o f Drabkin's reagent and 
mixed thoroughly. The tubes were centrifuged a t 2,000 rpm fo r 10 m inutes in a 
Beckman J6 centrifuge, and a fte r a fu rthe r 4 minutes, the extinctions o f the 
supernatants were measured a t 540 nm in a C ecil U.V. spectrophotom eter (model 
CE 272). A ll determ inations were carried out in duplicate and the extinctions o f 
a blank (Drabkin's reagent)andof a cyanomethaemoglobin standard containing 57.2 
mg cyanomethaemoglobin/100 m l,equ iva len t to a haemoglobin concentration o f 
11.5g/100ml,were also measured.
Determ ination o f haem atocrit
The re la tive  volume o f red blood cells to plasma was determ ined as 
follows.
Duplicate heparinised cap illa ry  m icrohaem atocrit tubes (M.S.E. L td ., 
Crawley, Sussex) were three-quarters f ille d  w ith  whole blood and sealed a t one
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end w ith  a sealing m ate ria l (Cristaseal Hawkley and Sons Ltd ., Lancing, Sussex). 
The tubes were then centrifuged fo r 10 minutes a t 12,400 rpm in a 
m icrohaem atocrit centrifuge (M.S.E. L td.). The haem atocrit value was then 
determ ined by the fo llow ing form ula:
H aem atocrit (%) = Hgight o f packed red cells (mm) x 100
Height o f red cells and plasma (mm)
Measurement o f in v itro  iron binding by wheat bran
Iron binding by wheat bran was measured by the method o f Reinhold, e t al. 
(1975) w ith  refinem ents designed to improve the s ta b ility  o f the iron in solution. 
Iron in solution becomes unstable as the pH approaches or exceeds 7.0 because of 
a tendency to form  poorly soluble hydroxides o f Fe . I n  the presence o f water 
and oxygen, these change spontaneously to hydroxides and oxides o f Fe^+ tha t 
have extrem ely low so lubilities. The conversion is prevented by the presence o f 
antioxidants, thus a low concentration o f ascorbic acid (0.114 ym o l/m l) was 
included in the incubation solution fo r th is purpose.
Preparation o f iron solution: This was prepared from  a glucose-saline
solution containing 7.5g o f NaCl, 0.3g KC1 and 5.0g o f glucose per litre .  
Approxim ately 240 m l o f the glucose-saline solution was placed in a 250 m l 
vo lum etric  flask, and to i t  was added in succession, 0.5 ml o f 0.1 M HC1, 2.5 m l 
o f 0.05 M im idazole, 2.5 m l o f 0.05 M sodium acetate trihydra te , 0.5 m l o f 1% 
(w /v) ascorbic acid and 0.5 m l o f standard iron solution. The iron was added to 
the solution shortly before i t  was to be used, and the volume was made up to  250 
m l w ith  glucose saline solution.
The standard iron solution was prepared by dissolving 1.273 g o f ( N H ^  Fe 
( S O ^  6 H2O in 500 m l o f deionised w ater containing 2 ml o f concentrated HCL. 
Although ascorbic acid form s complexes w ith  iron (Conrad and Schade, 1968) and
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inhib its binding, the concentration used was shown by experiment to have a 
negligible e ffe c t on the binding o f iron by fib re  (Reinhold, e t al., 1981). The 
fina l iron concentration was 0.725 yg /m l.
Incubation system: Most measurements were made a t pH 6.45 + 0.05. A t
2 *4*th is pH Fe was stable a t the concentrations used, and is w ith in  the range o f pH 
prevailing in the contents o f the small in testine (Reinhold, e t al., 1981). A ll 
incubations were perform ed a t 37°C.
Unprocessed wheat bran (20 mg) was weighed in to a 15 m l screw capped 
tube, and 10 m l o f iron-containing glucose-saline solution was added a fte r 
adjustment to the required pH. The tubes were capped, and placed on a tube 
ro ta to r and incubated fo r 2 hours at 37°C. Following incubation the tubes were 
centrifuged at 2,000 rpm fo r 15 minutes in a MSE M istra l 6L centrifuge. Iron 
analysis was then carried out on the supernatant using an Instrum entation 
Laboratory A tom ic Absorption Spectrophotometer, (model 357).
For each solution exposed to wheat bran, a contro l was prepared from  
which wheat bran was om itted. The d ifference in concentration o f iron between 
the contro l solution and tha t exposed to wheat bran measured the exten t o f 
uptake o f iron by the bran. Contro l solutions were found to be less stable than 
those containing wheat bran, as a result they were analysed soon a fte r  
preparation.
E ffe c t o f pH on iron binding to wheat bran in v itro
A fixed amount o f wheat bran (20 mg) was incubated w ith  10 m l o f the 
iron-containing glucose-saline solution a t a pH range o f 1 to 7 fo r 2 hours a t 
37°C by the method described above.
Concentration response curve o f iron binding to wheat bran in v itro
Wheat bran at concentrations from  1 to 10 m g/m l were incubated w ith
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10 m l o f the iron-contain ing glucose-saline solution at pH 6.45 fo r 2 hours at 
37°C by the method described above.
E ffe c t o f chelators on iron binding to wheat bran in v itro
A fixed amount o f wheat bran (20 mg), and 10 m l o f iron-contain ing 
glucose-saline solution were incubated w ith  several concentrations (50 - 1000 
yM ) o f EDTA and c it r ic  acid a t pH 6.45 fo r 2 hours at 37°C by the method 
described above.
Iron binding and dephytinised wheat bran
Phytic acid was removed from  wheat bran by pe rm itting  the phytase 
natura lly  present in the bran to act a t 38°C fo r 5 hours a t pH 4.7 (Reinhold, et 
al., 1981). The bran so trea ted was filte re d  through clo th, washed free o f acid 
and dr i ed in air.
The e ffe c t o f pH, and bran concentration on the binding o f inorganic iron 
to dephytinised wheat bran was then investigated by the methods described 
above.
6.2.5 S ta tis tica l analysis
S ta tis tica l analysis was carried out using Student's unpaired t- te s t, the 
level o f significance based on this test being indicated in the tables o f results.
6.3 Results
6.3.1 The e ffe c t o f feeding D ie t A (starch contro l) D ie t G (high bran)
D ie t F (low bran) D ie t H (high fa t) and D ie t J (stock d ie t 41b) on
plasma m ineral concentration
Growth curves, food intake and live r weight data fo r the ra ts used in th is 
study are presented and discussed in Chapters 2 and 4.
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The results o f feeding the starch contro l (D ie t A), high bran (D ie t G), low
bran (D ie t F), high fa t (D ie t H) and the stock d iet 41b (D ie t J) on ra t
haemoglobin, haem atocrit and plasma m ineral concentrations are summarised in 
Tables 6:1 to 6:8 respective ly. The low bran (D ie t F), high bran (D ie t G) and
stock d ie t 41b (D ie t J) had no s ign ifican t e ffe c t on blood haemoglobin
concentration during the study when compared to those animals fed the starch 
contro l d ie t (D ie t A). However, male rats fed the high fa t d ie t (D ie t H) had a 
s ign ifican t decrease o f 37% (p < 0.001) in blood haemoglobin concentration a fte r  
seventy-two weeks o f feeding compared to those animals fed the starch con tro l 
d ie t (D ie t A) (Table 6:1). Moreover, diets F, G, H and J had no s ign ifican t e ffe c t 
on blood haem atocrit levels throughout the study when compared to the starch 
contro l d ie t (D ie t A) (Table 6:2).
Male rats fed the high bran d ie t (D ie t G) fo r four weeks had a s ign ifican t 
increase in plasma calcium  concentration (p < 0.05) when compared to those 
animals fed the starch contro l d ie t (D ie t A). However, in those animals fed the 
low bran, (D ie t F) high fa t (D ie t H) and stock d ie t 41b (D ie t J), the levels 
remained unchanged (Table 6:3).
Male rats fed the high bran d ie t (D ie t G) had a s ign ifican t increase in 
plasma sodium concentration a fte r four weeks, (p < 0.02) while male ra ts  fed the 
high fa t d ie t (D ie t H) had a s ign ifican t decrease o f 24% (p < 0.01) a fte r  e ight 
weeks o f feeding compared to those animals fed the starch contro l d ie t (D ie t A). 
The low bran (D ie t F) and stock d ie t 41b (D ie t J) had no s ign ifican t e ffe c t on 
plasma sodium concentration during this study (Table 6:4).
Both the high bran (D ie t G) and high fa t (D ie t H) fed animals had a 
s ign ifican t decrease o f 27% (p < 0.05) in the ir plasma potassium concentra tion 
a fte r  four weeks, compared to those animals fed the starch contro l d ie t (D ie t A). 
However, the low bran (D ie t F) and stock d ie t 41b (D ie t J) had no s ig n ifica n t 
e ffe c t on plasma potassium concentration (Table 6:5). Plasma zinc and 
magnesium levels remained unchanged in animals fed the low bran (D ie t F), high
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bran (D ie t G), high fa t (D ie t H) and stock d ie t 41b (D ie t J), compared to those 
animals fed the starch contro l d ie t (D ie t A) (Tables 6:6 and 6:7 respectively).
The high bran d ie t (D ie t G) s ign ifican tly  increased plasma phosphorus levels 
in both male and female rats a fte r twelve weeks o f feeding (p < 0.01), compared 
to those animals fed the starch contro l d ie t (D ie t A), while no s ign ifican t e ffe c t 
on plasma phosphorus levels was found in those animals fed the low bran (D ie t F), 
high fa t (D ie t H) and stock d ie t 41b (D ie t J) compared to those animals fed the 
starch contro l d ie t (D ie t A) (Table 6:8). Male rats fed the high fa t d ie t (D ie t H) 
fo r four weeks, and female rats fed the high fa t d iet fo r seventy-two weeks had 
s ign ifican t increases in hepatic phosphorus levels compared to those animals fed 
the starch con tro l d ie t (D ie t A) (p < 0.05 fo r four week fed male rats, p < 0.02 
fo r seventy-two week fed female rats). Both male and female rats fed the stock 
d ie t 41b (D ie t J) fo r seventy-two weeks had s ign ificant increases in hepatic 
phosphorus levels when compared to those animals fed the starch con tro l d ie t 
(D ie t A) (p < 0.05 and p < 0.02 fo r male and female rats respective ly) (Table 6:9).
6.3.2 E ffe c t o f pH on inorganic iron binding to wheat bran in v itro
In the absence o f wheat bran, iron remained dissolved in the equ ilib ra ting  
solution u n til its  pH approached 7.0, when a tendency to form  a p rec ip ita te  o f 
iron hydroxide became evident. However, in the presence o f wheat bran and 
dephytinised wheat bran, concentrations o f iron in solution began to decrease 
appreciably as the pH rose above 3.0 presumably because o f the fo rm ation  o f 
complexes o f iron w ith  the fib re . The a ff in ity  fo r fib re  continued to increase as 
the pH rose, and at approxim ately pH 7.0, the l im it  o f s ta b ility  o f the system, 
71% o f the iron was bound to wheat bran, and 66% o f the iron was bound to the 
dephytinised bran (Figure 6:1). The uptake o f iron in both systems w ith  
increasing pH traced a sinusoidal curve w ith  its  m idpoint a t approxim ate ly pH 
4.3. Thus, dephytinisation had no s ign ifican t e ffe c t on the position or 
conform ation o f the binding curves.
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Figure 6:1 E ffec t o f pH on the binding o f inorganic iron  by Wheat bran ( o ) 
and dephytinised wheat bran ( • ) . A ll measurements were made 
fo llow ing  the incubation o f wheat bran (2 mg/ml) w ith  iron  
(0.725 yg/m l) fo r  2 hours a t 37°C.
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Figure 6:2 E ffec t o f wheat bran (o  ) and dephytinised wheat bran ( •  ) 
concentration on the binding o f inorganic iro n . A ll 
measurements were made fo llo w in g  the incubation o f wheat 
bran w ith iron  (0.725 yg /m l) a t pH 6.45 fo r  2 hours a t 37°C.
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Some iron, less than 10% o f the to ta l remained bound to the wheat bran 
and dephytinised bran below pH 2.0. This frac tion  was released when the pH was 
lowered to less than pH 2.0. In this region, inorganic iron present in the wheat 
bran as distinguished from  added iron may also become soluble (Figure 6:1).
6.3.3 Concentration response e ffe c t o f inorganic iron binding to wheat
bran in v itro
Figure 6:2 show tha t both wheat bran, and dephytinised wheat bran bind 
inorganic iron a t low concentrations, less than 1 m g/m l, and thus in ranges tha t 
m ight be achieved in physiological circumstances.
6.3.4 E ffe c t o f chelators on the a b ility  o f wheat bran to bind inorganic
iron in v itro
C itr ic  acid and EDTA were added at concentrations o f up to 1 mM, and 
both had potent inh ib ito ry  e ffec ts  on the binding o f inorganic iron to  wheat bran 
(Figure 6:3). For both chelators, inh ib ition  o f iron binding occurred a t less than 1 
mM, the extent o f inh ib ition  being 100% at concentrations o f 400 pM  and 100 pM  
fo r c it r ic  acid and EDTA respective ly (Figure 6:3).
6.4 Discussion
The low bran (D ie t F), high bran (D ie t G), high fa t (D ie t H) and stock d ie t 
41b (D ie t J) had no overa ll e ffe c t on haemoglobin, and plasma m inera l
concentration throughout the study, when compared to those animals fed the
starch contro l d ie t (D ie t A) (Table 6:1 to 6:8). However, a number o f reports in 
the lite ra tu re  indicate tha t d ie ta ry fib re  may decrease blood levels o f some 
m inerals. Serum calcium  levels were decreased in one study in which subjects 
received 18g to lOOg o f unprocessed wheat bran per day (Heaton and Pomare, 
1974). While in other studies in which subjects received 20g o f wheat bran per 
day, (Persson, e t al., 1973), or an increase o f 2.5g to 4.5g o f fib re  from  wheat
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bran (Connell, e t al., 1973) no such decrease in plasma m ineral levels was 
observed. Serum iron concentration was decreased in two studies in which wheat 
fib re  was given, (Jenkins, e t al., 1975b, Persson, et al., 1975) and mean 
corpuscular volume and haemoglobin levels were also decreased in one study 
(Jenkins, e t al., 1975b). However, in another study in which wholemeal bread was 
substituted fo r w h ite , haemoglobin levels were not a ffected (Heaton, e t al., 
1976). Thus the contrad ic to ry  results reported in this chapter and in the 
lite ra tu re , may be due to a number o f factors, some of which are discussed 
below.
Wheat bran not only contains d ietary fib re , but is also a source o f prote in, 
fa t and m inerals (especially magnesium and phosphorus). Hence diets containing 
a higher proportion o f bran may thus have larger quantities o f these m inerals 
present. Although the a va ila b ility  o f these elements from  bran is s t i l l  not 
known, the s ign ifican t increase in plasma phosphorus levels in male and female 
rats fed the high bran d ie t (D ie t G) fo r twelve weeks may therefore  be re la ted to 
the possible higher phosphorus content o f this d ie t (Table 6:8). The physical fo rm  
o f the bran may also influence m ineral absorption in tha t the response between 
coarse and fine bran may d iffe r  (van Soest, e t al., 1978).
The methods used in th is chapter to investigate the in v itro  binding o f 
inorganic iron to wheat bran were simple ones. A fte r  incubation o f insoluble 
wheat bran and iron i t  was possible by centrifugation  to separate bound, from  
free iron, the la tte r  being measured in the supernatant by atom ic absorption 
spectrophotom etry. The results o f th is study indicate tha t dephytinised wheat 
bran bound inorganic iron as e ffe c tive ly  as the whole bran, however, the 
presence o f phytate in wheat bran has been suggested in the lite ra tu re  to be the 
most active substance responsible fo r iron binding (Reinhold, e t a l., 1976). 
Therefore the results o f th is study seem to con trad ic t these claims, and support
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the view tha t i t  is the fib re  its e lf which is responsible fo r the iron binding and 
not the phytate. However, these results may also be explained by the possible 
localisation o f phytate in certa in  fragments o f bran from  which i t  does not 
escape readily (Reinhold, e t al., 1981).
Ferrous iron was selected as the inorganic form  o f iron in this study 
because i t  is more soluble than fe rr ic  iron at the pH o f the in testine, moreover i t  
is commonly used therapeu tica lly . Both ferrous and fe rr ic  hydroxides have
lim ite d  so lubilities at higher pH i.e. fe rr ic  iron has a so lub ility  o f lC f^M  a t pH 2,
-1R -1 -3but only 10" M at pH 7. Ferrous iron is soluble to 10” M a t pH 2 and 10 M at
pH 8 (Spiro and Saltman, 1974). A pH dependence fo r binding o f iron by d ie ta ry
fib re  was described by R e illy  (1979), and Thompson and Weber (1979). Each
measured binding only a t strongly acid and nearly neutra l reactions. Both found
tha t binding was m inim al a t acid pH and maximal a t pH 6.8 or above. Sequential
trea tm ent a t pH 0.6 and 6.8 did not change the a ffin itie s  o f fib re  fo r iron a t the
la tte r  pH (Thompson and Weber, 1979). The sinusoidal pH -iron binding curve
found w ith  wheat bran in th is study suggests the presence o f a p ro ton-
dissociating group (Figure 6:1). Moreover, work recently  carried out by
Reinhold, e t al. (1981) has suggested tha t the binding o f iron by d ie ta ry  fib re
pa rticu la rly  hemicellulose, is probably re lated to the presence o f unsubstituted
uronic acid groups. These groups are also believed to explain the binding o f
calcium  by d ietary fib re  (James, e t al. 1978).
As discussed in the in troduction to th is chapter, d ie ta ry fib re  intakes tend 
to be higher in the lower socio-economic groups throughout the world. In such 
circumstances, the intake o f d ie ta ry fib re  w ill be su ffic ien t to fo rm  complexes 
w ith  a ll o f the free inorganic iron in the in testina l contents. Low income groups 
are also like ly  to have a low consumption o f natura lly  occurring inh ib ito rs  o f iron 
binding to fib re . Consequently, a com bination o f these facto rs may explain in 
part the prevalence o f iron-defic iency anaemia among the poor populations, in
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which fib re  rich  bread is a major component o f the d iet. However, recent work 
has suggested tha t digestion o f hemicellulose may occur in the small in testine 
(Holloway, e t al., 1980). I f  th is does occur then iron bound by i t  w ill be released. 
Therefore, the fina l aspect o f th is study concerned the in te raction  o f iron, wheat 
bran, and chelators o f iron. The two chelators chosen fo r th is study were c it r ic  
acid and EDTA, both are h igh -s tab ility  chelators which have been used 
extensively as food additives in recent years (Forth and Rummel, 1973; W ill and 
V itte r, 1954; Hodgkinson, 1961). Figure 6:3 show tha t both c it r ic  acid and EDTA 
even at low concentrations, decrease the binding o f iron to wheat bran markedly. 
Thus the high degree o f effectiveness o f c it r ic  acid as an inh ib ito r o f iron binding 
by wheat bran, should give i t  superior capabilities as an adjuvant fo r inorganic 
iron absorption. Moreover, EDTA improves iron absorption by releasing iron 
from  its  com bination w ith  wheat bran a t a much lower concentration than c it r ic  
acid (Figure 6:3). However, recently  EDTA has been found to have another ro le , 
as shown by its  a b ility  to  prom ote iron absorption from  isolated ra t in tes tina l 
loops in the absence o f fib re  (Monsen and Page, 1978).
I t  appears from  these results tha t much o f the inorganic iron o f the 
in testina l contents becomes bound to  wheat bran in the presence o f ordinary 
levels o f fib re  intake. Therefore, when bran intakes are high, d ie ta ry  inorganic 
iron would be to ta lly  bound, and as a result would be largely unavailable fo r 
absorption, however i t  may be released by fluxes o f acid entering the gut, or by 
the presence o f inh ib itors o f binding such as c it r ic  acid or EDTA.
Throughout the experim ent the presence o f wheat bran improved the 
2+s ta b ility  o f solutions o f Fe , presumably by decreasing free iron concentrations. 
Hence, binding o f iron by wheat bran may serve a useful function by dim inishing 
the tendency fo r fo rm ation  o f poorly soluble iron hydroxides in the in testine. I t  
may also prevent, or decrease the risk o f lip id  peroxidation, and thus tissue 
degradation, by binding excess inorganic iron, which is a known free rad ica l
in it ia to r. The experiments reported in this chapter however, cannot be 
extrapolated d irec tly  to the e ffec ts  o f natural foods on the absorption o f d ie ta ry 
iron in man. However, by m im icking postprandial conditions in the bowel as 
closely as possible i t  is hoped tha t th is study has iden tified  some o f the 
competing factors tha t m ight influence the b ioava ilab ility  o f iron in subjects 
consuming large quantities o f wheat bran.
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CHAPTER 7 
FIN AL DISCUSSION
Early protagonists o f the 'fib re  hypothesis', including Trowell, Walker and 
B u rk itt drew a tten tion  to the ra r ity  o f ischaemic heart disease (IHD) and 
gallstones in centra l and southern A fr ica  (Walker and Arvidsson, 1954; Trow ell 
1972b; Walker, 1975, Trowell and B u rk itt, 1977). Age-specific death rates 
indicated tha t life  expectancy were not solely accountable; nor were genetic 
differences, since the m anifestations o f IHD rose dram atica lly  w ith  the 
acquisition o f an occidental d ie t and life -s ty le . The low incidence o f IHD in 
A fr ica  was linked w ith  a scarc ity  o f a number o f risk factors including c igare tte  
smoking, obesity and hypertension. Most notably, mean plasma cholesterol 
concentrations were very low. Moreover, the d ietary patterns o f these 
populations were characterised by a high intake o f fib re , averaging 60-80g/day, 
four tim es the Western norm. However, studies in Westernised populations have 
also indicated tha t d ie ta ry fib re  may contribu te  to the maintenance o f low levels 
o f plasma cholesterol. Thus the in te rest tha t has been aroused by the d ie ta ry 
fib re  hypothesis in recent years has lead to a considerable amount o f work on the 
chem istry and pharmacological e ffec ts  o f the d iffe re n t fibres, and to a number 
o f experim ental, epidem iological and c lin ica l studies.
One o f the f irs t, and possibly most im portan t finding concerning d ie tary 
fib re  research is the observed inaccuracy o f generalisation; in tha t no two 
sources o f d ie ta ry fib re  seem to have the same e ffe c t. Moreover, ce rta in  types 
o f d ie ta ry fib re  and fib re  isolates appear to influence lip id  metabolism  by 
mechanisms involving both in testina l and ex tra -in tes tina l sites o f action. This 
may u ltim a te ly  be re flec ted  in changes in plasma trig lyce rides and/or 
cholesterol and in sh ifts in plasma lipoprote in  profiles, the advantages o f which 
have been discussed. Wheat bran, in spite o f its  effectiveness in trea ting  
d ive rticu la r disease (Painter, e t al. 1972; Findlay, e t al., 1974), has from  the 
present work been shown to  have l i t t le  e ffe c t on the plasma lip ids o f e ithe r
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human or animal subjects. These results however, are consistent w ith  the 
findings o f Truswell and Kay (1976) and Arvanitakis, et al. (1977). Munoz, et alv. 
(1979) demonstrated tha t whereas so ft wheat bran .
had no e ffe c t on serum lipids, hard red spring (HRS) wheat bran 
(26g/day) s ign ifican tly  lowered plasma to ta l cholesterol levels by 12%. However, 
i t  is not known i f  this e ffe c t was due to differences in fib re  composition, or to 
the presence o f a pharm acologically active  component in the HRS bran. In 
contrast to the general negative e ffe c t o f wheat bran on plasma lip id  levels, oat 
bran does appear to have s ign ifican t hypocholesterolaemic properties (K irby, e t 
al., 1981). Unlike wheat bran, oat bran contains a glycan and is somewhat 
mucilaginous (Kay and Truswell, 1980). Anderson and Chen (1979) have reported 
tha t oat bran s ign ifican tly  decreased plasma LD L- cholesterol, while HD L- 
cholesterol concentrations have tended to increase.
Inform ation on the e ffe c t o f wheat bran on plasma H D L-cholestero l is 
lim ite d  and variable (Dixon, 1978; McDougall, e t al., 1978; van-Berge 
Henegouwen, e t al., 1979; Asp, e t al., 1981). The present study reports 
s ign ifican t increases in plasma HD L-cholesterol a fte r tw e lve weeks o f bran 
supplementation to male rats, and a fte r seventy-two weeks o f feeding to female 
rats (Table 2:16); thus, these results support the findings o f Asp, e t al. (1981). 
Moreover, Chen and Anderson (1979b) reported tha t while serum to ta l 
cholesterol was decreased, HD L-cholesterol levels increased s ig n ifica n tly  in ra ts  
fed 10% guar gum, oat bran or pectin  (compared w ith  10% cellulose). In the 
present study carried out on human volunteers whose norm al d ie t was 
supplemented w ith  0.3 g/kg body weight wheat bran, increases in plasma H D L- 
cholesterol, and decreases in plasma LD L-cholestero l were reported throughout 
the study, and were s ign ifican t a fte r six weeks o f feeding (Table 3:4). The 
a b ility  o f wheat bran to increase plasma HDL-cholesterol levels and decrease 
plasma LD L-cholestero l levels in humans may be associated w ith  freedom from
cardiovascular disease (M ille r, e t al., 1977) in tha t LD L-cholesterol is reported 
to be atherogenic (Gordon, e t ah, 1977), thus in this respect wheat bran may be 
benefic ia l to the body. However, the mechanism by which this is achieved is not 
known.
In assessing po tentia l sites o f action o f d ie ta ry fibres on lip id  metabolism, 
the in testine has been the prim ary focus o f a tten tion . The variable 
physicochemical properties o f individual fib re  components or isolates, however, 
do not allow  fo r broad generalisations or d irec t extrapolation to the e ffe c ts  o f 
in ta c t d ie ta ry fibres. The gelling and mucilaginous fib re  components, and lign in, 
have been shown to possess bile acid sequestering properties in vivo (Leve ille  and 
Sauberlich, 1966; Kay and Truswell, 1977a; Judd, e t al., 1976), which in te rfe re  
w ith  the enterohepatic rec ircu la tion  o f b ile acids, resulting in increased faecal 
excretion o f these acidic steroids. These cholesterol m etabolites comprise one 
of the major amphipaths responsible fo r mixed m icelle  fo rm ation  and 
solubilisation o f lum inal cholesterol and lip id  digestion products. Thus, the 
in te raction  o f the components o f d ie ta ry fib re  w ith  b ile acids is a m ajor 
con tribu to r to the observed e ffec ts  o f d ie ta ry fib re  on plasma cholesterol; while 
changes in other lip id  parameters do not seem to  be influenced as d ram atica lly  
by this mechanism.
The m etabolic conversion o f cholesterol in to bile acids, which occurs in the 
live r, forms a major catabolic route o f cholesterol in the body, and as cholesterol 
7a-hydroxylase functions as the main ra te -lim itin g  enzyme in th is pathway, i t  
w ill have im portan t ram ifica tions on the disposal o f cholesterol from  the body, 
as discussed more fu lly  in the in troduction. For example, the serum cho lestero l- 
lowering e ffe c t obtained by adm in istra tion o f cholestyram ine in the d ie t is 
generally a ttribu ted  to decreased enteroheaptic c ircu la tion  o f b ile  acids, and 
consequent enhancement o f cholesterol 7a-hydroxylase a c tiv ity  produced by th is 
agent. Thus i t  is feasible tha t low a c tiv ity  o f cholesterol 7a-hydroxylase may be
involved in the production o f hyperlipidaem ia and would be consistent w ith  the 
low levels o f faecal bile acid excretion noted in such individuals (Nestel and 
Hunter, 1974). However, the in ab ility  o f wheat bran to decrease plasma 
cholesterol levels in the present study is re flected  in its in ab ility  to sequester 
bile acids in vivo (Table 4:7) and to its  lack o f e ffe c t on hepatic cholesterol 7a- 
hydroxylase a c tiv ity  (Table 4:5). However, these results are largely consistent 
w ith  earlie r studies using this fib re  source (Vahouny, et al., 1980a; Kay and 
Strasberg, 1978).
Much o f the in te rest in the relationship o f d ie tary fib re  to carbohydrate 
metabolism has stemmed from  the suggestion tha t diabetes should be included in 
the long lis t o f Western diseases tha t are associated w ith  a defic iency o f d ie ta ry 
fib re . Recent studies have demonstrated the therapeutic u t i l i ty  o f d ie ta ry fib re  
in lowering blood glucose concentrations and insulin requirements in d iabetic 
patients (Jenkins, e t al., 1977b; Jenkins, e t al., 1978b). This has been evaluated 
by supplementing the d ie t w ith  fib re  or fib re  components (Jenkins, 1980), or by 
m odifying the d ie t to provide high fib re  foods (Anderson, 1980). In general, both 
approaches result in the fo llow ing changes - a s light decrease in fasting glucose 
levels; a decrease in d iabetic glycosuria, a s light to moderate decrease in insulin 
requirements, an apparent increase in insulin sensitiv ity  and improved glucose 
metabolism. The present study has shown tha t normal healthy subjects given 
supplements o f 0.3g/kg body weight o f unprocessed wheat bran fo r six weeks had 
sign ifican t decreases in glycosylated haemoglobin (Table 3:5), although fasting 
glucose levels were not a ffected  (Table 3:5). However, i t  would be bene fic ia l to 
expand this study to include a la rger number o f subjects, and to investigate i f  
wheat bran supplementation a ffec ts  the post-prandial hyperglycaem ia fo llow ing  
an oral glucose tolerance test, as this would help demonstrate the e ffe c t o f 
wheat bran on the ra te  o f in testina l glucose absorption.
The mechanisms by which d ie ta ry  fib re  influences glucose m etabolism  have
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not been fu lly  elucidated. A major e ffe c t o f the gelling or mucilaginous fibres 
appears to involve delayed gastric  emptying resulting in decreased carbohydrate 
absorption. Other physiological responses to d ie tary fib re  which may influence 
rates o f glucose absorption include altered in testina l trans it and changes in 
in testina l m o tility . Serum insulin responses to fibre-supplemented meals or 
fibre-supplemented glucose loads are lower than to fib re -free  meals or fib re -fre e  
glucose loads (Jenkins, e t al., 1976a; Jenkins, e t al., 1977a; Jenkins, e t al., 
1978a). The slower absorption o f glucose evokes a smaller insulin response. 
Plasma glucagon values also are s ign ifican tly  lower on high fib re  diets than on 
low -fib re  diets (Miranda and H orw itz , 1978). Since glucagon acts to oppose the 
action o f insulin, the lower glucagon levels would enhance tissue sens itiv ity  to 
insulin and improve glucose metabolism. Thus the e ffec ts  o f wheat bran 
ingestion on gastro in testina l hormones such as gastric inh ib ito ry  peptide (GIP), 
vasoactive in testina l peptide (VIP), and gut-glucagon requires fu rth e r 
investigation, as diminished release o f these hormones may contribu te  to the 
lower insulin response observed a fte r wheat bran ingestion (Jenkins, e t al., 
1978a). Although the d irec t e ffec ts  o f these gastro in testina l hormones on 
glucose metabolism in hepatic and extrahepatic tissues have not been 
determ ined, th e ir actions probably resemble the e ffe c t o f glucagon more closely 
than tha t o f insulin (Ohneda, e t al., 1977). Thus, decreased secretion o f 
pancreatic glucagon and various gastro in testina l hormones in response to fib re  
ingestion m ight lead to improved glucose metabolism and enhanced tissue 
sensitiv ity  to insulin.
In developed countries where a wide varie ty  o f food is consumed, i t  is 
unlike ly tha t the intake o f d ie ta ry fib re -rich  food has an adverse e ffe c t on 
m ineral and v itam in  b ioava ilab ility . In these countries, diets are generally 
adequate or high in prote in, m inerals, and v itam in content and are moderate in 
fib re  and phytate content. There may however, be exceptions in unique
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population groups, including infants and the elderly, whose food intake patterns 
may d iffe r  s ign ifican tly  from  the population in general. In some developing 
countries, large segments o f the population consume re la tive ly  high levels o f 
d ie tary fib re -rich  foods, and re la tive ly  low, or borderline levels o f a va rie ty  o f 
m acro- and m icro -nu trien ts . Reports o f the e ffe c t o f d ie tary fib re  intake on 
m ineral and trace element balances in man have not been consistent. This is 
due in part to several variables including differences in the nature and level o f 
d ie tary fib re , or the fib re  component, d ifferences in levels o f ingested m icro- 
nutrients, the duration o f the balance study and to the presence o f phytates and 
oxalates (Vahouny, 1982).
The present study has shown tha t wheat bran had no s ign ifican t a ffe c t on 
plasma m ineral concentrations, however, a complete m ineral balance study was 
not carried out in this experiment. Wheat bran is known to in h ib it iron 
absorption, but the nature o f th is inh ib ition  is unknown and has been a ttr ib u te d  in 
d iffe re n t reports to phytate, phosphate and d ie tary fib re . Thus the series o f 
experiments undertaken during this study attem pted to define the mechanism o f 
this e ffe c t. Many workers report tha t phytate s ign ifican tly  inh ib ited iron 
absorption (Widdowson and McCance, 1942; Turnbull, e t al., 1962; Davies and 
N ightingale, 1975), but others report tha t the e ffe c t o f phytate on iron 
absorption was neglig ible (Sharpe, e t al., 1950; Cowen, e t al., 1966; Ranhotra, 
e t al., 1974). Some discrepancies could be a ttribu ted  to d ifferences among 
species in the assim ilation o f iron phytate, but o ften the inh ib ito ry  e ffe c t was 
studied only ind irec tly  by adding purified  phytate to food. The present study 
approached the question o f the phytate e ffe c t on iron absorption by measuring 
the binding o f inorganic iron to phyta te -free  wheat bran in v it ro . However, the 
dephytinised wheat bran produced the same degree o f iron binding as whole 
wheat bran, (Figure 6:11) indicating tha t the inh ib ito ry  e ffe c t o f wheat bran on 
iron binding should not be a ttr ib u te d  to its  phytate content. Therefore, fu rth e r
work is required using hydrolysed wheat bran to determ ine i f  fib re  ra ther than 
the phytate is p rim a rily  responsible fo r the inh ib itory e ffe c t o f wheat bran on 
iron absorption.
D iets rich  in d ie ta ry fib re  are finding an increased application in the 
management and trea tm ent o f gastro in testina l and metabolic diseases. Thus 
w ith  the long-te rm  treatm ents being recommended, i t  is reasonable to ascertain 
whether the intakes o f large amounts o f d ie ta ry fib re  may give rise to some 
undesired s ide-e ffects. The im portance o f v itam in  E as an antioxidant has been 
considered by others (B ie ri and Anderson, 1960), while v itam in C has been found 
necessary fo r the metabolism o f drugs and other xenobiotics (Zannoni, 1977). 
Moreover, ascorbate is found to p ro tec t against the carcinogenic action o f 
d ie ta ry n itr ite  and n itra te  in form ing nitrosamines from  secondary and te rt ia ry  
amines present in food such as dim ethylam ine (Cardesa, et al., 1974), and drugs, 
such as aminopyrine (G reenblatt, 1973; Kamm, e t al., 1973). Therefore, because 
o f the importance o f v itam in  E and v itam in  C in health i t  would be o f in te res t to 
establish the extent to which the uptake o f these vitam ins is influenced by wheat 
bran.
The cause o f tumours o f the colon in man is unknown, but chem ical 
carcinogens from  the environment, or produced w ith in  the body from  foods are 
im portant candidates. Thus the role o f d ie ta ry ingredients as e ither prim ary or 
secondary factors in causing cancer o f the colon is o f considerable curren t 
in te rest (Vahouny, 1982). I t  is d if f ic u lt  to obtain d e fin itive  data on the re la tive  
im portance o f d ie ta ry components in th is regard, but the most convincing 
corre lations o f colon cancer and d ie t composition is w ith  high animal fa t, animal 
prote in and low d ie ta ry  fib re  intakes. An im portan t e ffe c t o f wheat bran 
observed in th is and other studies was a s ign ifican t increase in stool weight, 
which may result in the d ilu tion  o f po ten tia l carcinogenic compounds. Moreover, 
although wheat bran bound carcinogens in v it ro , i t  fa iled to do so in v ivo , thus
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emphasising the need to consider the differences in physiochemical properties o f 
individual fib re  components, the ir influence on physiological responses in v ivo , 
the composition o f the diets and in testina l bacteria l action upon them.
In conclusion, fu tu re  n u tritio n a l studies w ith  d ie tary fib re  should define the 
relationship between the re la tive  roles o f individual d ie tary components in 
various physiological responses to d ie tary fib re . In th is regard, comparisons o f 
experim ental results would be fa c ilita te d  by improved standardisation o f d ie ta ry 
fibres and fib re  components fo r use in n u trition a l studies.
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APPENDIX 1
INSTRUCTIONS FOR RECORDING DIETARY INTAKES
Record a ll item s o f food and drink consumed fo r four consecutive days 
(Sunday - Wednesday).
Record the tim e o f each meal.
Record the quantities o f a ll items o f food and drink consumed. I f  weighing 
is not possible then describe the quantity  as accurately as possible using 
household measures or other applicable methods, 
e.g. 2 large th in  slices o f bread,
1 tablespoon o f peas,
2 p in t o f beer,
1 digestive b iscuit, 
carton o f yoghurt.
Describe the type o f food,
e.g. vegetables - fresh, frozen, tinned,
bread - white, brown, wheatmeal, wholemeal, sliced or uncut, 
sausages - pork or beef.
Describe how the food is cooked, 
e.g. g rilled , fried , roasted, boiled.
Record any recipes used.
I f  using convenience foods, please give the m anufacturer’s name i f  possible.
Record any le ft-overs.
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Starch and D ie tary  Fibre Composition o f the 
"2nd. ta ils "  Bran from  Heyqate's Tring M ill
%w/w
Moisture 11.0
Starch 14.1
Hemicelluloses 27.3
hexoses 3.5
pentoses 20.9
uronic acids 0.85
Cellulose 9.45
hexoses 8.23
pentoses 0.41
uronic acids 0.82
Liqnin 4.8
Total DF 41.6
Acknowledgements are due to the F lour M illing  and Baking Research Association 
fo r supplying this data.
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Composition o f the Experimental D iets by Analysis
Analysis o f diets adjusted to  12% moisture basis
D ie t Moisture
%
Ash
%
Nitrogen
%
Fat
%
NDF
%
Fibre Free (A) 9 .6+  0.9 3 .9 + 0 .3 2 .7 + 0 .2 4.6 + 0.3 0.07 + 0.04
17% White Bread 10 .0+ 0 .7 4.2 + 0.3 2 .7+  0.1 4.6 + 0.4 0.5 + 0.1
34% White Bread 10.2 + 1 .0 4.3 + 0.3 2.7 + 0.1 5.0 + 0.5 0.8 + 0.3
17% Wholemeal Bread ' 9 .9+  0.8 4 .2 + 0 .3 2.7 + 0.2 4 .9 + 0 .5 1.9 +0.2
34% Wholemeal Bread 10.3 + 1.2 4.3 + 0.2 2.8 + 0.1 5.0 + 0.4 3.7 + 0.4
4.8% Bran (F) 9 .8+  0.8 4.1 + 0.2 2 .7 + 0 .1 4.6 + 0.4 2.1 + 0.3
9.6% Bran (G) 9 .9+  0.8 4.4. + 0.3 2 .7+  0.1 4.7 + 0.4 4.2 + 0.5
8.3% Beef Suet (H) 8.8 + 0.7 3 .8 + 0 .2 2.6 + 0.1 11.4 + 1.6 0.15 + 0.14
Stock d ie t 41b (J) 12 .6+ 0 .7 6.0 + 1.0 2.4 + 0.2 4.0 + 0.5 17.6 + 0.25
Lette rs in parentheses represents the diets used in the tex t.
NDF = Neutra l Detergent Fibre.
Values are mean + SD o f 21 batches o f d ie t.
Wheat bran was incorporated in to the test diets at a level to  represent human diets 
containing 17% and 34% wholemeal bread respective ly, and represented a low and 
high fib re  intake in a normal d iet.
Acknowledgements are due to the Flour M illing  and Baking Research Association fo r 
supplying this data.
